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Abbreviations
Ach Acetylcholine
ADP Adenosine diphosphate
AMP Adenosine monophosphate
ANS Autonomic nervous system
ATP Adenosine triphosphate
BRP Bovine retractor penis
[Ca2+]j Intracellular free Ca2+
cAMP Cyclic adenosine 3', 5'-monophosphate
[cAMP]j Intracellular cyclic adenosine 3', 5'-monophosphate
CCK Choleocystokinin
cGMP Cyclic guanosine 3', 5'-monophosphate
[cGMPJi Intracellular cyclic guanosine 3', 5'-monophosphate
DAG Diacylglycerol
DMPP Dimethylphenylpiperazinium
EDRF Endothelium-derived relaxing factor
gpIAS Guinea-pig internal anal sphincter
GI Gastrointestinal
GTN Glyceryl trinitrate
GTP Guanosine triphosphate
HbO Oxyhaemoglobin
IAS Internal anal sphincter
ICS Ileocolonic sphincter
IDN Isosorbide dinitrate
IF Inhibitory factor
IJP Inhibitory junction potential
2
IP3 Inositol 1,4,5-triphosphate
[K+]0 Extracellular potassium concentration
42K+ Radiolabelled potassium
Katp ATP-activated potassium channels
L-Arg L-arginine
L-NAME N®-nitro-L-arginine methyl ester
L-NMMA N®-monomethyl-L-arginine
L-NNA N®-nitro-L-arginine
LOS Lower oesophageal sphincter
MeB Methylene blue
MLCK Myosin light chain kinase
MLCP Myosin light chain phosphatase
NA Noradrenaline
NADPH Reduced nicotinamide adenine dinucleotide phosphate
NANC Non-cholinergic, non-adrenergic
NO Nitric oxide
NOS Nitric oxide synthase
P Probability
PACAP Pituitary adenylate cyclase activating peptide
PDE Phosphodiesterase
PI Inositol phosphate
PKA cAMP-dependent protein kinase
PKG cGMP-dependent protein kinase
PLC Phospholipase C
PS Pyloric sphincter
RAc Rat anococcygeus
RB2 Reactive blue 2
3
SNP Sodium nitroprusside
S.R. Sarcoplasmic reticulum
TEA T etraethy lammonium
TTX Tetrodotoxin
VIP Vasoactive intestinal polypeptide
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SUMMARY
1) The responses of the guinea-pig internal anal sphincter (gpIAS) to non- 
adrenergic, non-cholinergic (NANC) inhibitory nerve stimulation have been 
measured using electrical and mechanical recording, as well as biochemical, 
techniques in an attempt to determine the nature of the neuronally-released, 
relaxation-inducing substances.
2) The first method of study involved the use of intracellular electrical, and 
simultaneous mechanical recording techniques, to measure the effects o f electrical 
field stimulation (EFS; supramaximal voltage, 0.1ms, single stimuli and 5 stimuli 
at 5, 10, 20 and 40Hz) of the gpIAS on NANC-evoked IJPs. These were 
frequency-dependent, could reach up to 60mV in amplitude, accompanied by 
relaxations o f up to 80-90% of muscle tone and abolished by tetrodotoxin (TTX; 
lpM ).
3) The characteristics of the evoked IJPs were analysed using drugs. The 
bee venom apamin (0.3 pM) uncovered two separate TTX-sensitive IJP 
components; a large, fast-to-peak (361±31ms, n=25 cells from 8 preparations 
following a single stimulus) component abolished by the venom, and a second, 
slower-to-peak (530±17ms, n=16 cells from 4 preparations following a single 
stimulus) apamin-insensitive component.
4) The apamin-sensitive component appeared to be mediated by adenosine 
^ triphosphate  (ATP). The evidence supporting this view was;
6
a) Exogenous ATP (0.1-lmM) added either by pressure injection or microsyringe, |into the bath 
hyperpolarized and relaxed the gpIAS and these effects mimicked, in amplitude
and duration, the responses to EFS.
b) The hyperpolarization and relaxations produced by ATP were antagonized by 
apamin (0.3 pM).
c) The P2-purinoceptor antagonist suramin (lOOpM) reduced IJP amplitude; 
reactive blue 2 (lOOpM) hyperpolarized the membrane.
5) The apamin-insensitive component was responsible for up to 80% of the 
relaxation produced by EFS and was mediated by nitric oxide (NO) or a 
NO-related substance, acting via guanylyl cyclase. The evidence supporting this 
view was;
a) The NO synthase inhibitor, N^-nitro-L-arginine methyl ester (L-NAME; 
lOOpM) stereospecifically antagonized the IJPs and relaxations, an effect reversed 
by the NO precusor L-arginine (lOOpM).
b) The NO scavenger, oxyhaemoglobin (HbO; lOpM), reduced, but did not 
abolish, the IJP component and relaxation.
c) Sodium nitroprusside (SNP; 50pM), which releases NO, also hyperpolarized 
and relaxed the gpIAS, effects which were mimicked, to a lesser degree, by the 
membrane-permeable cGMP analogue, 8-bromo-cGMP (lOOpM) and the cGMP 
phosphodiesterase inhibitor, methylene blue (MeB; 30pM).
d) The guanylyl cyclase inhibitor LY83583 (lOpM) abolished the apamin- 
insensitive IJPs.
e) NADPH-diaphorase, which is a marker for nitric oxide synthase (NOS), staining 
of transverse sections (25 pM) of gpIAS revealed NOS-containing neurons within 
the myenteric plexus.
7
6) The P2-purinoceptor antagonist suramin (lOOpM) aslo revealed 
smaller, slower-to-peak (510±9ms, n=17 cells from 7 tissues following a single 
stimulus) suramin-insensitive IJPs which were abolished by L-NAME (each 
lOOpM) and significantly reduced, but not abolished, by HbO (lOpM). This 
indicated that the suramin-insensitive IJPs, like the apamin-insensitive IJPs, were 
also mediated by NO.
7) These results suggest that the neuronally-mediated IJPs and relaxations 
consist of two components; a) a large, fast, apamin- and suramin-sensitive 
component mediated by ATP or a closely related analogue and b) a smaller, 
slower, apamin- and suramin-insensitive component mediated by NO or a closely 
related substance.
8) In addition to measuring responses with electrical and mechanical 
techniques, changes in the intracellular levels of the second messengers cyclic 
adenosine 3', 5'-monophosphate (cAMP) and cyclic guanosine 3', 5'- 
monophosphate (cGMP) were also measured using a radioimmunoassay technique.
9) Field stimulation produced significant increases in both cAMP and 
cGMP. These increases were not attenuated by apamin (0.5 pM) or suramin 
(lOOpM) (which each abolished the purinergic component of the relaxation), but 
were each abolished by a combination of either apamin or suramin, and L-NAME 
(lOOpM). Field stimulation in the presence of L-NAME alone, also abolished 
increases in both cyclic nucleotides. Both cyclic nucleotides therefore appear to be 
involved in neuronally-mediated relaxation.
8
10) Exogenous SNP (lOpM), stimulated significant increases in both cAMP 
and cGMP, mimicking the effects of field stimulation. Exogenous ATP (10|iM) 
produced only a small, but significant, elevation in cAMP. These results imply that 
the neurogenically-mediated increase in cyclic nucleotide levels may be due to the 
action of NO alone as electrically-evoked IJPs, in the absence of apamin or 
suramin, remain unaffected by L-NAME, although increases in both cGMP and 
cAMP are apparently abolished. This implies that ATP may produce relaxation in 
a cyclic nucleotide-independent manner.
9
INTRODUCTION
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SMOOTH MUSCLE RELAXATION
1) PREFACE
Smooth muscle embraces a wide variety of tissue types, capable of 
performing numerous different functions within the body. These range from the 
precision, second by second, control exhibited by tissues such as the iris, in the 
control o f the amount of light entering the eye, to the contractions of the uterus at 
the end o f gestation. However, two features are common to all smooth muscles 
regardless o f their anatomical location, time scale or function, namely, the ability 
to contract and relax. This thesis is concerned with the process o f smooth muscle 
relaxation, specifically within the gastrointestinal (GI) tract.
Smooth muscle relaxation can be induced both physiologically (either by 
nerve stimulation or hormones) and pharmacologically. However, despite nearly a 
century of research, it is a process which is still relatively poorly understood. The 
last 50 years have exemplified the difficulties encountered by researchers who 
have tried to describe the mechanisms by which neuronally-mediated smooth 
muscle relaxation is produced. The success of investigators such as Dale, Loewi 
and Von Euler in establishing the existence of the so-called "classical" transmitters 
has not been repeated by those investigating the mediators of neuronal smooth 
muscle relaxation. As a result, several mediators have been proposed, each greeted 
with differing degrees of acceptance and scepticism by the scientific community. 
These mediators, or putative transmitters, each with substantial experimental 
support, have introduced to the scientific vocabulary the so-called purinergic, 
peptidergic and nitrergic theories of transmission (see Bumstock, 1972; 
Fahrenkrug, 1978 a,b; Moncada et al, 1991). Hence today, the investigation of 
smooth muscle relaxation has revealed a complex and not yet fully understood 
process involving several different substances and mechanisms.
11
The lack of scientific understanding of smooth muscle relaxation has had a 
knock-on effect on dependent disciplines. This is felt nowhere more than in 
clinical medicine where a wide range of pathophysiological disorders such as 
achalasia, intestinal colic, irritable bowel syndrome and spasm of the internal anal 
sphincter, which often derive from an inability of precontracted smooth muscle to 
relax, are poorly understood. The inability to successfully treat, or even allay, these 
conditions stems from a lack of understanding of those factors controlling 
contraction and the mechanisms underlying smooth muscle relaxation.
In discussing smooth muscle relaxation, for the purposes o f this thesis, a 
distinction will be drawn between the processes by which smooth muscle 
relaxation occurs and the activators of these processes. The latter will be discussed 
initially.
2) MECHANISMS OF SMOOTH MUSCLE RELAXATION
At a molecular level, the mechanics of smooth muscle relaxation are 
reasonably well understood. Smooth muscle tone depends on the interaction of the 
intracellular macromolecules actin and myosin. Contraction is triggered when the 
actin and myosin filaments are able to form cross-bridges and slide over one 
another after the myosin light chain becomes phosphorylated by myosin light 
chain kinase (MLCK). This process is driven by the hydrolysis of adenosine 
triphosphate (ATP) and is dependent on Ca2+ and calmodulin (for review see 
Harthstone, 1987; see Fig. 1). Relaxation on the other hand, is thought to occur 
when either the affinity of MLCK for myosin light chain is reduced by the 
phosphorylation of MLCK (Conti & Adelstein, 1980; Adelstein et al, 1982), or 
enhanced dephosphorylation of myosin light chain occurs due to an increased
12
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activity of the myosin light chain phosphatases (Driska et al, 1989; Adelstein et al, 
1982; see Fig. 1).
This thesis is specifically concerned with the mechanisms by which the 
processes regulating smooth muscle relaxation are activated. Such mechanisms 
involve prostaglandins, hormones and, in particular, autonomic nerves. 
Interference with those neuronal processes using drugs has advanced our 
understanding of the contractile process, and has been particularly rewarding in 
clinical terms. On the other hand our incomplete and often fragmentary 
understanding of the neuronal control of relaxation has prevented the activation of 
relaxation to be modified for clinical advantage; the following pages describe the 
major steps taken towards the discovery of the mechanisms controlling smooth 
muscle relaxation, beginning with neuronal control.
I) Neuronal Control of Relaxation in the GI Tract
This is exercised by the release of substances from autonomic sympathetic 
and parasympathetic nerves including the "classical" transmitters acetylcholine and 
noradrenaline, as well as the less well identified substances released from so-called 
non-adrenergic, non-cholinergic (NANC) nerves which appear to be responsible 
for the majority of neuronally-mediated relaxant events within GI smooth muscle. 
It is not clear, however, whether all neuronally-released substances fulfil the 
accepted criteria for the establishment of a neurotransmitter (Eccles, 1964) nor, in 
many cases, is there agreement as to whether transmission relies on one, or more 
than one, of these "neuromediators" (see Bartfai et al, 1988) acting in consort.
Within this thesis, it is convenient to describe the effects o f neuronally- 
released substances, particularly the classical transmitters, in terms of two main 
types; direct and indirect. Direct effects can be considered as those which involve 
the stimulation of post-synaptic receptors situated on smooth muscle cells, whereas
13
indirect effects are those which involve the activation of pre-synaptic receptors on 
nerve terminals, which in turn modify contractile (usually cholinergic in the GI 
tract) events.
a) Cholinergically-Mediated Relaxation
Cholinergically-mediated effects are not commonly employed as 
mechanisms of inducing smooth muscle relaxation. However, one well known 
example o f this phenomenon, but which cannot be classed as neuronal, although it 
concerns the cholinergic transmitter, occurs within the vasculature where 
acetylcholine (Ach) effects relaxation by stimulating endothelial cells to produce 
and release endothelium-derived relaxing factor (EDRF; Furchgott & Zawadski, 
1980), which may be nitric oxide (NO; Moncada et al, 1988). On the other hand, 
examples o f direct cholinergically-mediated relaxation within the GI tract are rare, 
whether in response to nerve stimulation or exogenous Ach. Evidence, albeit 
contradictory, exists for such a role within the cat lower oesphageal sphincter 
(LOS; Clark & Vane, 1961) and human internal anal sphincter (IAS; Parks et al, 
1969; Burleigh et al, 1979; Paskins et al, 1982; Carpenedo et al, 1983). Both 
sphincters relax, in an atropine-sensitive manner, to exogenous Ach and, in the 
IAS, to other cholinergic agonists. Doubt has been cast, however, on each 
observation. Within the cat LOS contraction, as well as relaxation, to Ach has also 
been observed (Schenck et al, 1961) and within the human IAS part o f the 
response may have been indirect (Burleigh & D'Mello, 1983) because tetrodotoxin 
(TTX) inhibited the response by varying degrees. Although no further evidence 
has so far been uncovered to support the hypothesis, it may imply that Ach, in the 
human IAS, stimulates pre-synaptic muscarinic receptors, located on non- 
adrenergic nerves, to release an inhibitory transmitter(s).
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Most examples of cholinergically-mediated inhibition in the GI tract are 
attributable to the stimulation of muscarinic receptors located pre-synaptically and 
pre-junctionally. These inhibitory receptors are situated on the enteric (Sawynok & 
Jhamandas, 1977; Kilbinger & Wessler, 1980 Morita et al, 1982; Kilbinger & 
Nafziger, 1985) and parasympathetic nerves (Gilbert et al, 1984). When activated, 
they block Ach release from cholinergic motor neurons supplying the gut, so 
causing the latter to relax. The mechanism underlying this inhibition by muscarinic 
receptors is probably an increase in membrane K+ conductance, leading to 
hyperpolarization and inhibition of Ach release (Hartzell et al, 1977; Dodd & 
Horn, 1983).
b) Adrenergicallv-Mediated Relaxation
In the main, with only a few exceptions, such as rabbit, cat and guinea-pig 
ilea (Gonella & Lecchini, 1971; Silva et al, 1971; Furness & Costa, 1974) and 
certain sphincters (Howard & Garret, 1973; see Papasova, 1989), sympathetic 
nerves in the GI tract do not directly innervate smooth muscle. Most post­
ganglionic sympathetic fibres, all of which are noradrenergic (Costa & Furness, 
1982), form perivascular nerve trunks running parallel to the blood vessels 
(Norberg, 1964). These nerves branch within the intestinal wall and terminate 
around the nerve cell bodies of the intramural plexuses supplying the GI tract. 
Stimulation of noradrenergic nerves usually causes indirect relaxation of GI 
smooth muscle by inhibiting acetylcholine release, for example in guinea-pig 
colon (Beani et al, 1969), ileum (Wikberg, 1977), rabbit jejenum (Vizi, 1970; 
Wikberg, 1977), and canine ileum and duodenum (Sakai et al, 1984), thereby 
inducing relaxation (see also Christ & Nishi, 1971; Knoll & Vizi, 1971; Gabella, 
1979). This inhibition may occur as a result of a hyperpolarization of the enteric 
cholinergic neurons, thus reducing Ach release and tone (Bauer, 1981; Morita &
15
North, 1981; Costa & Furness, 1982). However, this hypothesis has been 
questioned by findings which demonstrate that a) cholinergic block by atropine 
had no effect on responses to sympathetic nerve stimulation (Gershon, 1967), and
b) sympathetic nerve stimulation did not affect electrical activity recorded from 
ganglia in the myenteric plexus (Takayanagi et al, 1977).
In the absence of direct innervation, smooth muscle cells may be stimulated 
by catecholamines that are either present in the circulation, or released following 
high frequency nerve stimulation by overflow from sympathetic nerve terminals 
within the enteric plexuses (Gillespie, 1962; Gillespie, 1982).
The inhibitory effects of neuronally-released or circulating/exogenous 
catecholamines are mediated by receptors originally classified as a -  and p- 
adrenoceptors (Ahlquist, 1948). Both adrenoceptor subtypes were subsequently 
further subdivided into a r  and a 2-, and pr  and p2-adrenoceptors. Now, with the 
aid of molecular cloning techniques, further subtypes of receptor have also been 
proposed (see Ruffolo et al, 1991; Van Zwieten, 1991). However, the exact 
function and location of most of these receptors has yet to be determined, so only 
the effects of a r  and a 2-, and pr  and p2-adrenoceptor stimulation will be 
discussed here.
i) a-Adrenoceptor-Mediated Relaxation
The inhibitory a-action is usually only seen in spontaneously active smooth 
muscles such as the guinea-pig taenia caeci (BUlbring, 1979), proximal or terminal 
ileum (Fagbemi & Salako, 1980, 1982), rabbit jejenum and colon (Andersson, 
1972; Wikberg, 1977) and human colon (Huizingza et al, 1986), but can also be 
witnessed in less excitable tissues such as the guinea-pig and rabbit stomach 
(Guimares, 1969; Bailey, 1971; Haffner, 1971).
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Both a r  and a 2-adrenoceptor sub-types are capable of mediating relaxation 
of the GI tract and can be located both pre- (Bauer, 1981; Wikberg, 1977, 1979) 
and post- (Bulbring, 1979; Huizinga et al, 1986; Bauer, 1982 a) synaptically. 
Inhibitory effects, produced by stimulation of these receptors, can be seen in 
several GI smooth muscles;
Taenia Caeci
The effects of a-adrenoceptor stimulation have been studied most 
intensively in this longitudinal muscle. Activation of taenia caeci a!-adrenoceptors 
causes a hyperpolarization of the membrane by increasing K+ (and possibly Cl") 
conductance which leads to a cessation of spontaneous activity resulting in 
relaxation (Jenkinson & Morton, 1967 a, b; Bulbring & Tomita, 1969).
The mechanism(s) underlying the increase in K+ conductance is still a 
matter o f debate, but results suggest that a  r-adrenoceptors, by activating 
phospholipase C (PLC) via a pertussis toxin-insensitive Gs protein, stimulates 
diacylglycerol (DAG) as well as inositol 1,4,5 trisphosphate (IP3) formation which 
increases intracellular Ca2+ levels ([Ca2+]j; Nelemans & Den Hertog, 1987 a,b; 
Minneman, 1988; for PLC/IP3 pathway see Relaxant Transduction 
Mechanisms). This process is also dependent on a Ca2+ influx, probably to 
replenish the intracellular Ca2+ stores (Bulbring & Tomita, 1977; Den Hertog, 
1981, 1982; Timmermans & Van Zwieten, 1981; Tomita et al, 1985).
It is clear that the intracellular mechanisms mediating a r-adrenoceptor- 
induced relaxation of GI smooth muscle, are different from those mediating a r  
adrenoceptor-induced contraction, for example, in vascular smooth muscle 
(Minneman, 1988), although both adrenoceptor effects apparently involve the 
hydrolysis o f inositol phosphates and mobilization of intracellular Ca2+.
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Small and Large Intestine
The longitudinal muscle of the small and large intestine has similar 
properties to taenia caeci (Bolton, 1971, 1972; Suzuki & Kuriyama, 1975) in that it 
produces spike-type action potentials and the spontaneous activity occurs in bursts. 
Within the guinea-pig, the main action of catecholamines on the small and large 
intestine is likely to be an a 2-adrenoceptor-mediated suppression of Ach release 
from cholinergic nerve fibres (Paton & Vizi, 1969; Kosterlitz et al, 1970; Wikberg, 
1977; Broadley & Grassby, 1985). However, direct inhibitory actions on the 
smooth muscle have been observed (Bowman & Hall, 1970, Broadley & Grassby, 
1985). In the proximal and terminal ileum these are mediated by aj-receptors 
(Fagbemi & Salako, 1980, 1982), although a 2-receptors have also been implicated 
in the proximal ileum (Bauer, 1982 a).
The mechanisms underlying these responses have not been investigated as 
intensively as in the taenia caeci but it appears that the a 2-adrenoceptors in the 
guinea-pig proximal ileum produce a hyperpolarization (Bauer, 1982 a). Thus, the 
inhibitory action of catecholamines is apparently similar to that observed in the 
taenia but, in the small intestine is mediated by a 2- rather than a x-adrenoceptors. 
In the rabbit jejenum and colon, as in the guinea-pig taenia, a x-adrenoceptor 
stimulation also produces a hyperpolarization attributable to a Ca2+-dependent 
increase in K+ conductance (Andersson, 1972).
Stomach
In the guinea-pig and rabbit stomach, stimulation of a-adrenoceptors 
produces both excitatory and inhibitory effects depending on the area o f the 
stomach, the degree of existing mechanical activity and the concentration of 
agonist used (Guimares, 1969; Bailey, 1971; Haffher, 1971). However, it seems 
that in most species relaxatipn is mediated mainly by a !-adrenoceptors
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(Magaribuchi et al, 1972; Sahyoun et al, 1982) probably via a K+-dependent 
hyperpolarization (Haffner, 1972; Magaribuchi et al, 1972; Haffner et al, 1973; El- 
Sharkaway & Szurszewski, 1978).
The mechanisms underlying the post-junctional effects o f a 2-adrenoceptors 
are not known, although they would appear to be fundamentally different from 
those in the vasculature which cause a constriction (Medgett & Rajanayagam,
1984).
The mechanism(s) responsible for the pre-synaptic a 2-adrenoceptor- 
mediated inhibition of neurotransmitter release is equally unclear but may involve 
decreasing neuronal Ca2+ influx, as release of transmitter is dependent on this ion. 
This phenomenon has been observed in rat cortical synaptosomes (Adamson et al,
1987).
ii) p-Adrenoceptor-Mediated Relaxation
As with the a-adrenoceptors, p-adrenoceptor -mediated events within the 
GI tract have been investigated mainly on spontaneously active tissues such as 
guinea-pig taenia caeci (Bulbring & Tomita, 1969) and rabbit small intestine (Van 
Rossum & Mujic, 1965; Lands et al, 1967 a,b; Bowman & Hall, 1970) although 
less spontaneously active tissues like the guinea-pig stomach (Bailey, 1971) have 
also been utilised.
Both pr  and p2-adrenoceptor sub-types are capable of mediating relaxation 
of the GI tract (Bulbring et al, 1981; Huizinga et al, 1986). The inhibitory effects 
produced by stimulating these receptors are also best illustrated by describing p- 
mediated responses in different GI smooth muscles.
Taenia Caeci
Isoprenaline-induced activation of p-adrenoceptors in this tissue causes 
relaxation, by suppressing the spike activity, and a small membrane
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hyperpolarization (Bulbring & Tomita, 1969). These responses are mediated by 
both p r  and P2- receptors. The p2-mediated response is proposed to activate 
events at the membrane, resulting in spike inhibition and hyperpolarization (Bauer, 
1982 b) whereas P!-adrenoceptor activation influences intracellular events, 
probably raising intracellular cyclic adenosine 3', 5'-monophosphate (cAMP; 
Kimura et al, 1983; Stiles et al, 1984). The hyperpolarization is probably due to an 
increase in K+ conductance (Tomita et al, 1985) but may not be necessary for 
relaxation to take place (Bowman & Hall, 1970; Bulbring & Den Hertog, 1980; 
Bulbring et al, 1981; Chow & Huizinga, 1987). The mechanisms mediating the 
relaxation will be discussed at the end of this section.
Small and Large Intestine
The activity of the longitudinal muscle of the guinea-pig ileum, as well as 
rabbit duodenum and jejenum, was also suppressed by activation o f p r  
adrenoceptors on the smooth muscle cells (Lands et al, 1967 a, b; Kosterlitz et al, 
1970; Grassby & Broadley, 1984; Broadley & Grassley, 1985). However, within 
the rabbit large intestine and rat and cat colon p-adrenoceptors are predominantly 
of the p2-subtype (Sim & Lim, 1983; Ek, 1985).
The fundamental mechanisms causing relaxation through p-receptor 
activation are probably the same as in the taenia caeci; a small K+-dependent 
hyperpolarization accompanied by a second messenger-mediated relaxation 
(Bulbring & Tomita, 1987).
Stomach
Although this is the least well investigated of the tissues in terms of p- 
adrenegically-mediated events it is known that adrenergic inhibitory reponses 
within the stomach are mediated solely by p-adrenoceptors (Guimares, 1969;
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Bailey, 1971; Haffner, 1971) and that both (3r  and P2-adrenoceptors are probably 
involved, at least in the rat gastric fundus (Lefebvre et al, 1985).
The intracellular events leading to the actual instigation of relaxation by pr  
and p2-adrenoceptors are believed to involve stimulation of adenylyl cyclase, 
producing an increase in cyclic adenosine 3', 5'-monophosphate (cAMP; Stiles et 
al, 1984) which, presumably, leads to an alteration in the cells' Ca2+ handling 
capacity (see Relaxant Transduction Mechanisms). However, p-adrenoceptor- 
stimulated cAMP increases are not always correlated with relaxation; in the 
guinea-pig taenia caeci for example, isoprenaline-induced relaxation preceded an 
increase in tissue cAMP (Honda et al, 1977). Furthermore, prostaglandins 
produced a similar rise in cAMP levels to that of isoprenaline in the rat uterus, but 
caused a contraction (Harbon et al, 1976). These findings may refute a relationship 
between the relaxation and increased cAMP levels but, could also indicate a 
complex compartmentalization of the cAMP within the cells, such that the 
production of relaxation or contraction depends on which area of the cell that the 
increase occurs.
Although catecholamine- and cholinergically-induced relaxation both have 
important roles to play within the GI tract they do not constitute the full range of 
neuronal inhibitory mediators believed to control GI relaxation. Overwhelming 
evidence now suggests that one or more substances released from NANC nerves 
are responsible for controlling a wide range of inhibitory processes throughout the 
length o f the alimentary canal.
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c) Non-Adrenergic. Non-Cholinergic (NANC) Mediated-Relaxation
As early as 1898 Langley demonstrated that vagally-induced relaxation of 
the rabbit stomach was potentiated by the muscarinic antagonist atropine (Langley, 
1898). Atropine-resistant inhibitory responses were also demonstrated in several 
other tissues such as the dog small intestine (Bayliss & Starling, 1899), the rabbit 
cardiac sphincter (May, 1904), the cat stomach (Veach, 1925; McSwiney & 
Wadge, 1928; McSwiney & Robson, 1929), the rabbit and dog stomach 
(McSwiney & Robson, 1929) and the cat oesophagus (Veach, 1925). Various 
hypotheses were proposed to explain these "heretical" findings within the existing 
framework of the sympathetic and parasympathetic nervous system; perhaps the 
Ach receptors were inaccessible to atropine at the neuroeffector junction (Dale & 
Gaddum, 1930) because of very tight junctions proposed to separate nerve and 
muscle.This theory has been largely discounted by electron-microscopy which 
showed large gaps between the nerve endings and smooth muscle (Dumsday, 
1971). Atropine-resistant responses were proposed to have been due to stimulation 
of sympathetic nerves (known to be inhibitory) within the vagus (Harrison & 
McSwiney, 1936), or to a "peripheral mechanism" (McSwiney & Wadge, 1928) 
where the degree of muscle tone determined the response to nerve stimulation, i.e. 
in high tone, either sympathetic or parasympathetic stimulation would cause 
relaxation but, in low tone, contraction. Notwithstanding the attempts made to 
accommodate these observations within existing theories, Henderson and Roepke 
(1934) perceptively proposed that these autonomic nerves released a transmitter 
other than acetylcholine.
In the absence of specific antagonists however, it was impossible to 
determine the role of the inhibitory sympathetic nerves in these atropine-resistant 
effects. This confusion persisted until the advent of the adrenergic neurone 
blocking drugs such as guanethidine and bretylium, and the adrenoceptor
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antagonist phentolamine, in the late 1950's. The ability to block the actions o f both 
classical neurotransmitters using these drugs and atropine allowed, for the first 
time, the unequivocal identification of a new class of inhibitory, non-adrenergic, 
non-cholinergic (NANC) neurogenic response. These were characterised initially 
by two groups of workers, almost simultaneously, but using different techniques, 
in the early 1960's. First, using extracellular (sucrose-gap) recording, large 
tetrodotoxin-sensitive, neuronally-induced hyperpolarizations were elicited in the 
presence of atropine and bretylium (Bumstock et al 1963 a, b; 1964). Secondly, 
vagally-induced, atropine-resistant relaxations in the cat stomach which were 
unaffected by guanethidine, were seen (Martinson & Muren, 1963; Martinson, 
1965). NANC nerves have now been found at almost every level o f the GI tract in 
most mammalian species investigated. Principally, although not invariably (e.g. 
Shuttleworth et al, 1993; Zagorodnyuk et al, 1993), concerned with relaxation in 
the GI tract, they allow the passage of material along the tract; they control the 
"receptive relaxation" of the stomach, descending inhibition, which precedes 
contraction, in intestinal peristalsis (Bumstock & Costa, 1973) and the reflex 
opening of the sphincters. Although NANC nerves mediating these responses are 
intrinsic to the GI tract (Bumstock et al, 1966), they are linked to nerves by fibres 
from a) the vagus nerve (in the small intestine) b) the vagus and pelvic nerves (in 
the colon), the relative contribution of each being dependent on species, and c) the 
pelvic nerves (in the rectum and internal anal sphincter; see Gonella et al, 1987).
The electrical basis of the NANC responses was found to be membrane 
hyperpolarizations, or inhibitory junction potentials (IJPs), which preceded the 
relaxations (Bennett et al, 1966 b). Evoked NANC IJPs, recorded from 
anatomically distinct areas of the alimentary canal, such as the guinea-pig stomach 
(Kuriyama et al, 1970; Beani et al, 1971; Beck & Osa, 1971), ileum (Kuriyama et 
al, 1967), jejenum (Hidaka & Kuriyama, 1969), taenia ceaci (Bennett et al, 1966 a,
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b) and colon (Furness, 1969 a, b) are fundamentally different from those evoked 
by adrenergic nerve stimulation (Gillespie, 1962). Perivascular sympathetic nerve 
stimulation of guinea-pig taenia caeci, for example, using trains o f stimuli greater 
than 10Hz, produced relatively small (maximum amplitude 16mV), bretylium- 
sensitive hyperpolarizations and relaxations (Bennett et al, 1966 a). In contrast, 
stimulation of intramural NANC nerves with only a single pulse, in the same 
tissue, evoked relaxations and accompanying IJPs which could reach 25mV in 
amplitude (Bennett et al, 1966 b) and up to 35mV in response to trains o f stimuli 
around 8Hz which were unaffected by atropine or bretylium (Bennett et al, 1966
b). All NANC electrical responses are not similar however; the large IJPs found in 
the GI tract, which accompany relaxation, differ markedly from the much smaller 
ones found in the gastrointestinally-related accessory muscles of reproduction, 
such as the bovine retractor penis muscle (BRP; Klinge & Sjostrand, 1974; Byrne 
& Muir, 1984, 1985), rat anococcygeus (RAc; Gillespie, 1972, Creed et al, 1975; 
Gibson & Yu, 1983; Li & Rand,-1989) and rabbit rectococcygeus (King & Muir, 
1981). These IJPs may, however, play a less important role in relaxation (Creed et 
al, 1975; Byrne & Muir, 1984, 1985; Byrne et al, 1984). This may indicate either 
fundamental tissue-specific differences between the inhibitory transmitter(s) or, in 
the receptors mediating the responses (see Relaxant Transduction Mechanisms).
The identification of NANC nerves had a profound impact on scientific 
insight and research into autonomic systems. The success which had accompanied 
the establishment of Ach (Dale, 1937) and noradrenaline (NA; Von Euler, 1946) as 
classic (often excitatory) transmitters provided a template which encouraged the 
scientific community to investigate the mediators of those NANC nerve-mediated 
effects. There was no shortage of candidates, including prostaglandins, amino 
acids and peptides (see Hokfelt et al, 1980 a, b; Bumstock, 1981; Fumess et al, 
1989). However, for a substance to be considered an inhibitory transmitter it
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should satisfy each of the following five criteria (Eccles, 1964); it must 1) be 
synthesised and stored in nerve terminals 2) be released by a Ca2+-dependent 
process during nerve stimulation; 3) have a transmitter inactivation process 
present; 4) have its effects antagonized or potentiated by drugs which affect the 
responses to nerve stimulation in the same way; and 5) mimic the responses to 
nerve stimulation. Within the framework of these criteria, the only likely 
candidates to emerge from the many postulated inhibitory transmitters were, first, 
the purines, in particular ATP (see Bumstock, 1979), secondly, the peptides, such 
as vasoactive intestinal polypeptide (VIP; see Fahrenkrug, 1979) and finally, NO 
or a closely-related substance (see Rand, 1992). This is not to imply that each 
candidate satisfies all of the aforementioned criteria. The evidence for 
representatives of these three classes as inhibitory transmitters within the GI tract 
will be discussed.
i) Adenosine 5"-Trisphosphate (ATP)
Although smooth muscle sensitivity to adenine nucleotides was recognised 
in 1929 (Drury & Szent-Gyorgi, 1929) it took a further twenty years before ATP 
was proposed as a transmitter (Holton & Holton, 1953, 1954; Holton, 1958). The 
case for ATP being a NANC neurotransmitter has since strengthened (for reviews 
see Bumstock 1972, 1975, 1979, 1981, 1986 a, 1990 a) and there is now evidence 
that ATP largely satisfies the criteria for the establishment o f a neurotransmitter 
(Eccles, 1964) in that;
1) it is synthesised (Su et al, 1971) and stored in nerves (see for example 
Bumstock et al, 1978);
2) it is released by nerve stimulation (Su et al, 1971; Bumstock et al, 1978 
a, b). However, because of its ubiquitous nature as a cell metabolite, concern was 
expressed that the electrically-stimulated ATP release may have been from the
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muscle. Against this was the finding that while a 2-6 fold increase in ATP release 
from the guinea-pig taenia caeci and urinary bladder occurred after NANC nerve 
stimulation, no significant rise in ATP could be detected after direct muscle 
stimulation (Bumstock et al, 1978);
3) efficient inactivation processes exist for ATP in the form of 
ecto-ATPases and a 5'-nucleotidase. It is eventually deaminated to inosine or taken 
back up into smooth muscle or neurons (see Bumstock, 1972; 1979);
4) with regard to inhibitory effects, several putative purinoceptor 
antagonists such as reactive blue 2 (RB2; Crema et al, 1983; Manzini et al, 1986; 
Soediono & Bumstock, 1994) and suramin (Den Hertog et al, 1989; Ohno et al, 
1993; Brizzolara et al, 1993) reduced relaxations to ATP and/or evoked NANC- 
mediated IJPs. Indirect evidence also came from the use o f apamin, a bee venom 
which blocks small conductance Ca2+-activated K+ channels (Banks et al, 1979; 
Blatz & Magleby, 1986; Capoid & Ogden, 1989). Although not a purinoceptor 
antagonist per se apamin blocked the inhibitory effects o f both exogenous ATP 
and NANC nerve stimulation in various GI smooth muscles such as the guinea-pig 
taenia caeci (Maas & Den Hertog, 1979; Muller & Baer, 1980; Shuba & 
Vladimirova, 1980; Costa et al, 1986) and gpIAS (Lim & Muir, 1986);
5) the responses to ATP and inhibitory NANC nerve stimulation are very 
similar. These similarities, and their common resistance to adrenergic and 
cholinergic block, are perhaps the strongest indicators of an endogenous inhibitory 
transmitter role for ATP or 4 related nucleotide. Inhibitory NANC nerve 
stimulation and ATP both produce relaxations within the mammalian GI tract (see, 
inter alia, guinea-pig taenia caeci- Jager, 1974; rabbit intestine- McKenzie et al, 
1977; guinea-pig stomach- Huizinga & Den Hertog, 1980; guinea-pig internal anal 
sphincter (gpIAS); Lim & Muir, 1986) which are often followed by rebound 
excitations (Tomita & Watanabe, 1973; MacKenzie & Bumstock, 1980). The
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concentration-dependent, rapid and relatively brief membrane hyperpolarizations 
induced by exogenous ATP are also similar to IJPs evoked by NANC nerve 
stimulation in several tissues such as the guinea-pig taenia caeci (Axelsson & 
Holmberg, 1969; Tomita & Watanabe, 1973; Jager, 1974; Jager & Schevers, 
1980), gpIAS (Lim & Muir, 1986) and rabbit caecum (Small, 1974). However, 
doubts regarding ATP's mimicry of inhibitory NANC stimulation persist; first, 
very high (0.1-ImM) concentrations of ATP were used to mimic NANC responses 
(e.g. Tomita & Watanabe, 1973; Maas & Den Hertog, 1979; Lim & Muir, 1986; 
Zagorodnyuk & Shuba, 1986). This was explained, for the guinea-pig urinary 
bladder at least, as being due to the rapid breakdown of ATP to adenosine. In 
support o f this view, a stable ATP analogue, py-methylene ATP, which was not 
degraded to adenosine, was found to be more potent than ATP in producing 
contraction (Brown et al, 1979). Secondly, in many tissues, the responses to ATP 
did not mimic NANC nerve stimulation, for example, in the pig stomach (Ohga & 
Taneika, 1977), oesophageal smooth muscle (Daniel et al, 1983), dog stomach 
(Sakai & Daniel, 1984) and RAc (Gillespie, 1972) but in these cases another 
NANC transmitter, possibly related to ATP, could have been responsible for the 
inhibitory responses. Finally, in certain smooth muscles, such as the guinea-pig 
fundus, (Baer & Frew, 1979), ileum (Weston, 1973 a), taenia caeci (Ambache et 
al, 1977), pig stomach (Ohga & Taneika, 1977) and rabbit duodenum (Weston, 
1973 b) responses to repeated application of ATP desensitized, whereas those to 
NANC nerve stimulation did not. Although this has been contradicted (Bumstock 
et al, 1970; Kasakov & Bumstock, 1983) it remains a significant barrier to 
acceptance of ATP as an inhibitory transmitter.
The investigation of a proposed transmitter role for ATP led, not 
surprisingly, to studies on the receptors involved. Based on rank order of potency 
studies, purinergic receptors were initially divided into two main categories; P r
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purinoceptors, which were more sensitive to adenosine and adenosine 
5'-monophosphate (AMP) than to ATP, and P2-purinoceptors, which were more 
sensitive to ATP and adenosine 5'-diphosphate (ADP) than adenosine (Bumstock, 
1978). Purinoceptors have since been further subdivided; the P r division into A r  
and A2-purinoceptors (Van Calker et al, 1979) and the P2-division into P2x- and 
P2y-purinoceptors (see Bumstock & Kennedy, 1985; Kennedy, 1990). The 
subdivision of P2-purinoceptors • was also based on studies of rank orders of 
potency of structural analogues of ATP (see Bumstock & Kennedy, 1985). 
However, differences between P2x- and P2y-purinoceptors seem to exist at a more 
basic level than relative sensitivities to nucleotide analogues, i.e. P2x-receptors 
mediate contraction in tissues such as the rat vas deferens (Taylor et al, 1983; 
Bumstock et al, 1985) and guinea-pig urinary bladder (Brown et al, 1979; Dahlen 
& Hedquist, 1980), whereas P2y-purinoceptors mediate relaxation in the guinea-pig 
taenia caeci (Satchell & Maguire, 1975; Bumstock et al, 1983) and gpIAS (Lim,
1985). Furthermore, P2y-purinoceptors constitute G protein-linked receptors 
(Fredholm et al, 1994) whereas P2x -purinoceptors represent an intrinsic ion 
channel permeable to Na+, K+, and Ca2+ (Bean, 1992).
Following the discovery, of receptors activated by ATP and uridine 
triphosphate, but not by P2x- or P2y-purinoceptor agonists (Brown et al, 1991; 
Dubyak et al, 1988; Okajima et al, 1989; Stutchfield & Cockroft, 1990), it was 
postulated that further subtypes of P2x- or P2y-purinoceptors may exist. This would 
explain why proposed P2y-receptors could apparently couple to two separate 
second messenger systems, either inhibition of adenylyl cyclase (Boyer et al, 1993, 
1994; Lin & Chuang, 1993; Okajima et al, 1987; Pianet et al, 1989) or stimulation 
of the polyphosphoinositide system (see inter alia Pirotton et al, 1987; Berrie et al, 
1989; Boyer et al, 1989; Cooper et al, 1989; Van der Merwe, 1989; Harden et al, 
1990; Flitz et al, 1994; for second messenger systems see Relaxant Transduction
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M echanisms), and has been supported by studies using novel selective agonists 
for P2x- and P2y-purinoceptors (Fischer et al, 1993; Bumstock et al, 1994).
ii) Vasoactive Intestinal Polypeptide (VIP)
More than twenty peptides have now been identified in mammalian brain, 
spinal cord and peripheral neurons, principally using immunohistochemical or 
radioimmunoassay techniques (see Hokfelt et al, 1980 a). O f these, only VIP has 
emerged as a likely inhibitory transmitter within smooth muscle, as it more 
adequately fulfills, than any other peptide, the criteria required to establish the 
existence of a substance as a neurotransmitter (Eccles, 1964), thus;
1) it is synthesised and stored in nerves throughout the GI tract (Alumets et 
al, 1979; Hokfelt et al, 1980 a,b; Fahrenkrug et al, 1985; Biancani et al, 1988; 
Wattchow et al, 1988; Lynn et al, 1994; Bandyopadhyay et al, 1994).
2) it is released from NANC-innervated tissues such as the taenia caeci 
(Fahrenkrug et al, 1978 a), LOS (Goyal & Cobb, 1981) and small intestine 
(Fahrenkrug et al, 1978 b; Bloom & Edwards, 1980).
3) it is inactivated by relatively slowly (4-15 minutes) acting peptidases 
(Fahrenkrug, 1979). However, no specific process comparable to that of the 
classical transmitters exists for VIP (Hokfelt et al, 1980 a) which means that the 
action of exogenous VIP is much more prolonged than that of inhibitory nerve 
stimulation in certain tissues such as the guinea-pig taenia caeci (Cocks & 
Bumstock, 1979) and gpIAS (Lim & Muir, 1986).
4) its effects are inhibited by several putative antagonists; a-chymotrypsin, 
VIP antiserum and the C-terminal VIP fragment, VIP (10-28). a-Chymotrypsin, 
which degrades certain peptides, abolishes responses to exogenous VIP in the 
guinea-pig taenia caeci (MacKenzie & Bumstock, 1980). VIP antiserum reduces 
the relaxations of several tissues in response to exogenous VIP and electrical or
29
chemical stimulation of NANC nerves (Goyal et al, 1980; Ito & Takeda, 1982; 
Biancani et al, 1985 a, b). VIP (10-28) antagonized VIP-induced 
hyperpolarizations in the guinea-pig ileum (Grider & Rivier, 1990; Crist et al,
1992). However, strong doubts exist regarding the specificity of these 
aforementioned VIP antagonists. a-Chymotrypsin reduced responses to exogenous 
VIP but had no effect on NANC nerve-mediated reponses in the taenia caeci 
(MacKenzie & Bumstock, 1980). The inhibitory effect o f VIP antiserum on 
NANC nerve stimulation in cat (Ito & Takeda, 1982; Biancani et al, 1985 a) and 
opossum (Goyal et al, 1980) oesophageal tissues was not shown in human 
oesophageal and gastric tissues (De Carle & Pye, 1982), while VIP (10-28) shows 
low affinity for VIP receptors and may act as a partial agonist in some systems 
(Robberecht et al, 1990). A final point concerns the ability o f apamin to block 
NANC neuronally-mediated events, but not those of exogenous VIP, in certain 
tissues such as the guinea-pig taenia caeci (MacKenzie & Bumstock, 1980), which 
suggests that VIP is not the inhibitory transmitter in these cases.
5) VIP, among the peptides, is uniquely able to relax and hyperpolarize 
virtually all areas of the GI tract such as the rat colon (Grider & Rivier, 1990), rat, 
guinea-pig and cat gastric fundus (Grider et al, 1985; D'Amato et al, 1988, 1992; 
De Beurme & Lefebvre, 1988; Grider & Rivier, 1990; Li & Rand, 1990) and 
guinea-pig taenia caeci, circular smooth muscle of the stomach and ileum (Kamata 
et al, 1988; Grider et al, 1983; Crist et al, 1992) as well as the sphincters (LOS- 
Biancani et al, 1984; 1989; Goyal et al, 1980; sphincter o f Oddi-Wiley et al, 1988; 
IAS-Burleigh, 1983; Biancani et al, 1985; Nurko & Rattan, 1988; Nurko et al, 
1989; Lim & Muir, 1986). However, probably due to the absence of a rapid 
inactivation system, the time course of the VIP-mediated events does not correlate 
well with the much faster (in both onset and recovery) NANC nerve-mediated 
responses in most tissues (Cocks & Bumstock, 1979; Lim & Muir, 1986).
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Notwithstanding the doubts regarding its proposed transmitter role, two VIP 
receptors have been proposed (VIPj and VIP2; Robberecht et al, 1990). This 
classification was based on the binding of VIP, peptide histidine isoleucine (PHI), 
which is processed from a common precursor peptide (Itoh et al, 1983), and 
helodermin, a lizard peptide belonging to the VIP-PHI-secretin-GRF family 
(Robberecht et al, 1984), to a human lymphoblast cell line (SUP T l; Robberecht et 
al, 1988; Robberecht et al, 1990). Further classification has been restricted by the 
lack of selective synthetic ligands (Robberecht et al, 1990). However, all VIPergic 
inhibition is induced via stimulation of adenylyl cyclase leading to increased 
intracellular cAMP levels (Schwartz et al, 1974; Simon & Kather, 1978; Frandsen 
et al, 1978; Torphy et al, 1986; Ito et al, 1990; for cAMP actions see Relaxant 
Transduction Mechanisms).
iii) Nitric Oxide (NO)
EDRF is released from vascular endothelial cells in response to a variety of 
stimuli such as Ach, ATP and shear stress (Furchgott & Zawadzki, 1980; see 
Kerwin & Heller, 1994). EDRF has many pharmacological features in common 
with the gas nitric oxide (NO); each relaxes both vascular and non-vascular 
tissues, raises cyclic guanosine 3 ',5 '-monophosphate (cGMP) levels, and is 
antagonized by methylene blue (MeB), oxyhaemoglobin (HbO) and superoxide 
anions (Martin et al, 1985 a,b; Griffith et al, 1984; Forstermann et al, 1986; 
Grylewski et al, 1986; Rubanyi & Vanhoutte, 1986). That EDRF was indeed NO 
was demonstrated by Palmer et al (1987) when NO was measured as the 
chemiluminescent product of EDRF's reaction with ozone. The similarities 
between the actions of EDRF and NO have now been demonstrated in both 
vascular and non-vascular tissues (Hutchinson et al, 1987; Gillespie & Sheng, 
1988; Cocks & Angus, 1990; Tare et al, 1990; Mathie et al, 1991).
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Outwith the vasculature, following the identification of the "inhibitory 
factor" (IF), released by the BRP and the RAc (Ambache et al, 1975; Gillespie & 
Martin, 1980), as NO or a closely related substance (Furchgott, 1988; Martin et al,
1988), it was proposed that NO may also be a peripheral inhibitory transmitter as it 
is a very potent and ubiquitous relaxant agent. However, NO is probably released 
as a highly labile gas^nd has a short half-life of around 5s (although values of up 
to 30s have been reported; see Rand, 1992), making it unique in comparison to 
other proven and putative neurotransmitters. Because of this uniqueness it is 
perhaps unlikely that it can satisfy all o f the criteria previously proposed for the 
establishment of a substance as a transmitter (Eccles, 1964). Thus:-
1) in a reaction catalysed by nitric oxide synthase (NOS) NO is synthesised 
from the terminal guanido nitrogen atoms of L-arginine in a stereospecific manner 
(Palmer & Moncada, 1989). Perhaps not surprisingly, bearing in mind its gaseous 
and labile nature, no evidence exists for the pre-packaging o f NO or a NO 
precursor within nerve terminals, suggesting that it is synthesised only on demand 
(see Stark et al, 1991). However, in the absence of stored NO, the presence of 
NOS within neurons is often accepted as proof of the presence of NO. 
Constitutive, as opposed to inducible, NOS is found in many tissues both centrally 
(Bredt et al, 1990) and peripherally (Gillespie et al, 1989; Li & Rand, 1989), 
particularly concentrated within cell bodies and nerve fibres of the myenteric 
plexus (Bredt et al, 1990; Llewellyn-Smith et al, 1992; Ward et al, 1992 d; 
O'Kelly etal, 1994);
2) to date, only one group has actually demonstrated its release from 
smooth muscle. TTX-sensitive, calcium-dependent electrical and DMPP nerve 
stimulation of the canine ileocolonic sphincter (ICS) and rat gastric fundus, 
released NO, as demonstrated by bioassay (Bult et al, 1990; Boeckxstaens et al, 
1991 a, b, c; Boeckxstaens et al, 1993).
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3) with regard to an inactivation process, none is actually required since NO 
has a very short half-life in physiological solutions (Griffith et al, 1984; 
Forstermann et al, 1984; Rubanyi et al, 1985; Cocks et al, 1985; Palmer et al, 
1987; Ignarro, 1990), and it is perhaps unnecessary to assume such a conventional 
process exists.
4) its effects can be antagonized a) at source, b) in transit or c) at its 
receptor;
a) Synthesis of NO can be blocked by inhibition of NOS activity. Structural 
analogues of the NO precursor, L-arginine, such as N®-monomethyl-L-arginine 
(L-NMMA), N®-nitro-L-arginine (L-NNA) and N®-nitro-L-arginine methyl ester 
(L-NAME), (Palmer & Moncada, 1989; Hobbs & Gibson, 1990; Fleming et al, 
1991) can each stereoselectively inhibit NOS activity in a reversible manner.
b) By binding to NO, -after its proposed neuronal release into the 
extracellular fluid, HbO is able to antagonize its effects (Martin et al, 1985 a, b; 
Forstermann et al, 1986; Thombury et al, 1991). Superoxide anions, which are 
present in physiological solutions, are also capable of rapidly oxidizing and 
inactivating NO (Grylewski et al, 1986; Rubanyi & Vanhoutte, 1986).
c) Unlike other neuromediators, the receptor for NO, cytosolic guanylyl 
cyclase, is located intracellularly. Inhibition of guanylyl cyclase activity can be 
accomplished with MeB (Gruetter et al, 1981 a, b; Ignarro et al, 1986; Martin et 
al, 1985 a) or LY83583 (Miilsch et al, 1988; Brandt & Conrad, 1991) thereby 
antagonizing the responses to NO.
5) Exogenous NO mimics the inhibitory NANC nerve-mediated responses. 
It hyperpolarizes and relaxes almost all smooth muscles, effects which are resistant 
to cholinergic and adrenergic block. Electrical and mechanical responses to both 
NANC nerve stimulation and exogenous NO are rapid in onset and decline (for 
reviews see Rand, 1992; Sanders et al, 1992; Sanders & Ward, 1992; Stark &
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Szurszewski, 1992). In addition increased cGMP levels follow NANC inhibitory 
nerve stimulation (in the opossum LOS - Torphy et al, 1986; opossum and guinea- 
pig IAS - Baird & Muir, 1990; Chakder & Rattan, 1993 b) and also exogenous NO 
(see Waldman & Murad, 1987; Baird & Muir, 1990; Chakder & Rattan, 1993 b).
iv) Synergistic Transmitter-Mediated Relaxation
Current views on autonomic transmission are no longer restricted to 
consideration of only one mediator. There is now widespread acceptance that 
neuronally-mediated relaxation and contraction, in many smooth muscles, involves 
the release of more than one substance (e.g. Lundberg, 1981; Hokfelt et al, 1980 b; 
Campbell, 1987; Furness et al, 1989). This does not imply that all such substances 
can automatically be considered as transmitters even though this could be the case. 
In the main, a transmitter role has not been proven for many neuronally-released 
substances and for this reason, where two or more transmitters are found within the 
same nerve ending, the terms co-existence, co-localization or co-release, rather 
than co-transmission, are often preferred.
The release of more than one substance during nerve stimulation has led to 
a re-examination of "Dale's Principle", mistakenly ascribed to Sir Henry Dale by 
Eccles in the mid-1950's, which asserts that “at all the axonal branches of a 
neurone, there is liberation of the same transmitter substance or substances” (see 
Eccles, 1976). This principle has been interpreted, some would say incorrectly, to 
mean that one nerve fibre makes and releases only one transmitter. This 
interpretation was widely held for a number of years before Bumstock (1976) 
questioned its validity by suggesting that, since more than one substance appeared 
to be released during nerve stimulation, some nerve fibres synthesised and released 
more than one substance. This dissenting viewpoint has gained support with the 
identification of numerous examples of co-localized substances within neurons.
Both central and peripheral neurons appear to contain, and probably release, 
several different combinations of substances such as two or more peptides 
(Furness et al, 1989); peptides and classical transmitters (Hokfelt et al, 1980 a,b; 
Furness et al, 1989, 1992); purines and classical transmitters (Bumstock, 1985, 
1986 b, 1990 a); or, more recently, peptides or purines with NOS (Fumess et al, 
1992; Costa et al, 1992; Lynn et al, 1994; Soediono & Bumstock, 1994; Ward et 
al, 1994). Notwithstanding, in only in a very few instances has the co-release of 
these substances been demonstrated, for example, Ach and VIP in the cat exocrine 
glands (Lundberg, 1981; Lundberg et al, 1980, 1982 a, b; see also Campbell, 
1987). Indeed, where dual or multiple mediators are proposed to act 
synergistically, co-transmission, and contradiction of "Dale's Principle" have yet 
to be demonstrated unequivocally.
Notwithstanding this controversy, the weight of evidence suggests that in 
many cases more than one substance can be released from autonomic nerves onto 
smooth muscle. Unlike the majority of examples of proposed dual transmission 
which are excitatory/contractile, such as NA and ATP release from 
sympathetically-innervated blood vessels (Bumstock, 1990 b; Bumstock, 1988) or 
Ach and ATP release from somatic and autonomic nerves (Richardson & Brown, 
1987; Bumstock, 1986 b), inhibitory processes can apparently also be regulated by 
more than one substance.
Three inhibitory transmitter combinations have been proposed a) ATP and 
NO, b) VIP and NO and c) VIP, PACAP and NO.
ATP and NO
The first convincing evidence for the involvement o f two inhibitory 
transmitters mediating NANC nerve-mediated responses was obtained when, using 
apamin, the nerve-evoked large, fast IJPs of the guinea-pig ileum or distal colon,
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were converted to slower, smaller, distinct, so-called, "apamin-insensitive" IJPs 
(Niel et al, 1983 a,b; Smith & Bywater, 1983). Verification soon followed in the 
same (see inter alia Costa et al, 1986; Crist et al, 1991 c; Crist & He, 1991; Maggi 
& Giuliani, 1993) and other tissues such as guinea-pig stomach, small and large 
intestine (Vladimirova & Shuba, 1984), taenia caeci (Bridgewater et al, (1995) and 
human colonic circular muscle (Keef et al, 1993).
The apamin-resistant IJP component in the guinea-pig ileum (Humphreys et 
al, 1991; Lyster et al, 1992 a, b; Bywater et al, 1993; He & Goyal, 1993) and 
colon (Zagorodnyuk & Maggi, 1994) but not, interestingly, in the guinea-pig 
taenia caeci (Bridgewater et al, 1995 ), was abolished by NOS inhibitors, indicating 
its mediation by NO. Attempts to identify the "apamin-sensitive" component soon 
followed. Most evidence implicates ATP; apamin is a recognised antagonist of 
ATP-mediated responses in certain tissues (MacKenzie & Bumstock, 1980; Shuba 
& Vladimirova, 1980; Costa et al, 1986; Boeckxstaens et al, 1993). In addition, 
antagonists o f P2-purinergically-mediated responses, such as reactive blue 2 (RB2; 
Kerr & Krantis, 1979, Choo, 1980, Crema et al, 1983) and suramin (Dunn & 
Blakeley, 1988; Den Hertog et al, 1989; Ohno et al, 1993), together with NOS 
inhibitors, abolished the inhibitory responses to NANC nerve stimulation in the rat 
pyloric sphincter (PS; Soedino & Bumstock, 1994), guinea-pig colon (Maggi & 
Guiliani, 1993; Zagorodnyuk & Maggi, 1994) and rabbit portal vein (Brizzolara et 
al, 1993). ATP and NO may also be responsible for the separate IJP components 
seen in the circular muscle of the guinea-pig ileum (Humphreys et al, 1991; Lyster 
et al, 1992 a, b; Bywater et al, 1993; He & Goyal, 1993), stomach, small and large 
intestine (Vladimirova & Shuba, 1984) and human colonic muscle (Keef et al, 
1993; Boeckxstaens et al, 1993). The question remains as to whether these putative 
inhibitory transmitters are released from the same or different neuronal sources. In 
the guinea-pig taenia caeci, the fast, but not the slow IJP, was selectively abolished
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by ©-conotoxin GVIA which blocks neuronal Ca2+ channels, suggesting that the 
two IJP components were probably mediated by different populations o f nerves 
although different release mechanisms within the same nerves could also account 
for such a finding (Bridgewater et al, |l 995). Whether or not NO and ATP play a 
synergistic role within certain GI smooth muscles and if  so, how this is achieved, 
remains unclear.
VIP and NO
There is increasing evidence in favour of a synergistic relationship between 
VIP and NO within GI smooth muscles (see Makhlouf, 1994, Makhlouf & Grider, 
1993). Their roles are closely interlinked but in a different manner from that for 
ATP and NO together, such that VIP release may be dependent on NO production 
and vice versa.
Electrically or%)MPP-stimulated VIP release from isolated intestinal 
ganglia, it has been proposed, depends on NO production (Grider & Jin, 1993 a), 
as L-NAME abolished, and exogenous NO-stimulated, VIP production. In 
innervated muscles such as the guinea-pig gastric fundus (Grider et al, 1992) and 
rat colon (Grider, 1993) however, while NO production facilitated VIP release, 
liberation of the peptide could still occur independently. Thus, VIP antagonists, 
such as VIP (10-28), inhibited NO production (Grider et al, 1992; Jin & Grider, 
1993). This implies that VIP stimulates NO production within the target muscle 
cells (Grider et al, 1992; Jin & Grider, 1993; Grider & Jin, 1993 b), potentiating 
the relaxant effects of the peptide and enhancing neuronal VIP release. This also 
occurs with isolated, nerve free, gastric smooth muscle cells (Murthy et al, 1993
b). VIP reportedly stimulated NO production by interacting with a membrane 
bound NOS (Murthy et al, 1994; Murthy & Makhhlouf, 1994).
Ganglion stimulant
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Electrical studies have lent further weight to the proposed synergism 
between VIP and NO. Apamin-resistant IJPs in guinea-pig and canine ileum 
involve both NO and VIP; the effects of exogenous VIP in these tissues are 
suppressed by NOS inhibitors, implying VIP-induced NO release (Grider & Jin, 
1993 b; He & Goyal, 1992, 1993). If  this were so then at least three inhibitory 
mediators could be involved in mediating inhibitory responses in these tissues, an 
apamin-sensitive component, VIP and NO.
However, if  NO and VIP' act synergistically, then a number o f problems 
arise. If, following VIP stimulation, NO is synthesised within muscle cells rather 
than in neurons, it cannot be acting as a neurotransmitter in these tissues. This 
contrasts with the finding that HbO, which is unable to cross cell membranes, 
greatly reduces NANC responses in most GI smooth muscles (see Sanders & 
Ward, 1992; Sanders et al, 1992; Rand, 1992). Presumably, VIP is unaffected by 
HbO and, as the major effect of NO would be produced intracellularly on the NO- 
synthesising cells, it is unclear how HbO could exert its antagonistic effects. 
Importantly, TTX blocks the portion of the VIP relaxation attributed to NO 
(Huizinga et al, 1992) and co-conotoxin GVIA, which blocks neuronal calcium 
channels (McCleskey et al, 1987), reduces the contractile response to L-NAME in 
canine ileal segments (Daniel et aj, 1994). Each finding indicates a neuronal origin 
for NO. One might also ask why such a system should exist; the very short half- 
life o f NO makes it extremely unlikely that it would reach many cells that 
remained untouched by VIP.
PACAP, VIP and NO
A novel brain-gut peptide with a high sequence homology to VIP, pituitary 
adenylate cyclase-activating peptide (PACAP; Schworer et al, 1992, 1993) relaxes 
guinea-pig taenia caeci and human colon in an apamin-sensitive manner (Schworer
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et al, 1992, 1993; Jin et al, 1994 a, b; McConalogue et al, 1994). PACAP may 
regulate the descending phase of peristalsis in conjunction with VIP and NO, in rat 
ileum (Grider et al, 1994) and be an inhibitory substance in the guinea-pig taenia 
caeci where VIP and PACAP are proposed co-transmitters (Jin et al, 1994 b), 
however, further information regarding this transmitter combination is still sparse.
The discussion of relaxation has so far concentrated on mediators which are 
either proposed to be released from nerves or mimic the effects o f neuronal 
mediators. There are ways, however, o f inducing smooth muscle relaxation in the 
absence of any neuronal stimulation.
II) Non-Neuronal Control of Relaxation in the GI tract
Compounds that can be classed as non-neuronal relaxants are either, 
a) endogenous substances that are released from non-neuronal sources (e.g. 
circulating hormones) or b) drugs whose actions are mediated in ways other than 
by mimicking the action of known or putative transmitters, or transduction 
pathways (e.g. ATP activated K+ channel (KATP) openers). Research into non­
neuronal control of smooth muscle relaxation has not been extensive. This is 
probably because of its perceived relative unimportance in comparison to neuronal 
relaxation. Probably the most widely investigated endogenous non-neuronal 
inhibitory agents are the prostaglandins.
Prostaglandins mediate both excitatory and inhibitory effects (see Sanders, 
1984 b) and are synthesised by GI smooth muscle cells (Ali & McDonald, 1980; 
Bennett et al, 1968; LeDuc & Needleman, 1979; Sanders, 1978). They may act as 
local regulators, with their effects being mediated on, or near, the cell that 
produces them (Needleman, 1978; Sanders, 1984 a). The most likely candidates as
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inhibitory prostanoids are PGI2 and PGE2 (Sanders, 1984 a, b; Daniel, 1979). They 
allegedly act by decreasing the ability of calcium channels to open, thereby 
limiting membrane excitability (Sanders, 1984 a). An inhibitory role for 
prostaglandins within certain tissues is supported by the fact that indomethacin and 
other prostaglandin synthesis blockers enhance contractile activity, and suggests 
that sufficient quantities are produced to be of physiological relevance (Duthie & 
Kirk, 1978; El-Sharkawy, 1983; Sanders, 1984 a, b). However, in the opossum 
LOS (Daniel et al, 1979) a prostaglandin, released from intestinal interstitial cells 
during inhibitory nerve stimulation, facilitated the additional release o f the NANC 
transmitter (Daniel et al, 1979), but was not necessary for relaxation to be induced 
(Daniel, 1979).
Circulating hormones represent another form of non-neuronal inhibitory 
substances. As with the prostaglandins, hormones such as gastrin and 
choleocystokinin (CCK) each mediate excitation and inhibition in GI smooth 
muscle (see Bloom, 1977). However, examples of inhibitory effects on GI smooth 
muscles are relatively scarce; secretin and pancreatic glucagon each inhibit gastric 
motility (Bloom, 1975; Hubei, 1972); secretin alone inhibits tone in the human 
small intestine (Hubei, 1972) and motor activity in the human duodenum 
(Gutierrez et al, 1974). CCK reduces LOS pressure (Resin et al, 1973; Fisher et al, 
1975; Rehfeld, 1978) by inhibiting the effects of endogenous gastrin (Fisher et al, 
1975). As with the final example, the majority of hormonal effects are probably 
the result of these compounds acting to either facilitate or inhibit the release o f a 
secondary transmitter (e.g. Wiley et al, 1988; Bauer et al, 1991).
Within the vasculature the dilation induced by a large number o f substances 
such as ATP and bradykinin (see Kerwin & Heller, 1994) could be described as 
non-neuronal since the relaxation itself is due to the release of NO from the 
vascular endothelium rather than the "primary transmitter" (see Kerwin & Heller,
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1994; Moncada et al, 1991), although this may, initially, be released from a 
neuronal source. However, where mechanical stimuli, such as shear stress, 
stimulates endothelial NO production (Pohl et al, 1991; Shen et al, 1992) this may 
be considered as true non-neuronally-mediated relaxation.
One example of non-neuronally-acting drugs, i.e. drugs that do not mimic 
any known transmitter or transduction mechanism, are the so-called K+ channel 
opening drugs such as cromakalim (Hamilton et al, 1986) and other compounds 
based on a benzopyran nucleus (see Edwards & Weston, 1990). The ability of 
these drugs to hyperpolarize, and induce relaxation of, smooth muscle has direct 
therapeutic implications, for example, in the treatment o f hypertension. They are 
believed to mediate their inhibitory effects by, as their name suggests, opening K+ 
channels, possibly KATP (Sanguinetti et al, 1988; Buckingham et al, 1989; Garrino 
et al, 1989), although this has been disputed (Weston & Edwards, 1992; Carl et al, 
1992; Quast, 1993).
One other group of pharmacological agents that may modify membrane 
responses to both excitatory and inhibitory stimuli are the so-called membrane 
"stabilizers" and "labilizers" (Shanes, 1958). These compounds were first 
described in the context of neuronal activity, but the term has now been extended 
to also include muscle activity. Membrane stabilizers such as quinidine, procaine, 
cocaine, lignocaine and lanthanum (Shanes, 1958; Bowman & Hall, 1970; 
Biilbring & Kuriyama, 1973; Marshall & Kroeger, 1973) as their name suggests, 
stabilize the membrane by inhibiting changes in its permeability to either Ca2+ 
(Marshall & Kroeger, 1973) and/or K+ ions (Shanes, 1948 a) thereby inhibiting 
voltage-dependent changes in tone. For example, procaine and lignocaine inhibited 
a-, but not p-adrenoceptor-mediated relaxation, of rabbit intestine (Bowman & 
Hall, 1970) and cocaine inhibited the potassium depolarization of muscle (Shanes, 
1948 a, b). Labilizers, on the other hand, are the reverse of stabilizers and
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accentuate electrical change. These include veratrum alkaliods, calcium chelating 
agents and low calcium. As with the stabilizers, labilizers do not generally alter 
membrane potential per se but accentuate changes in membmae potential such as 
C 0 2-induced hyperpolarization (Shanes, 1951), and potassium and sodium- 
induced depolarization, of nerves (Stampfli & Nishie, 1956).
3) RELAXANT TRANSDTJCTTON MECHANISMS
The neuronal control of smooth muscle relaxation has so far been discussed 
in terms of inhibitory chemical messengers liberated from neurons. However, 
before relaxation occurs in response to these chemical messengers, mechanisms 
function to translate the primary signal, delivered by the chemical mediator, into a 
cellular response. Initially, this is achieved through the interaction of the 
messenger with cellular receptors located either in the cell membrane or in the 
cytosol. A number of mechanisms exist to transduce the agonist message into a 
cellular response (summarised in Fig. 2) but, with the exception of guanylyl 
cyclase, the receptor for NO, inhibitory receptors within the GI tract initially 
trigger relaxation only following an agonist-induced conformational change. This 
enables the receptors to interact with, and activate, specific membrane-bound 
proteins, G proteins, following the binding of guanosine triphosphate. The G 
proteins in turn, stimulate the formation of specific intracellular second 
messengers via the activation of membrane-associated enzymes (Ross, 1989). The 
second messengers trigger relaxation by reducing free [Ca2+]j within the smooth 
muscle cell (summarised in Fig. 3).
O f the known second messengers systems, the inositol phosphates, diacyl 
glycerol (DAG) and the cyclic nucleotides, cAMP and cGMP are the best
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understood. How these second messengers are activated and manipulate free 
[Ca2+]j levels will be discussed.
I) The Phosphoinositide System and Ca2+ regulation
Four decades have passed since the discovery that stimulation of muscarinic 
acetylcholine receptors provoked a striking enhancement in the turnover of the 
minor cell membrane constituent phosphatidyl inositol (PI) and its precursor 
phosphatidic acid (Hokin & Hokin, 1953). It was not until the mid 1970's 
however, that the role of polyphosphoinositides in receptor function, and their 
direct link with [Ca2+]j mobilization and PI turnover levels was fully 
acknowledged (see Michell, 1975). Stimulation of over twenty different types of 
cell-surface receptors leads to the hydrolysis of phosphatidyl 4,5-bisphosphate 
(Kirk et al, 1981), yielding the biologically active second messengers inositol 
1,4,5-trisphosphate (IP3), DAG (Berridge, 1987; Berridge & Irvine, 1989; Chuang, 
1989; Joseph & Williamson, 1989) and, possibly, inositol 1,3,4,5- 
tetrakisphosphate (IP4; Joseph & Williamson, 1989; Benham, 1992). This 
hydrolysis is catalysed by the membrane-associated enzyme phospholipase C 
(PLC) which is coupled to the receptor by a transducing Gs protein (Smrcka et al,
1993).
DAG is a lipid soluble second messenger molecule which remains in the 
plane of the plasma membrane to activate another membrane-bound enzyme, 
protein kinase C. This kinase phosphorylates a number of proteins in cell-free 
systems (Benham, 1992) but in vivo it is likely that its physiological targets are 
more limited. Postulated protein kinase C actions on acute signalling processes can 
be broken down into processes that are synergistic to the parallel Ca2+ 
mobilization, such as maintained smooth muscle contraction (Benham, 1992; 
Rasmussen, 1989), and a negative feedback role, which either involves inhibiting
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inositol phospholipid breakdown or an increase in the rate of Ca2+ efflux from cells 
(Nishizuka, 1986).
IP3 stimulates the release of Ca2+ from a non-mitochondrial store (Joseph & 
Willaimson, 1989; Nahorski, 1988; Nahorski & Potter, 1989), probably the 
sarcoplasmic or endoplasmic reticulum (Ross et al, 1989), by coupling to a 
specific intracellular receptor protein (Furuichi et al, 1989). The Ca2+ so released 
is generally associated with smoQth muscle contraction (Ochs, 1986), i.e. via a p  
adrenoceptors in the vasculature (Minneman, 1988). Conversely however, ocj- 
adrenoceptor stimulation within GI smooth muscle, despite also causing IP3 
generation (Nelemans & Den Hertog 1987 a, b), hyperpolarizes and relaxes 
smooth muscle. This may be due to elevated IP3-stimulated Ca2+ levels, which are 
probably restricted to the membrane, and which cause a membrane 
hyperpolarization by increasing the open probability of Ca2+-activated K+ channels 
(Bennett et al, 1963; Holman, 1970; Tomita, 1972; Den Hertog, 1981, 1982; Maas 
et al, 1980; Nelemans & Den Hertog 1987 a,b). This hypothesis is supported by 
patch-clamp studies which have demonstrated that noradrenaline application, to 
the outside o f single cells, increased the open probability of these channels, an 
effect similar to that produced by increasing the intracellular Ca2+ concentration 
([Ca2+]j; see BUlbring & Tomita, 1987).
The question arises however, as to how hyperpolarization o f the cell 
membrane, results in relaxation. [Ca2+]j is the prime regulator o f smooth muscle 
tone, both in the vasculature and GI tract (Rembold & Murphy, 1988, Bulbring & 
Tomita, 1987), and maintenance of tone depends on the long term balance between 
the entry of extracellular Ca2+ and its extrusion (Ashida & Blaustein, 1987; Quayle 
et al, 1990). Hyperpolarization, in order to produce relaxation, probably interferes 
with this [Ca2+]j homeostasis. Within spontaneously active smooth muscle, 
calcium entry is largely regulated by Ca2+ channels sensitive to membrane
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potential (see Sanders, 1989), such that lower (depolarized) membrane potentials 
increase the open probability (Droogmans & Callewaert, 1986) of these channels 
and vice versa for more negative membrane potentials. As a consequence of this 
coupling, any stimulus causing even a slight hyperpolarization of the membrane 
such as inhibitory NANC nerve stimulation or KATP openers blocks Ca2+ entry and 
therefore reduces tone.
O f the proposed NANC neuronally-released substances ATP, via activation 
of P2y-purinoceptors, stimulates PLC activation and [Ca2+]j mobilization within 
several systems (e.g. primary cultures of sheep anterior pituitary cells - Van Der 
Merwe et al, 1989; turkey erythrocyte membranes - Berrie et al, 1989; Boyer et 
al, 1989; Cooper et al, 1989, Harden et al, 1990; and vascular and adrenal 
endothelial cells - Forsberg et al, 1987; Pirotton et al, 1987; Boeynaems & 
Pearson, 1990). Within GI smooth muscle, P2y-purinoceptors, like a r  
adrenoceptors, are associated with hyperpolarization and relaxation (see Bumstock 
& Kennedy, 1985; Lim, 1985; Kennedy, 1990). To date however, only one study, 
using canine kidney cells, has directly implicated an ATP-induced, IP3-stimulated 
rise in [Ca2+]j in producing membrane hyperpolarization (Paulmichl & Lang, 
1991). This system could also account for the ATP-induced hyperpolarization and 
relaxation of GI smooth muscle.
II) Cyclic Adenosine 3\5"-M onophosphate (cAMP)
Relaxation of smooth muscle is more commonly associated with elevations 
of cAMP, as well as cGMP (see later). The identification of the second messenger, 
cAMP (Sutherland & Rail, 1958), was a landmark step in the discovery of how a 
number o f neurotransmitters, hormones and drugs produced their inhibitory effects 
on target tissues. Cyclic AMP is synthesised within cells by the enzyme adenylyl
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cyclase via the catalytic formation of cAMP from ATP (see Greengard et al, 1972) 
following receptor, and subsequent G protein, activation.
Initially, although there • was a clear correlation between a rise in 
intracellular cAMP levels ([cAMP]j) and relaxation (see Andersson et al, 1972), 
the mechanism of cAMP-induced relaxation remained obscure until the discovery 
of an intracellular receptor protein for cAMP; cAMP-dependent protein kinase 
(PKA), in skeletal muscle (Walsh et al, 1968) and liver (Langan, 1968). PKA, 
which exists as several different isozymes (Francis & Corbin, 1994), is found in all 
mammalian tissues (Francis & Corbin, 1994) and mediates the majority (Beebe & 
Corbin, 1986; Barnette et al, 1990), although not all (Nakamura & Gold, 1987), of 
the effects o f cAMP.
The inhibitory effects of cAMP/PKA are attributable to the regulation of 
[Ca2+]j. This regulation can take several forms. Either by:-
a) Prom oting Ca2+ Extrusion from the Cell: Calcium extrusion is 
probably achieved by activation of the two major energy-linked Ca2+ efflux 
pathways across the plasma membrane; the Ca2+-2H+-ATPase (or Ca2+ pump) 
(Niggli et al, 1982; Smallwood et al, 1983) and the 3Na+/Ca2+ exchanger, which is 
driven by the [Na+] gradient that exists across the plasma membrane, maintained 
by the Na+/K+-ATPase (Carafoli, 1987; Nicholls, 1986; Borle, 1981; Rasmussen & 
Rasmussen, 1990). Both ATPases may undergo a cAMP/PKA-dependent increase 
in activity (Scheid et al, 1979), enhancing the extrusion of [Ca2+]j. Isoprenaline, 
which relaxes and promotes increased intracellular cAMP levels in most smooth 
muscles (Andersson et al, 1972), is proposed to produce its inhibitory effects by 
promoting Ca2+ extrusion (Marshall & Kroeger, 1973; Bulbring & Den Hertog, 
1980).
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b) Promoting Intracellular Sequestration or Binding of Ca2+: Cyclic 
AMP and PKA have been implicated in the accumulation of Ca2+ into an 
intracellular storage site within smooth muscle (Andersson & Nilsson, 1972; 
Casteels & Raeymakers, 1979). The most likely intracellular structure to be 
involved in this process is the sarcoplasmic reticulum (S.R.). The S.R. accumulates 
Ca2+ from the cytosol through a specific ATPase (Tada & Katz, 1982; Carafoli, 
1987), therefore its activation, possibly by PKA, would increase Ca2+ 
sequestration.
c) Modifying the Activity of the Contractile Apparatus: Cyclic AMP is 
also proposed to induce relaxation via the suppression of Ca2+ binding, required to 
activate the contractile proteins actin and myosin (Adelstein et al, 1982; Nishimura 
& Van Breeman, 1989; Smith et al, 1993). Phosphorylation of the Ca2+- 
calmodulin-dependent enzyme, MLCK, by PKA (Conti & Adelstein, 1980; 
Adelstein et al, 1981), led to a shift in the Ca2+ dependency of MLCK, such that a 
higher Ca2+ concentration was required to activate the enzyme (Adelstein et al, 
1982). Although this has been demonstrated in skinned smooth muscle fibres 
(Meisheri & Riiegg, 1983; Meisheri et al, 1986 a) it has yet to be clearly 
demonstrated in vivo (Miller et al, 1983; Obara & De Lanerolle, 1989).
d) Inhibiting the Formation and Action of Inositol Phosphates: Cyclic 
AMP inhibited the agonist-induced hydrolysis of polyphosphoinositides (Hall et 
al, 1989; Hall & Hill, 1988; Jones et al, 1987; Madison et al, 1988). It also 
antagonized agonist-induced, IP3-dependent, Ca2+ release (Murthy et al, 1993 a) 
probably as a result of PKA-dependent phosphorylation of the IP3 receptor situated 
on the S.R. (Supattapone et al, 1988).
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e) Reducing Extracellular Ca2+ E ntry  by Channel C losure: This occurs 
in several smooth muscles such as guinea-pig taenia caeci (Den Hertog et al, 1985, 
Bulbring & Tomita, 1987), dispersed smooth muscle cells (Yamaguchi et al, 1988) 
and the canine colon (Smith et al, 1993; Du et al, 1994) where forskolin- 
stimulated adenylyl cyclase activity produced membrane hyperpolarization and 
relaxation. Membrane hyperpolarization, probably a result o f K+ efflux (Carl et al, 
1991; Smith et al, 1993; Du et al, 1994), would decrease the open probability of 
voltage-dependent Ca2+ channels (Langton et al, 1989) thereby inhibiting Ca2+ 
entry.
I ll)  Cyclic Guanosine 3 \  S^-Monophosphate (cGMP)
Although cGMP was discovered shortly after cAMP (Ashman et al, 1963), 
its role in biological regulation has been, until recently, considerably less well 
understood than that of cAMP. It is a ubiquitous second messenger which 
regulates many cell functions including smooth muscle relaxation (for review see 
Waldman & Murad, 1987; Tremblay et al, 1988;). Cyclic GMP formation, from 
guanosine triphosphate, is catalysed by the action of an enzyme, guanylyl cyclase, 
which exists in both particulate and soluble forms (Hardman & Sutherland, 1969; 
Schultz et al, 1969; White & Aurbach, 1969). The importance of cGMP as a 
smooth muscle relaxant has recently come to prominence with the identification of 
the putative transmitter NO (see Non-Adrenergic, Non-Cholinergic (NANC)- 
M ediated Relaxation) which mediates its widespread inhibitory effects by 
increasing intracellular cGMP levels (see Kerwin & Heller, 1994).
It was originally thought (Goldberg et al, 1973) that cGMP stimulated the 
contraction of smooth muscle (Dunham et al, 1974; Clyman et al, 1975; Amer & 
McKinney, 1975; Andersson et al, 1975), however the contractions described in 
these cases preceded the rises in cGMP by as much as fifteen seconds (Diamond &
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Hartle, 1976) indicating that the cGMP elevation was a result of, rather than the 
cause of, the contractions (Diamond & Hartle, 1974; Diamond & Holmes, 1976). It 
is now accepted that cGMP relaxes, rather than contracts, smooth muscle. 
Evidence for this was obtained using nitrovasodilators, which release the smooth 
muscle relaxant NO (Ignarro & Kadowitz, 1985; Murad, 1986; Waldman & 
Murad, 1987; Kerwin & Heller, 1994; see below), and produced relaxation 
concomitantly with increased intracellular cGMP levels ([cGMPJj; e.g. in rat 
myometrium (Diamond & Holmes, 1975) canine femoral artery (Diamond & 
Blisard, 1976) and several other smooth muscles (Schultz et al, 1977; Katsuki et 
al, 1977 b)). NO increases cGMP levels via activation of soluble guanylyl
cyclase (Murad & Aurbach, 1977; Katsuki et al, 1977 a; Arnold et al, 1977; Murad 
et al, 1978, 1981) by binding to its active haem centre (Gerzer et al, 1988). The 
evidence is now such, that it is almost universally accepted that cGMP is the 
inhibitory second messenger for NO (see Nakatsu & Diamond, 1989; Ward et al, 
1992 a).
The intracellular receptor protein for cGMP, cGMP-dependent protein 
kinase (PKG), was first described in 1970 (Kuo & Greengard, 1970). PKG is 
closely related in structure and function to PKA, discussed earlier, but is less 
widely distributed, with highest concentrations found in smooth muscles (Francis 
& Corbin, 1994). PKG is probably responsible for mediating the
majority, but not all (Wrenn & Kuo, 1981; Hartzell & Fischmeister, 1986; 
Hofmann et al, 1992; Altenhofen et al, 1991), of the inhibitory effects of cGMP 
within smooth muscles (see Francis & Corbin, 1994) by modulating smooth 
muscle [Ca2+]j metabolism (Collins et al, 1986; Schini et al, 1987; Bukoski et al, 
1989; Morgan & Morgan, 1984). One, or several, of the following mechanisms 
could explain the cGMP/PKG-evoked relaxation. Either by:-
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a) Prom oting Ca2+ Extrusion from the Cell: Ca2+ efflux may be achieved 
by PKG-dependent activation of the plasma membrane associated, calmodulin- 
stimulated Ca2+-ATPase (Popescu et al, 1985; Rashatwar et al, 1987; Yoshida et 
al, 1991) although a direct phosphorylation of the ATPase has yet to be 
demonstrated (Vrolix et al, 1988). A second mechanism could be the stimulation 
of the 3Na+/Ca2+-exchanger, possibly via stimulation of the Na+/K+-ATPase, 
which has been demonstrated in vascular smooth muscle cells (Furukawa et al,
1991).
b) Prom oting Intracellular Ca2+ Sequestration or Binding: Most 
evidence for this mechanism comes from vascular smooth muscle. Nitroprusside 
and the membrane permeable cGMP analogue, 8-bromo-cGMP, each inhibited 
noradrenaline-induced contractions of rat aortic rings in Ca2+-free medium 
(Lincoln, 1983; Karaki et al, 1988), suggesting intracellular sequestration o f Ca2+, 
stimulated by cGMP. The intracellular store for this sequestered Ca2+ is probably 
the S.R.. Cyclic GMP directly increased Ca2+ uptake into the S.R. o f rat aortic cells 
(Twort et al, 1988) and selective inhibitors of the S.R. Ca2+-ATPase, inhibited 
nitroglycerin-induced relaxations (Luo et al, 1993). These processes are probably 
regulated by PKG (Cornwell & Lincoln, 1989). Indeed, PKG catalyzed the 
phosphorylation of the S.R. Ca2+-ATPase regulatory protein, phospholamban, in 
vitro (Sarcevic et al, 1989; Cornwell et al, 1991; Karczewski et al, 1992) which 
was correlated with its activation and reduced [Ca2+]j.
c) Modifying the Activity of the Contractile A pparatus: As with cAMP 
and PKA, cGMP-activated PKG is probably involved in decreasing the Ca2+
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sensitivity o f MLCK (Adelstein et al, 1982; Pfitzer et al, 1982; Karaki et al, 1988; 
Rapoport & Murad, 1983; Nishimura & Van Breeman, 1989; McDaniel et al,
1992; Smith et al, 1993) although, to date, this hypothesis lacks direct 
experimental support. PKG may also activate protein phosphatases, resulting in 
dephosphorylation of the contractile protein, myosin light chain, thereby eliciting a 
relaxation (Driska et al, 1989; see Fig 1).
d) Inhibiting the Formation and Action of Inositol Phosphates: Several 
investigators have suggested that cGMP elevations inhibit the release of Ca2+ from 
IP3-sensitive storage sites in smooth muscle cells (Collins et al, 1986; Godfraind, 
1986; Meisheri et al, 1986 b; Rapoport, 1986; Jin et al, 1993; Murthy et al, 1993
a). Several lines of evidence support this; transfected PKG inhibited IP3 formation 
and thrombin-evoked [Ca2+]j mobilization in Chinese hamster ovary cells (Ruth et 
al, 1993). PLC activation, which stimulates IP3 formation, was also inhibitied due 
to the phosphorylation of one or more G proteins by PKG thereby inhibiting their 
GTPase activity (Hirata et al, 1990; Light et al, 1990). Recently PKG, like PKA, 
has been shown to phosphorylate the IP3 receptor, inhibiting IP3 receptor- 
dependent Ca2+ activation (Komalavilas & Lincoln, 1994).
e) Reducing Extracellular Ca2+ Entry by Channel Closure: NO, and
NO-donors, presumably acting via cGMP, and possibly PKG, hyperpolarized 
certain vascular and non-vascular tissues such as the canine proximal colon 
(Thombury et al, 1991; Ward et al, 1992 a; Koh et al, 1995) and pyloric sphincter 
(Bayguinov & Sanders, 1993), opossum oesophagus (Du et al, 1991; Conklin & 
Du, 1992), rabbit basilar and canine and porcine coronary arteries (Tare et al, 
1990; Rand & Garland, 1992; Taniguchi et al, 1993). Recent evidence suggests 
that within the canine colon there are three types of K+ channel which are activated
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by NO or NO donors (Koh et al, 1995). One of these channel types is the BK, 
Ca2+-activated K+ channel, which corresponds with previous studies on the
channel-opening effects of NO (Thombury et al, 1991; Murray et al, 1994; Khan 
et al, 1993). When activated, these channels hyperpolarize the membrane and 
inhibit Ca2+ entry through voltage-activated Ca2+ channels, thereby producing a 
relaxation. Significantly, Ca2+-activated K+ channels are also targets for PKG 
(Robertson e ta l , 1993; Taniguchi et al, 1993; White et al, 1993).
The relative importance of these various [Ca2+]i control systems probably 
varies within different tissues and it may be that, in certain cases, more than one of 
these systems is activated at a time to induce relaxation.
IV) Cyclic Nucleotide Cross-Activation of Protein Kinases
Smooth muscle relaxation is not always due to the actions of one 
biochemical process acting in isolation from other intracellular mediators. The 
phenomenon of cross-activation, defined as a cross interaction between two or 
more second messenger pathways under physiological conditions, is believed to 
occur with cyclic nucleotides and their respective protein kinases.
Originally, the cyclic nucleotide specificities of PKA and PKG were 
thought to serve as precise means of regulating cellular function, allowing the 
changes in only one cyclic nucleotide, followed by activation of its protein kinase, 
to control a particular regulatory pathway (Lincoln & Corbin, 1983). However, 
PKA and PKG are homologous proteins that share similar functions (Gill et al, 
1976; Corbin & Lincoln, 1978; Lincoln & Corbin, 1983; Takio et al, 1984; Hanks 
et al, 1988; Scott, 1991; Hoffmann et al, 1992) and a structural similarity between 
their cyclic nucleotide binding sites (Weber et al, 1987, 1989). Because of this
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structural similarity PKG is able to bind cAMP, although with an affinity some 50 
times lower than that of PKA for cAMP. However, autophosphorylation of PKG 
improves its affinity for cAMP by up to 10 times (Foster et al, 1981; Landgraff et
al, 1986). This, paired with the fact that cAMP levels in most smooth muscles can 
be up to 5 times higher than cGMP levels (Francis et al, 1988) means that small 
elevations in [cAMP]j could cross-activate PKG, possibly producing relaxation. 
Support for this has recently emerged; relaxing agents which raised [cAMP]j in 
gastric muscle cells and pig coronary arteries, besides activating PKA, also 
increased PKG activity (Jiang et al, 1992; Jin et al, 1993). Indeed, in some cases 
PKG may mediate the relaxation of both cyclic nucleotides (Cornwell & L incoln, 
1989; Lincoln et al, 1990; Lincoln & Cornwell 1991), for example;
1) PKG-specific analogues, but not PKA-specific ones, relaxed guinea-pig 
coronary arterial and tracheal smooth muscle (Francis et al, 1988).
2) Restoration of PKG, but not PKA, to PKG-depleted aortic smooth 
muscle cells restored the Ca2+-lowering {i.e. relaxing) effects elicited by either 
cGMP or cAMP (Lincoln et a/,1990).
3) Low concentrations of cAMP increased, whereas cGMP and higher 
concentrations of cAMP inhibited, Ca2+ channel opening in rabbit portal vein cells 
(Ishikawa et al, 1993), indicating a cAMP concentration-dependent activation of 
PKG.
PKA may also be cross-activated by cGMP, but this is rare and not directly 
applicable to smooth muscle relaxation. For example, the cGMP-induced 
accumulation by a heat stable enterotoxin in intestinal epithelial cells, increased 
chloride conductance (Forte et al, 1992), an effect mimicked by cAMP analogues 
that potently activate PKA. This contrasts with the ineffectiveness of cGMP 
analogues. PKA is present within these cells whereas there is no measurable PKG
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(Forte et al, 1992). This type of cross-activation may also occur in vivo for 
example in Leydig cells where atrial natriuretic factor-induced cGMP increases are 
proposed to increase testosterone production by activating PKA (Schumacher et al,
1992).
In general, although the effector specificity of protein kinases provides a 
mechanism for defined and precise regulation of cellular function, cross-activation 
of these enzymes permits some flexibility in this regulation, perhaps reflecting an 
opportunist mechanism of the cell, i.e. the utilisation of an additional second 
messenger to regulate a pathway that is already in place. This may be analogous to 
the situation whereby two inhibitory transmitters, which perform essentially the 
same function, appear to be released together within the same tissue (see 
Synergistic Transmitter-Mediated Relaxation).
4) ATMS
Clearly, relaxation of smooth muscle involves several different processes, 
from the initial agonist-receptor interaction to the ultimate movement o f the actin 
and myosin filaments creating the relaxation event. This thesis has targeted, for 
study, the identification of the transmitter processes underlying relaxation, which 
encompasses both the putative transmitter substance(s), and the intracellular 
transduction process(es) activated by the transmitter(s). It represents my 
contribution to furthering the understanding of one particular aspect o f neuronally- 
mediated relaxation namely, NANC-mediated relaxation.
This can no longer be regarded as involving a single inhibitory mediator 
and is now commonly accepted as being the result o f two or more substances. The 
added complexity of such a system requires definitive investigation to determine
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the nature of the substances involved. For this puipose electrical, mechanical and 
biochemical procedures were employed utilising the spontaneously active, non- 
propulsive smooth muscle of the gpIAS, eminently suited to this purpose, 
possessing as it did, a well defined and developed NANC inhibitory innervation 
which was manifested as large IJPs and relaxations in response to nerve 
stimulation.
A study of the membrane responses to neuronally-released transmitters, 
using intracellular electrical recording, simultaneously with corresponding 
mechanical events, was undertaken. The electrical changes produced by nerve 
stimulation were measured as IJPs, the initial responses to neuronally released 
inhibitory transmitters. The electrically-evoked IJPs comprised two components, 
the nature of which, by pharmacological analysis, were found to be ATP or a 
closely-related analogue and NO, or a related substance.
The IJPs produced by nerve-stimulated release of these substances acting 
on the tissue are a result of large changes in ionic fluxes across the cell membrane. 
The identity of the ion(s) responsible for the separate IJP components, as revealed 
pharmacologically and by altering the external ionic enviroment of the tissue, 
probably involve K+ but not Cl".
The electrical responses which preceded relaxation were, however, only 
one aspect of the inhibitory response. Accompanying these were changes in the 
levels of the intracellular cyclic nucleotides most often associated with relaxation, 
cAMP and cGMP. These changes, in response to drugs and field stimulation, were 
studied a) indirectly, using drugs which modulated the activity of the cyclic 
nucleotides and b) directly, by measuring the levels of the intracellular cyclic 
nucleotides using radioimmunoassay.
By combining the information obtained from the two aspects of this study, 
a direct correlation could be made between the electrical, mechanical and
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biochemical events involved in the relaxation of the gpIAS, thereby producing a 
more integrated picture of relaxation in this tissue and fulfilling the aims of this 
thesis.
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METHODS AND MATERIALS
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n  SPHINCTERTC SMOOTH MUSCLE
The GI sphincters are located at various levels of the alimentary canal, 
separating specialised regions of the tract, where they function to prevent the 
reflux of contents and ensure their distal propulsion. No major anatomical 
differences distinguish sphincteric from non-sphincteric tissues, apart from a 
greater density of circular muscle in the former. However, due to their dense 
inhibitory NANC innervation, each sphincter responds to nerve stimulation 
with a profound relaxation. This inhibitory innervation, combined with the 
inherent tone displayed by most sphincters, makes them especially useful for 
the study of relaxation (for general review of sphincteric function see Papasova, 
1989). Within this context the gpIAS was chosen for further study because of 
its particularly well developed inhibitory innervation, even in relation to other 
sphincters, which is manifested as large inhibitory junction potentials and 
reductions in tone in response to nerve stimulation.
I) Guinea-Pig Internal Anal Sphincter (gpIAS)
The sphincteric region at the distal end of the digestive tract actually 
consists of two sphincters, the internal and external anal sphincters. However 
the external anal sphincter is skeletal rather than smooth muscle. The internal 
anal sphincter (IAS) is responsible for the involuntary retention of contents in 
the anal canal and is nearly always in a contracted state, resulting in a higher 
intraluminal pressure than the rectum (see Papasova, 1989).
The anatomy of the anal region in the guinea-pig has been described by 
Furness and Costa (1973). The guinea-pig IAS coincides with a thickening of 
the rectal wall (approximately 15-20mm long x 5mm broad), which can usually 
be recognised externally, and consists of a band of circular fibres more densely 
arranged than elsewhere in the rectoanal region (Fig. 4). The rectum and IAS 
consists of two muscle layers, the outer longitudinal muscle extending over the 
inner circular sphincteric muscle. Each muscle layer terminates some 5-10 mm
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short of the anal margin and is separated from the skin by a band of largely 
connective tissue with a few circular muscle fibres. The term gpIAS throughout 
this thesis refers to the circular muscle free from the longitudinal muscle layer 
(Fig. 4).
The gpIAS is innervated by three types of efferent nerves. First, 
sympathetic noradrenergic excitatory innervation. Pre-ganglionic axons 
emanating from the lumbar spinal cord synapse in the inferior mesenteric 
ganglion with postganglionic noradrenergic neurons. The latter directly 
innervate the gpIAS via the pudendal nerves. Secondly, cholinergic excitatory 
nerves running via the pelvic nerves enter both the circular and longitudinal 
muscles of the IAS and synapse with postganglionic intramural neurons. The 
third type of efferent nerves is parasympathetic, with cell bodies located in the 
sacral region of the spinal cord. Axons of this third type leave by the sacral 
ventral roots and run in the pelvic nerves to synapse with postganglionic non- 
adrenergic, non-cholinergic (NANC) intramural neurons in the pelvic plexuses 
which then enter the IAS (Costa & Furness, 1973) (see Fig. 4). In vivo the 
inhibitory motor responses emanating from the myenteric plexus are activated 
only during the rectoanal inhibitory reflex caused by rectal distension (Costa & 
Furness, 1973; Frenckner, 1975; Frenckner & Ihre, 1976; Tamura et al, 1989). 
In vitro electrical stimulation of the IAS results in a profound relaxation in this 
(Crema et al, 1983; Lim & Muir, 1983, 1985, 1986) and other species such as 
humans (Burleigh et al, 1973, 1979; Burleigh, 1991, 1992) and monkeys 
(Rayner, 1979). Proposed mediators of these inhibitory responses are ATP 
(Lim & Muir, 1986), VIP (Biancani et al, 1984, 1985; Rattan & Chakder, 1992) 
and, more recently, NO (Burleigh, 1991, 1992; Chakder & Rattan, 1992, 1993 
a, b; Craig & Muir, 1991; McKirdy, 1992; O'Kelly et al, 1992, 1993; Rattan et 
al, 1992; Rattan & Chakder, 1992; Tottrup et al, 1992).
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Figure 4 Top: Position of the guinea-pig internal anal sphincter (x5). In 
the stretched, intact preparation (a) the approximate location of the sphincter is 
indicated by a slight swelling of the rectal wall. In (b) a longitudinal incision in 
the rectum has been made and the mucosa and submucosa removed. The 
sphincter can be identified as a band of circular smooth muscle in which the 
fibres are more densely arranged than elsewhere in the rectal wall. The 
sphincter is thus easily differentiated from the connective tissue, which is 
adjacent to the anus. Bottom: Schematic representation of the innervation of 
the internal anal sphincter. 1 & 3 are cholinergic intramural excitatory neurons; 
2 is a intramural inhibitory NANC neuron; and 4 is a sympathetic excitatory 
neuron. (Adapted from Gonella, Bouvier & Blanquet, 1987).
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2) DISSECTION
I) Guinea-Pig Internal Anal Sphincter
Dunkin-Hartley guinea-pigs (250-500g) of either sex were killed by 
cervical dislocation and bled. Following a mid-line incision, the peritoneal 
cavity was opened, and the descending colon exposed as it passed into the 
pelvic cavity. The pubic symphisis was split and a segment of the rectum, 
including the anal region (~5cm), removed and transferred to a Sylgard-coated 
petri dish containing oxygenated Krebs solution (95% 0 2, 5% C 0 2). A 
longitudinal incision was made in the rectoanal canal from the anal end. The 
rectum was pinned out, and the skeletal and connective tissue forming the 
external sphincter, removed. The mucosa and submucosa were removed and the 
sphincter identified with the aid of a dissecting microscope (Fig. 3). The 
longitudinal muscle layer was carefully removed to leave only the circular 
muscle of the IAS. The gpIAS was then transferred to a horizontal organ bath 
and pinned to the Sylgard-coated base (Fig. 5). It was continually perfused with 
oxygenated Krebs solution, using a pump (Gilson minipuls 3; 4ml min-1), at 
37±0.5°C, containing atropine and phentolamine (each lpM), except when 
stated otherwise. The gpIAS was attached by a thread to an isometric force 
displacement transducer (Grass FT03C) to measure mechanical activity. The 
other end was threaded through a bipolar Ag/AgCl ring electrode (o.d. 2mm 
and 2mm apart) for electrical field stimulation (EFS) which was provided by a 
Devices type 2521 stimulator, triggered by a Devices Digitimer (0.1ms, 
l-40Hz, supramaximal voltage).
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Figure 5: Organ bath for simultaneous measurements of intracellular 
electrical and mechanical activity. The bath comprised a central trough (50 x 10 
x 10mm) cut from a perspex block (110 x 80 x 20mm). The block was drilled to 
accept stainless steel inlet tubes (o.d. 2mm) for Krebs' solution perfusion and 
two outlets for drainage. One end of the tissue was pinned to the Sylgard base 
of the bath, the other attached, by a thread, to an isometric transducer. Field 
stimulation by an isolated stimulator was affected via Ag/AgCl ring electrodes 
(V+ - V“). The bath was perfused (4ml min-1), using a pump, with oxygenated, 
pre-heated Krebs' solution (37±0.5°C), via the two inlets. The polythene tubing 
(o.d. 2mm) containing the Krebs' solution was surrounded by an outer tubing 
(o.d. 10mm) containing heated liquid paraffin, circulated by a thermostatically 
controlled pump (Tempette TE-7).
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3) APPARATUS AND TECHNIQUES
I) Intracellular Electrical and Simultaneous Mechanical Recording
The perspex horizontal organ bath (50 x 10 x 10mm; volume 3ml; 
Figure showing organ bath) was mounted on two non-conducting Bakelite 
supports attached to a steel plate (200kg) which in turn rested on a marble table, 
supported by anti-vibration dampers.
The bath was perfused with Krebs' solution, using a pump (Gilson 
minipuls 3; 4ml min-1) contained in polythene tubing (o.d. 2mm) surrounded by 
an outer polythene tube (o.d. 10mm) containing liquid paraffin, pumped and 
heated to 40±0.5°C by a modified Tempette (TE-7) pump in order to maintain 
the Krebs at the constant temperature stated above.
Other apparatus included Ag/AgCl ring electrodes (o.d. 3mm), capillary 
glass electrodes (Clark Electromedical Instruments, GC 200F-15), Ag/AgCl 
plated indifferent electrode, D.C. preamplifier (Neurolog NL102), dual beam 
storage oscilloscope (Tekronix 5103N), voltmeter and gated pulse generator 
(Devices type 2521), digital recorder (CRC VR-100B, Instrutech Corp., 
U.S.A.), VHS video recorder (Sharp VC-A30HM), U.V. oscillograph (6150 
Mk II, Thom EMI) and computer (Dell 486P/33).
Intracellular electrical recordings were made using conventional 
capillary glass microelectrodes (Clark Electromedical Instruments, GC 200F- 
15, resistance 10-80MQ) filled with 3M KC1, connected to a probe. The 
indifferent electrode was a Ag/AgCl pellet attached to the side o f the organ bath 
and placed in the bathing solution. Electrical signals were passed to a 
preamplifier (Neurolog NL102) and displayed on a storage oscilloscope 
(Tektronix 5103N). Electrical and mechanical signals were digitized (CRC VR- 
100B, Instutech Corp., U.S.A.) and stored on a video cassette recorder (Sharp 
VC-A30HM) and played back, when required, onto a U.V. oscillograph (6150 
Mk II, Thom EMI)(Fig. 6).
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II) Criteria For Cell Penetration
A cell was accepted for electrophysiological investigation provided the 
following criteria were satisfied;
a) the penetration was sharp and the membrane potential stable, varying 
by not more than 2mV, over an initial period of approximately 10s,
b) inhibitory junction potentials were observed in response to nerve 
stimulation,
c) the voltage measured prior to cell penetration was restored following 
withdrawal of the microelectrode.
III) Administration of Drugs
Drugs were administered in three ways:
1) By addition to the reservoir containing the Krebs' perfusing the organ 
bath. Drugs were prepared in distilled water before dilution with Krebs' 
solution and subsequent addition to the reservoir, 2) from a microsyringe 
(volume 25pi) placed directly into the bath close to the recording site, or 3) by 
pressure injection using a Picospritzer (Picospritzer II, General Valve 
Corporation, N.J., U.S.A.). Using this technique, although the concentration of 
drug may be high, the applied substances are less likely to cause desensitization 
of the entire tissue because of the small area over which the drug is added. 
However, for the same reason, no changes in tension are detectable. Using this 
method drugs were applied, from micropipettes which had their tips broken 
back to 2-20 pM diameter. The pipette tip was placed to within approximately 
1mm of the recording site before application of the drugs (20-30 psi). The 
variation in ejection duration is indicated in the text.
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IV) NADPH-Diaphorase Staining
NADPH-diaphorase, is proposed to be nitric oxide synthase (NOS; Hope 
et al, 1991; Valtschanoff et al, 1992). Histochemical staining for this enzyme is 
now routinely used to detect the presence of NOS within tissues. NOS 
containing regions stained dark blue using this technique.
Following dissection the gpIAS was placed in fixative containing 4% 
paraformaldehyde in 0.1M phosphate buffer solution (PBS) for 1 hour at 37°C. 
The tissues were then transferred to a cryoprotectant solution containing 30% 
sucrose in 0.1M PBS until they sank to the bottom (-15 minutes), signifying 
that the tissues were saturated with the cryoprotectant, after which they were 
snap frozen in liquid nitrogen. Transverse and longitudinal sections (20pM) 
were cut using a Cryocut 1800 (Reichert-Jung). The slivers of tissue were 
transferred to glycerine-coated slides and incubated in 0.1M PBS containing
0.25% Triton X-100 for 10 minutes. The slides were then placed in a 0.1 M PBS 
solution containing 0.2mg/ml nitro blue tetrazolium and 0.5mg/ml p-NADPH 
and incubated in the dark at 37°C for one to two hours. The reaction was 
terminated by washing the slides in 1M PBS. The slides were then dehydrated 
in increasing concentrations of ethanol (75%, 95% and 100%) for 1 minute at a 
time and then transferred to increasing concentrations of Histoclear (50%, 75% 
and 100%) for approximately five minutes each. The slides were allowed to dry 
before being mounted.
V) Measurement of Cyclic Nucleotides
Levels of both cyclic adenosine 3', 5'-monophosphate (cAMP) and 
cyclic guanosine 3', 5'-monophosphate (cGMP) in the gpIAS were measured 
by radioimmunoassay (RIA; Steiner et al, 1972), using the scintillation 
proximity assay (SPA) technique. The effects on cyclic nucleotide levels o f 
drugs and field stimulation were measured.
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a) Sample Collection
Tissues were dissected out as previously described, weighed, mounted 
between a pair of platinum electrodes (o.d. 4mm) and placed in a heated 
vertical organ bath (15ml) containing oxygenated Krebs' solution (95% 0 2, 5% 
C 0 2) at 37±0.5°C. Atropine and phentolamine (each lpM ) were always 
present. The organ bath temperature was maintained using an electric pump 
(Grant W6).
Tension on the gpIAS was monitored using an isometric force 
transducer (Maywood, Type 49034). Tissues were stimulated by agonists or an 
isolated stimulator (Pfizer; 0.1ms, 1-10Hz, supramaximal voltage), with 
mechanical activity measured and displayed on a pen recorder (Grass or 
Multitrace 8, Lectromed MT8P).
Upon field stimulation or drug addition, after maximal relaxation had 
been reached, the tissues were removed rapidly from the organ bath and snap 
frozen with a pair of stainless steel clamps which had previously been 
immersed in liquid nitrogen. After clamping, the tissues were immediately 
immersed in the liquid nitrogen to ensure freezing of the entire tissue. The 
whole process, from tissue removal to freezing took less than five seconds.
b) Preparation of Samples
Frozen gpIAS samples were thawed in trichloroacetic acid (0.5ml; 10% 
w/v) and homogenised using a ground glass/glass homogeniser. Cellular debris 
and precipitated proteins were removed by centrifugation (3000g; 10 min; 4°C). 
The acid-soluble fraction (the supernatant) was removed and the pellet 
discarded. The supernatant was washed with water-saturated diethyl ether 
(4 times with 5 ml), the upper ether layer being discarded each time. Remaining 
traces of ether were driven off by placing the glass sample tubes in a heated 
water bath (80°C for 5 mins). The samples were then frozen (-20°C) until 
required for assay.
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c) Radioimmunoassay for cAMP and cGMP
After thawing, an aliquot of each sample was made up to the appropriate 
volume with sodium acetate buffer (50mM, pH 5.8, 0.01% (w/v) sodium azide; 
55p,l o f sample diluted to 1 I O j l l I  with buffer, for cGMP assay and 10pi of 
sample diluted to 150pl with buffer for cAMP assay). Both cAMP and cGMP 
levels were measured using the acetylation method of Harper and Brooker 
(1975). The assay involves the competition between the unlabelled cyclic 
nucleotides and a fixed quantity of radioactively (125I)-labelled cAMP or cGMP 
for a limited number of binding sites on a cGMP specific antibody and a 
method to separate the antibody-bound from the unbound material. Unlabelled 
antigens, in this case cAMP or cGMP from samples or standards, together with 
a fixed amount of radioactively-labelled cyclic nucleotides are allowed to react 
with a constant amount of primary antibody raised to the appropriate cyclic 
nucleotide. An inverse relationship therefore exists between the amount of 
bound radioactivity and the amount of cAMP or cGMP present in the sample,
i.e. the higher the levels of cyclic nucleotide in the sample the smaller the 
degree of radioactively-labelled cyclic nucleotide binding to the primary 
antibody. The antibody-bound cAMP or cGMP is then reacted with the SPA 
reagent, which contains anti-rabbit second antibody bound to fluomicrospheres. 
Any radioactively-labelled cyclic nucleotide bound to the primary rabbit 
antibody will therefore be immobilized on the fluomicrosphere, which then 
produces light which can be measured using a scintillation counter. The 
acetylation method was used since it markedly increased the sensitivity o f the 
assay by increasing the affinity of the cyclic nucleotide for its antibody. The 
samples were acetylated at room temperature by adding lOpl of the acetylating 
reagent; a mixture of acetic anhydride and triethylamine (1:2, v/v), directly into 
the solution, and vortexed immediately. Either guanosine 3', 5'-cyclic 
phosphoric acid 2'-0-succinyl-3-[125I] iodotyrosine methyl ester or adenosine
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3', 5'-cyclic phosphoric acid 2'-0-succinyl-3-[125I] iodotyrosine methyl ester 
was then added (50pi), as the tracer, to each sample. Subsequently, either the 
cAMP or cGMP antiserum (50 pi), followed by the SPA anti-rabbit second 
antibody (50pi) were added. The samples were mixed on an orbital shaker for 
15-20 hours at room temperature (15-30°C) at 200 rpm. The radioactivity 
bound to the fluomicrospheres was then determined using a P-scintillation 
counter (Fig. 7).
A standard curve was constructed for each assay (Figs. 8 & 9); this 
consisted of a duplicate sample of each of the following concentrations of 
cAMP (expressed as fmol):
2, 4, 8, 16, 32, 64, 128
or concentrations of cGMP (expressed as fmol):
8, 16, 32, 64, 128, 256, 512
The standards were assayed as described above. The standard curves 
were used to obtain the unknown cAMP or cGMP content present in each 
sample.
4) SOLUTIONS AND DRUGS
I) Physiological Salt Solution
Krebs' solution with the following composition (mM) was used 
throughout the investigation: NaCl, 118.4; NaHC03, 25.0; NaH2P 0 4, 1.13; 
KC1, 4.7; CaCl2, 2.7; MgCl2, 1.3; glucose 11.0; pH 7.4.
CP-free (0[Cl"]o) Krebs solution was made by replacement o f NaCl with 
sodium glucuronate, CaCl2 with calcium gluconate, KC1 with potassium 
gluconate (Saha et al, 1992) and MgCl2 with M gS04. It contained (mM) 
sodium glucuronate, 118.4; potassium gluconate, 4.7; calcium gluconate, 12.0, 
M gS04, 6.0; NaHC03, 25.0; NaH2P 0 4, 1.13; glucose, 11.0; pH 7.4. The 
concentration of divalent ions was raised to compensate for binding of Ca2+ by 
organic anions (Aickin & Brading, 1984) as described by Saha et al (1992).
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Light if L* bound
Ab +(L or L*) 'sT Ab or AbL'
F = fluomicrosphere with anti-rabbit second antibody
Ab = primary antibody
L* = labelled ligand
L = unlabelled ligand
Figure 7: Representation of the scintillation proximity assay (SPA). The 
assay is based on the competition between radioactively (125I) labelled (L*) and 
unlabelled cyclic nucleotide (L; cAMP or cGMP) for a limited number of 
binding sites on a cyclic nucleotide-specific primary rabbit antibody. The 
antibody-bound cyclic nucleotide is reacted with the "SPA reagent" which 
contains anti-rabbit second antibody (Ab) bound to fluomicrospheres (F). Any 
labelled cyclic nucleotide bound to the primary rabbit antibody is immobilised 
on the fluomicrosphere, which then produces light. (Adapted from Amersham 
SPA handbook).
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Figure 8: Standard curve for the radioimmunoassay of cAMP. The 
concentration of cAMP (fmol/50pl) is plotted against the percentage bound for 
each standard (%B/B0). The concentration of cAMP is inversely proportional to 
%B/B0.
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Figure 9: Standard curve for the radioimmunoassay of cAMP. The 
concentration of cGMP (fmol/50pl) is plotted against the percentage bound for 
each standard (%B/B0). The concentration of cGMP is inversely proportional to 
%B/B0.
On occasion, nifedipine was added to the Krebs' perfusate to
reduce spontaneous or evoked movement of the muscle. The organic calcium 
entry blockers such as nifedipine have been shown to produce no significant 
effect on neuro-neuronal synaptic transmission (Smith & Furness, 1988; Smith 
et al, 1988; Wood, 1989) and neuro-muscular synaptic transmission enteric 
nerves of the guinea-pig small intestine (Bywater & Taylor, 1986).
Atropine and phentolamine (each lpM ) were always present except 
when stated otherwise.
II) Drugs
adenosine 5'-triphosphate disodium salt (ATP; Sigma), apamin (Sigma), 
L-arginine (L-arg; Sigma), atropine sulphate (Sigma), bovine haemoglobin 
(HbO; Sigma), BRL 38227, [(-)-6-cyano-3,4-dihydro-2,2-dimethyl-frvms-4-(2- 
oxo-l-pyrrolidyl)-2H-l-benzo-pyran-3-ol (lemakalim; kindly donated by Smith 
Kline Beecham), 8-bromoguanosine 3', 5' cyclic monophosphate (sodium salt) 
(8-Br-cGMP; Sigma), calcium gluconate (Sigma), R(+)-IAA-94, [(6,7- 
dichloro-2-cyclopentyl-2,3-dihydro-2-methyl-l-oxo-lH-inden-5-yl)-oxy] 
(Semat), cyclic AMP scintillation proximity assay radioimmunoassay kit 
(Amersham), cyclic GMP scintillation proximity assay radioimmunoassay kit 
(Amersham), (2,2'-di-p-nitrophenyl-5,5'-diphenyl-3,3'-[3,3'-dimethoxy-4,4'- 
diphenylene] ditetrazolium chloride (nitro blue tetrazolium; Sigma), 
glibenclamide (Semat), Histoclear (National Diagnostics), isosorbide dinitrate 
(IDN; Sigma), p-nicotinamide adenine dinucleotide phosphate diaphorase 
(p-NADPH; Sigma), N®-nitro-L-arginine methyl ester hydrochloride (L- 
NAME; Sigma), LY-83583, [6-(phenylamino)-5,8-quinolinedione] (Semat), 
phentolamine mesylate (Ciba-Geigy), phenylephrine hydrochloride (Sigma), 
pituitary adenylate cyclase activating polypeptide (PACAP; kindly donated by 
Dr. J. Morrison), potassium gluconate (Sigma), M&B 22948, [2-0- 
propoxyphenyl-8-azapurin-6-one] (May & Baker), nifedipine (Sigma), reactive
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blue 2 (procion blue; RB2; Sigma), sodium glucuronate (Sigma), sodium 
nitroprusside (SNP; BDH), suramin (kindly donated by Bayer A.G.), 
tetrodotoxin (TTX; Sigma), Triton X-100 (Sigma), vasoactive intestinal 
polypeptide (porcine; VIP, Sigma). Concentrations in the bath refer to the salts 
except TTX, apamin, VIP, PACAP and HbO, which are expressed as 
concentrations of the base.
With the following exceptions, stock solutions o f drugs were prepared in 
distilled water before dilution with Krebs' solution prior to use. The following 
were prepared as ImM stock solutions as indicated; R(+)-IAA-94 (50% 
ethanol), lemakalim (50% methanol), LY83583 (10% dimethyl sulphoxide), 
M&B 22948 (50% ethanol), nifedipine (50% methanol), before dilution with 
Krebs' solution prior to use. Oxyhaemoglobin was prepared by reduction of 
bovine haemoglobin as described previously (Martin et al, 1985 a,b).
5) ANALYSIS OF RESULTS
Where appropriate, results were expressed as mean ± S.E.M., of n (a 
number of) cells or preparations. Statistical analyses were performed by means 
of Student's t test for paired or unpaired data to test for significance between 
means. A t-value of P<0.05 was taken as being significant. A minimum of three 
tissues were used to investigate each drug or combination of drugs. 
Significance values, relative to control, are shown as asterisks, where P<0.05 is 
denoted by *, PO .Ol by ** and P<0.001 by ***. In figs. 55 & 56 significance 
between separate histograms, other than contol, where P<0.05 is denoted by #.
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RESULTS
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1) ELECTRICAL AND MECHANICAL
I) Resting Properties
Following pinning out in the organ bath the IAS, initially, exhibited no 
tone. However upon application of stretch (lg) and a 40 minute equilibration 
period, varying degrees of additional tone (l-3g) developed. This tone could be 
maintained for several hours without additional stretch or drugs. Prior to 
experimentation, phenylephrine (lpM ) was added to the bath; a contraction 
confirmed the presence of sphincteric muscle, as non-sphincteric tissue relaxes 
to a-adrenoceptor stimulation. Tone was dependent on the maintenance of a 
spontaneous action potential discharge - in the absence of tone action potentials 
were not obtained. The maintenance of tone was unaffected by muscarinic or a- 
adrenoceptor blockade, or tetrodotoxin (lpM ) confirming its myogenic origin.
Circular smooth muscle cells of the gpIAS had membrane potentials of - 
44.2±0.2 mV (n= 1119 cells from 117 preparations; Fig. 10). Electrically, they 
displayed either spontaneous oscillations in membrane potential and tone 
accompanied by a discharge of action potentials (maximum amplitude 60mV, 
1-2 Hz frequency; Fig. 11) or were relatively quiescent (e.g. see Fig. 13).
II) Response to Electrical Field Stimulation (EFS^
EFS (supramaximal voltage, 0.1ms, single stimulus (ss) or trains of 5 
stimuli at 5, 10, 20 or 40 Hz), inhibited spike discharge and evoked IJPs and 
relaxations (Fig. 12). IJP amplitude was not significantly affected by atropine 
and phentolamine (each lpM; Fig. 13). The ability to elicit them in the 
presence of both atropine and phentolamine indicated that the IJPs were 
mediated by NANC inhibitory nerves. Following a single stimulus, the IJPs 
peaked in 361±31 ms and lasted approximately Is (n=25 from 8 preparations). 
IJP amplitude increased with increasing frequency of stimulation 
(ss 19.7±l.lmV, n=165, 33 tissues; 5Hz 22.3±1.4mV, n=115, 23 tissues; 10 Hz 
27.5±1.2mV, n=145, 29 tissues; 20 Hz 29.6±1.3mV, n=151, 29 tissues; 40 Hz
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30.3±1.5mV, n=130, 26 tissues) and lasted between 1 and 2 seconds depending 
on the stimulation frequency (maximum duration at 5Hz). Following trains o f 
stimuli, IJPs were usually, but not invariably, followed by a rebound increase in 
action potential discharge, a common feature of NANC nerve-evoked IJPs in 
GI smooth muscle (Bennett et al, 1966 b; Ward et al, 1992 a). This rebound 
may be mediated by prostaglandins (Bumstock et al, 1975) or tachykinins 
(Zagorodynuk et al, 1993; Shuttleworth et al, 1993), although no evidence 
exists for this in the gpIAS. Responses to EFS were abolished by TTX (lpM ; 
Fig. 14).
On occasion, the Ca2+ channel antagonist nifedipine (lpM ) was used to 
ease impalement of cells by abolishing tone and spikes. The drug did not affect 
IJP amplitude (Fig. 15).
I ll)  Response to EFS in the Presence of L-NAME
NO is a widely distributed inhibitory transmitter within the GI tract 
(Sanders & Ward, 1992; Sanders e ta l, 1992; Rand, 1992; Stark & Szurszewski, 
1992). The effect of the NOS inhibitor L-NAME (lOOpM) was examined. 
L-NAME failed to affect resting membrane potential, as found by He & Goyal 
(1993) and Bywater et al (1993) in the guinea-pig ileum, or to significantly 
change the IJP response to EFS (supramaximal voltage, 0.1ms, single stimulus 
and trains o f 5 stimuli at 10 & 20 Hz; n=10 from 5 preparations, P>0.05; 
Fig. 16). These results apparently failed to implicate NO in the electrical 
response to EFS. However, L-NAME in the presence of high tone (~3-4g), 
significantly reduced relaxations to EFS (Fig. 17). This result confirmed the 
findings of Craig and Muir (1991) which implicated NO in neuronally- 
mediated relaxations in this tissue.
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A t r o p i n e  ( 1  p M )
+  P h e n t o l a m i n e  ( 1  p M )
I
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Figure 13: Failure of atropine and phentolamine (each lpM ) to 
significantly affect either the resting membrane potential or the intracellular 
electrical responses of the gpIAS to EFS (supramaximal voltage, 0.1ms, single 
stimulus (ss) and 5 stimuli at 5, 10, 20 and 40Hz) in the presence of nifedipine 
(IpM ). Records were obtained from approximately adjacent cells.
Tetrodotoxin(1 ^M)
10mV
10s
-46m V / W # i
-35rnV .................................... .... .............................
1 8g
0 5g
10s
0 8 g
SS 10Hz 20Hz 40Hz 5Hz S S 10Hz 20Hz 40Hz 5Hz
Figure 14: Effect of tetrodotoxin (TTX; lpM ) on the intracellular 
electrical (upper trace in each panel) and simultaneously recorded mechanical 
responses of the gpIAS to EFS (supramaximal voltage, 0.1ms, single stimulus 
(ss) and 5 stimuli at 10, 20 and 40Hz). TTX depolarized the membrane, 
increased tone and abolished the nerve-mediated IJPs and relaxations at each 
frequency. Records were obtained from approximately adjacent cells.
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IV) Response to EFS in the Presence of Oxyhaemoglobin (HbO)
HbO (lOpM), a proposed scavenger of NO (Martin et al, 1985 a, b), also 
failed to significantly attenuate the responses, either electrical or mechanical, to 
EFS (Fig. 18)
V) Response to EFS in the Presence of K+ Channel Modulators
In the gpIAS, the responses produced by inhibitory NANC nerve 
stimulation are mediated by an increase in K+ conductance (Lim & Muir, 1985) 
and are abolished by the the non-specific K+ channel blocker, 
tetraethylammonium (Lim, 1985; Baird, 1990). In the present study, the effects 
o f lemakalim (50pM), a proposed KA1P channel opener (Weston & Edwards, 
1992), glibenclamide (lOpM), a KATP channel blocker (Buckingham et al, 1989) 
and the bee venom apamin, which blocks small conductance Ca2+-activated K+ 
channels (Banks et al, 1979; Shuba & Vladimirova, 1980) were examined to try 
define, more fully, the K+ channel involved.
Lemakalim (30-50pM) slowly hyperpolarized the membrane and 
reduced tone. IJP amplitude was reduced, but this was probably due to the 
membrane hyperpolarization rather than an effect on the IJPs per se. Upon
washout of the drug, the membrane potential and IJPs were restored (Fig. 19) ( a .
(^i)
Glibenclamide (10pM) had no effect on IJPs or relaxations (Fig. 20^ These 
results indicated that the KATP channels did not mediate the neuronally evoked 
hyperpolarization of the gpIAS.
Previous studies had shown that apamin blocked evoked IJPs (Lim, 
1985; Baird, 1990), however, in contrast, the present investigation 
demonstrated that apamin failed to abolish either the IJPs or relaxations in 
response to EFS. Possible reasons for this anomaly will be discussed later.
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VI) Response to EFS in the Presence of Apamin
Apamin (0.3pM) evoked a transient depolarization (Fig. 21) and 
significantly (P<0.001) reduced IJP amplitude, evoked by EFS (supramaximal 
voltage, 0.1ms, single stimuli, 5 stimuli at 5, 10, 20 and 40Hz), at all 
frequencies (Figs. 21 & 22). Following a single stimulus (0.1ms, supramaximal 
voltage) IJPs could be resolved into two components. A fast-to-peak 
(3 61 ±3 lms, n=25 cells from 8 preparations) IJP component, obtained in the 
absence of apamin was changed and a significantly (P 0 .001) slower-to-peak 
(530±17ms, n=16 cells from 4 preparations) component revealed (Fig. 23). 
Higher concentrations of apamin (lpM ), far in excess of that required to block 
Ca2+-activated K+ channels (Capoid & Ogden, 1989), failed to further 
significantly reduce the electrical and mechanical responses to EFS 
(supramaximal voltage, 0.1ms, single stimuli, 5 stimuli at 5, 10, 20 and 40Hz). 
This would apparently indicate that two inhibitory substances mediate the IJP 
in this tissue.
VII) The Apamin-Sensitive Component of the IJP
The mediator of the fast, apamin-sensitive component, of the IJP was 
investigated using two purinoceptor antagonists, suramin (Dunn & Blakeley, 
1988; Ohno et al, 1993; Hoyle et al, 1990) and reactive blue 2 (Kerr & Krantis, 
1979; Choo, 1980; Crema et al, 1983; Manzini et al 1986). The reason for this 
choice was the evidence for ATP involvement in the evoked IJP in this tissue 
shown previously (Lim & Muir, 1986). Suramin has been claimed to be an 
effective P2-purinoceptor antagonist in reducing IJP amplitude in the guinea-pig
taenia caeci (Den Hertog et al, 1989), although this has been disputed 
(McConalogue et al, 1994). Suramin (lOOpM) reduced the mean amplitude of 
the IJP significantly (P 0 .001) following EFS (supramaximal voltage, 0.1ms, 
single stimuli, 5 stimuli at 5, 10, 20 and 40Hz), at all frequencies (Figs. 24 & 
25). This smaller suramin-insensitive component bore a marked resemblance to
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Figure 22: Effect of apamin (0.3pM) on IJP amplitude (mV) in response 
to increasing stimulation frequency (Hz; single stimulus (ss) and 5 stimuli at 5, 
10, 20 and 40 Hz, supramaximal voltage, 0.1ms). Each bar represents the mean 
± S.E.M., n = 27 (minimum), from 10 different tissues (minimum). Apamin 
significantly (P0 .001) reduced the amplitude of the IJPs at all frequencies.
-47mV
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ss
Figure 23: Effect of apamin (0.3 pM) on time-to peak of two evoked 
IJPs, from approximately adjacent cells (~lmm), superimposed by coincidence 
of their stimulus artefacts, in response to a ss (supramaximal voltage, 0.1ms) 
from the same experiment. Apamin significantly (P<0.05) increased the IJP 
time-to-peak, but reduced IJP amplitude.
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the apamin-insensitive component, not only in amplitude, but also in its 
significantly slower time to peak; following a single stimulus (0.1ms, 
supramaximal voltage) the fast-to-peak (349±4ms, n=23 cells from 7 
preparations) IJP component, obtained in the absence of suramin was changed, 
and a significantly (PO.OOl) slower-to-peak (510±9ms, n=17 cells from 7 
preparations) IJP component revealed (Fig. 26). The accompanying mechanical 
activity usually became irregular in the presence of suramin.
Reactive blue 2 (lOOpM) also reduced the amplitude of the apamin- 
sensitive IJP component but hyperpolarized the membrane and lowered tone 
irreversibly. These effects could, themselves, have accounted for the reduction 
in IJP amplitude and could not, unequivocally, be related to the action o f the 
antagonist (Fig. 27).
Together, these results suggested that purinoceptors, probably P2y (Lim, 
1985; Bumstock & Kennedy, 1985; Kennedy, 1990), were involved in the fast 
apamin-sensitive component of the IJP. Support for this view came from 
experiments using ATP itself applied either by microsyringe injection (lmM - 
injection volume 3pi) or by hydrostatic pressure ejection (lOOpM). Because of 
the small volume of the drug applied to the tissue using pressure ejection, 
mechanical effects were restricted to a small number of muscle bundles which 
did not affect the overall tone of the tissue and therfore could not be monitored. 
ATP hyperpolarized the membrane and relaxed the gpIAS. The 
hyperpolarization was dose-dependent (Fig. 28). ATP (ImM), injected directly 
onto the tissue by microsyringe, resembled the fast apamin-sensitive IJPs in 
amplitude, time-to-peak, and time course (16.9±1.1 mV, n=23, from 5 
preparations; 1.7±0.2s, n=27, from 5 preparations and 5.3±0.4s, n=23 cells 
from 5 preparations respectively, (Fig. 29; see page 70-71 for control IJP 
values). These hyperpolarizations were also accompanied by relaxations. 
Significantly, the membrane hyperpolarization and relaxation produced by ATP
74
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Figure 25: Effect of suramin (lOOpM) on IJP amplitude (mV) in 
response to increasing stimulation frequency (Hz; supramaximal voltage, 
0.1ms, single stimulus (ss) and 5 stimuli at 5, 10, 20 and 40 Hz). Each bar 
represents the mean ± S.E.M., n = 9 (minimum), from 4 different tissues 
(minimum). Suramin significantly (P< 0.01) reduced the amplitude of the IJPs 
at all frequencies.
Suramin (100|iM) ----------- 1
Figure 26: Effect of suramin (lOOpM) on time-to-peak of two IJPs, 
from approximately adjacent cells (~lmm), superimposed by coincidence of 
their stimulus artefacts, in response to a ss from the same experiment, suramin 
increases the IJP time-to-peak but reduces IJP amplitude.
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were blocked by apamin (0.3pM), an effect noted previously in several other 
tissues (Maas & Den Hertog, 1979; MacKenzie & Bumstock, 1980; Shuba & 
Vladimirova, 1980; Vladimirova & Shuba, 1978; Fig. 30). However, attempts 
to desensitize the tissue, by superperfiising it with ATP (lOOpM) and L-NAME 
(lOOpM), failed to abolish the evoked IJPs (Fig. 31).
VIII) The Apamin-Insensitive IJP
The possibility that the slow apamin-insensitive, TTX (lpM)-sensitive 
(Fig. 32) IJP component, responsible for the major component o f relaxation 
(79.1 ± 4.5%, n=5 preparations), may be mediated by NO was then 
investigated. NO is produced from L-arginine by NOS (Palmer & Moncada, 
1989) by a stereospecific process inhibited by the L-arginine analogue, 
L-NAME (Hobbs & Gibson, 1990). For this reason, the evoked IJPs were 
examined in the presence of apamin and L-NAME. In contrast to its lack of 
effect on the fast IJP component, L-NAME abolished the slow apamin- 
insensitive component of the IJPs and relaxations to EFS (supramaximal 
voltage, 0.1ms, single stimuli, 5 stimuli at 10, 20 and 40Hz; Fig. 33).
The inhibitory effect of L-NAME was not mimicked by its stereoisomer 
D-NAME (Fig. 34) and was partially reversed by perfusion (30 minutes) with 
the NO precursor L-arginine (to 62.7 ± 7.1% of control, n=8 from 
3 preparations, single stimulus, supramaximal voltage, 0.1ms; Fig. 33).
Support for the involvement of NO in the slow component of the IJP 
came also from the inhibitory effect of HbO, a NO scavenger (Martin et al, 
1985 a, b). HbO (10pM), despite having no effect on the amplitude of the 
apamin-sensitive IJP component (Fig. 18), significantly (P 0 .001) reduced, 
reversibly, the amplitude of the slow IJP component at all frequencies (0.1ms, 
supramaximal voltage, single stimulus and trains of 5 stimuli at 5, 10, 20 and 
40 Hz; Fig. 35 & 36).
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Figure 34: Effect o f apamin (0.3 pM) alone, and in the presence of 
D-NAME or L-NAME (each lOOpM) on the intracellular electrical (upper trace 
in each panel) and simultaneously recorded mechanical responses of the gpIAS 
to EFS (supramaximal voltage, 0.1ms, single stimulus (ss) and 5 stimuli at 10, 
20 and 40 Hz). Apamin itself, transiently depolarized the membrane and 
reduced both the amplitude of the IJPs and tone. These effects were not 
significantly altered in the combined presence of apamin and D-NAME. 
Apamin and L-NAME together abolished IJPs and relaxations leaving only 
stimulus artefacts. Records were obtained from approximately adjacent cells.
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Figure 36: Effect of apamin (0.3 pM) alone and in combination with 
oxyhaemoglobin (HbO; lOpM) on IJP amplitude (mV) in response to 
increasing stimulation frequency (Hz; single stimulus (ss) and 5 stimuli at 5, 
10, 20 and 40 Hz, supramaximal voltage, 0.1ms). Each bar represents the mean 
± S.E.M., n= 26 (minimum), from 4 different tissues (minimum). Significance 
refers to comparisons between controls and apamin and between apamin alone 
and with HbO. Apamin itself significantly reduced IJP amplitude at all 
frequencies (P0 .001). This reduction was significantly (P 0 .001) enhanced by 
HbO at all frequencies.
These observations implicated NO in the slow, apamin-insensitive IJP 
component. If  this view was correct, the smaller, slower-to-peak IJP 
component, revealed by suramin, might also be mediated by NO and a 
combination of suramin and L-NAME should abolish IJPs and accompanying 
relaxations. This was indeed the case (Fig. 37). The inhibitory effect of 
L-NAME on the suramin-insensitive IJP component was reversed by 
L-arginine (lOOpM; Fig. 37). The effect o f L-NAME on IJPs and relaxations 
was not mimicked by its stereoisomer D-NAME (Fig. 38).
RB2 (lOOpM), when combined with L-NAME (lOOpM), failed to 
abolish the "RB2-insensitive" IJPs, indicating a difference between the 
mechanism of action of RB2 and that of suramin (Fig. 39).
The effect of HbO upon the suramin-insensitive component of the IJP 
was also examined. In the presence of suramin, HbO further reduced IJP 
amplitude (reversibly) at all frequencies studied (ss and trains of 5 stimuli at 5, 
10, 20 and 40 Hz, 0.1ms, supramaximal voltage; Fig. 40 & 41).
IX) Effects of Drugs Affecting Guanylyl Cyclase Activity
If  NO was involved in the IJPs and relaxations, then guanylyl cyclase 
modulators should affect IJPs and relaxations, as the effects of NO are 
mediated via this enzyme (Rapoport & Murad, 1983). The guanylyl cyclase 
inhibitor LY83583 (lOpM; Mulsch et al, 1988; Jin et al, 1993) reduced IJP 
amplitude and relaxations . in the presence (Fig. 43) 
of apamin (0.3pM). The cGMP phophodiesterase inhibitor M&B 22948 (MeB; 
30pM) and the membrane permeable cGMP analogue 8-bromo cGMP 
(8-Br-cGMP; lOOpM), each of which may have been expected to enhance NO 
activity, significantly hyperpolarized the membrane (from -43.4±0.9 mV, n=30 
from 3 preparations, to -61.9±1.0 mV, n=30 from 3 preparations, P 0 .0 0 1 , and 
from -49.9±1.1 mV, n=36 from 3 preparations, to -64.4±0.8 mV, n=23 cells 
from 3 preparations respectively, P<0.001) and relaxed the tissue as anticipated
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Figure 41: Effect of suramin (IOOjiM) alone and in combination with 
oxyhaemoglobin (HbO; IOjiM) on IJP amplitude (mV) in response to 
increasing stimulation frequency (Hz; single stimulus (ss) and 5 stimuli at 5, 
10, 20 and 40 Hz, supramaximal voltage, 0.1ms). Each bar represents the mean 
± S.E.M., n = 9 (minimum), from 4 different tissues (minimum). Significance 
refers to comparisons between controls and suramin, and between suramin 
alone and with HbO. Suramin alone significantly reduced IJP amplitude at all 
frequencies (P<0.01); this reduction was significantly (P<0.05) enhanced by 
HbO at all frequencies except 40Hz.
(Figs. 44 & 45). Neither drug increased the duration of the IJPs as has been 
proposed (Ward et al, 1992 c). These results suggested that apamin- and 
suramin-insensitive IJPs and relaxations to NANC nerve stimulation and the 
drugs which increase guanylyl cyclase activity were acting by a similar 
mechanism. Sodium nitroprusside (SNP; 50 pM), a NO donor (Bates et al, 
1991), also significantly hyperpolarized the membrane (from -43.4±0.9 mV, 
n=15 from 3 preparations to -66.4±1.6 mV, n=8 from 3 preparations, PO.OOl) 
and abolished tone. The effects were transient and declined in the presence of 
the drug; however, the NO-generating mechanism rather than NO itself may be 
responsible for this decline. During hyperpolarization IJP amplitude was also 
reduced but recovered upon restoration of the membrane potential (Fig. 46).
XJ Effects of VIP
Although a combination of L-NAME and, either apamin or suramin, 
abolished the evoked IJPs, suggesting the participation of only two mediators, 
the effects of VIP, proposed as an inhibitory transmitter in other gastrointestinal 
tissues (Goyal et al, 1980; Grider et al, 1983, 1992; He & Goyal, 1993; Grider 
1993; Makhlouf & Grider, 1993), were examined. Alone, VIP reversibly 
hyperpolarized the membrane and relaxed the gpIAS. The membrane potential, 
in the absence of VIP, was -48±1.0 mV (n=23 from 4 preparations) and in its 
presence (0.01-0.25 pM) was -67.9±2.7 mV (n=13 from 4 preparations, 
PO.OOl). The duration of the VIP-induced hyperpolarizations were prolonged 
compared with those produced by ATP and EFS. The response to VIP was not 
modified by either L-NAME (Fig. 47) or apamin (Fig. 48) suggesting that the 
hyperpolarizations and relaxations produced by VIP were not mediated by the 
release o f NO from enteric nerves as proposed (Grider et al 1992; Grider, 1993; 
Makhlouf & Grider, 1993; Murthy et al, 1994), or that VIP was the apamin- 
sensitive mediator.
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XI) Effects of [Cl~]0 Substitution
Elimination of [Cl"]0 (0[Cl“]o) with a mixture of sodium glucuronate, 
potassium gluconate and calcium gluconate hyperpolarized the membrane from 
-46.9±0.7 mV (n=28 from 5 preparations) to -60.0±1.1 mV (n=17 from 5 
preparations, P<0.001) and reduced both apamin-sensitive and -insensitive IJP 
amplitude and tone. These effects were reversible on washing (Figs. 49 & 50).
0[Cl"]o almost abolished the apamin (0.3pM)-insensitive IJPs and tone,
leaving only spontaneous depolarizations and contractions.
XII) Effects of the Chloride Channel Antagonist. IAA-94
In the presence of the chloride channel antagonist IAA-94 (30-50jaM; 
Landry et al, 1987, 1989), alone, the membrane potential increased from 
-42.7±1.1 mV (n=30 from 6 preparations) to -56.6=1=1.2 mV (n=20 from 6 
preparations, P<0.001) and the IJPs were reduced. These effects were reversible 
on washing (Fig. 51). IAA-94 reduced the amplitude of the suramin-insensitive 
IJPs, the effect being concentration-dependent. Washing partially restored 
suramin-insensitive IJP amplitude (Fig. 52).
2) HISTOLOGY
I) NADPH-Diaphorase Staining
Distinct, non-diffuse, blue stained areas could clearly be seen between 
the circular and longitudinal muscles of the gpIAS following NADPH- 
diaphorase staining, indicating the presence of NOS-containing elements, 
probably neurons, within the myenteric plexus (Fig. 53).
3) CYCLIC NUCLEOTIDE CONTENT
I) Effects of Electrical Field Stimulation
Both the cAMP and cGMP levels of the gpIAS were significantly 
(PO.OOl) raised from control values of 461.0±60.8 fmol/mg (n=8) to
78
O
[C
I']
0 
W
as
h >
E03
>
E■<rin
cn
NXo■m-
NXo
CM
N
Xo
N
Xin
co
CO
N
Xo^r
N
Xo
CM
N
XO
N
Xm
cn
C/5
N
XOTT
N
Xo
CM
N
Xo
N
Xin
coco
>
Eo COo
O)ino
C/3o F
ig
ur
e 
49
: 
Ef
fe
ct 
of 
Cl
" 
re
pl
ac
em
en
t 
(0
[C
1"
]0
) 
by 
sod
ium
 
gl
uc
ur
on
at
e,
 p
ota
ssi
um
 
gl
uc
on
ate
 
and
 
ca
lci
um
 
gl
uc
on
at
e,
 
on 
th
e 
in
tra
ce
llu
la
r 
el
ec
tri
ca
l 
(u
pp
er
 
tra
ce
 
in 
eac
h 
pa
ne
l) 
and
 
sim
ul
ta
ne
ou
sly
 
re
co
rd
ed
 
m
ec
ha
ni
ca
l 
re
sp
on
se
s 
of 
the
 
gp
IA
S 
to 
EF
S 
(s
up
ra
m
ax
im
al
 v
ol
ta
ge
, 
0.
1m
s, 
sin
gle
 
sti
m
ul
us
 
(ss
) 
and
 
5 
sti
m
ul
i 
at 
5, 
10
, 
20 
and
 
40
H
z)
. 
Th
e 
0[
C1
"]
0 
so
lu
tio
n 
hy
pe
rp
ol
ar
iz
ed
 
th
e 
m
em
br
an
e,
 r
ed
uc
ed
 
ton
e 
and
 
IJP
 
am
pl
itu
de
. 
Th
es
e 
ef
fe
cts
 
we
re 
re
ve
rse
d 
on 
w
as
hi
ng
. 
Re
co
rd
s 
we
re 
ob
tai
ne
d 
fro
m 
ap
pr
ox
im
at
el
y 
ad
ja
ce
nt
 c
el
ls.
A
pa
m
in
 
(0
.3
pM
) 
A
pa
m
in
 
(0
.3
jll
M
)
po
tas
siu
m 
gl
uc
on
ate
 
and
 
ca
lci
um
 
gl
uc
on
ate
 
on 
the
 
in
tra
ce
llu
la
r 
el
ec
tri
ca
l 
(u
pp
er
 
tra
ce
 
in 
eac
h 
pa
ne
l) 
and
 
sim
ul
ta
ne
ou
sly
 
re
co
rd
ed
 
m
ec
ha
ni
ca
l 
re
sp
on
se
s 
of 
the
 
gp
IA
S 
to 
EF
S 
(s
up
ra
m
ax
im
al
 v
ol
ta
ge
, 
0.
1m
s, 
sin
gle
 
sti
m
ul
us
 
(ss
) 
and
 
5 
sti
m
ul
i 
at 
5, 
10
, 
20 
and
 
40 
H
z)
. 
Ap
am
in
 
alo
ne
 
tra
ns
ien
tly
 
de
po
la
riz
ed
 
the
 
m
em
br
an
e 
and
 
in
cr
ea
se
d 
to
ne
. 
IJP
 
am
pl
itu
de
 
wa
s 
re
du
ce
d 
bu
t 
re
la
xa
tio
ns
 
are
 
un
af
fe
ct
ed
. 
Ap
am
in
 
and
 
the
 
0[
C1
"]
0 
so
lu
tio
n 
hy
pe
rp
ol
ar
iz
ed
 
the
 
m
em
br
an
e,
 
ab
ol
ish
ed
 
ton
e 
and
 
fu
rth
er
 
re
du
ce
d 
IJP
 
am
pl
itu
de
. 
Re
co
rd
s 
w
er
e 
ob
tai
ne
d 
fro
m 
the
 
sa
me
 
ce
ll.
CD
CO
>
E
C D■"O'
o
C D
'O-
CDI<<
>
E
C D
I D
N
Xo
_N
_Lo
C \J
N
• i
N
•  X
I D
•  C/5
N
Xo
N
XO
C\J
N
XO
N
X
ID
CD
CD
N
XO
N
Xo
CM
N
XO
N
•  X
I D
>
E
C D
I D
>
Eo CDO
Fi
gu
re
 
51
: 
Ef
fe
ct 
of 
IA
A-
94
 
(3
0p
M
) 
on 
the
 
in
tra
ce
llu
la
r 
el
ec
tri
ca
l 
(u
pp
er
 
tra
ce
 
in 
eac
h 
pa
ne
l) 
and
 
sim
ul
ta
ne
ou
sly
 
re
co
rd
ed
 
m
ec
ha
ni
ca
l 
re
sp
on
se
s 
of 
the
 
gp
IA
S 
to 
EF
S 
(s
up
ra
m
ax
im
al
 v
ol
ta
ge
, 
0.
1m
s, 
sin
gle
 
sti
m
ul
us
 (
ss)
 a
nd
 
5 
sti
m
ul
i 
at 
5, 
10
, 
20 
and
 
40 
Hz
) 
in
 
the
 
pr
es
en
ce
 
of 
ni
fe
di
pi
ne
 
(lp
M
). 
IA
A-
94
 
hy
pe
rp
ol
ar
iz
ed
 
the
 
m
em
br
an
e 
and
 
re
du
ce
d 
IJP
 
am
pl
itu
de
, 
ef
fe
cts
 
re
ve
rse
d 
on 
w
as
hi
ng
. 
Re
co
rd
s 
we
re 
ob
tai
ne
d 
fro
m 
ap
pr
ox
im
at
el
y 
ad
ja
ce
nt
 c
’el
ls.
Fi
gu
re
 
52
: 
Ef
fe
ct 
of 
su
ra
m
in
 
(lO
Op
M
) 
alo
ne
 
and
 
in 
the
 
pr
es
en
ce
 
of 
IA
A-
94
 
(5
0p
M
) 
on 
the
 
in
tra
ce
llu
la
r 
el
ec
tri
ca
l 
re
sp
on
se
s 
of
 
the
 
gp
IA
S 
to 
EF
S 
(s
up
ra
m
ax
im
al
 
vo
lta
ge
, 
0.
1m
s, 
sin
gle
 
sti
m
ul
us
 
(ss
) 
and
 
5 
sti
m
ul
i 
at 
5, 
10
, 
20 
and
 
40 
Hz
) 
in 
the
 
pr
es
en
ce
 
of
 
ni
fe
di
pi
ne
. 
Su
ra
m
in
 
alo
ne
 
re
du
ce
d 
the
 
am
pl
itu
de
 
of 
the
 
IJP
s. 
Su
ra
m
in 
wi
th 
IA
A-
94
 
hy
pe
rp
ol
ar
iz
ed
 
the
 
m
em
br
an
e 
and
 
fu
rth
er
 r
ed
uc
ed
 
IJP
 
am
pl
itu
de
, 
ef
fe
cts
 w
hic
h 
we
re 
pa
rti
all
y 
re
ve
rse
d 
up
on
 
w
as
hi
ng
. 
Re
co
rd
s 
we
re 
ob
tai
ne
d 
fro
m 
ap
pr
ox
im
at
el
y 
ad
ja
ce
nt
 c
el
ls.
Oh
u S j
T 3  ^  <D O rj C/3
S s  
|S
b£) £d> J3 *“■ 3 o  o ■c *-<Vh • *-H<D oH-I
O  T 3
S c3  80
13 —H c 2c3 _3 
bD-a
’& 3
c3 '5b <u c e  o
3W) bQ fi <U •- 32 £ w O
o -g
^  <uC/3 3 
S-H033
§■
•T31
ffi
O h
Q< 
z
Vho
in<N
w
3_o
'-t—>O<uc/3
<DC/3S-h<d>C/3
In
H
m<n
0)
3
3
0X1
la
ye
rs
, 
wi
th 
the
 
m
ye
nt
er
ic
 
pl
ex
us
 
(M
P)
. 
Th
e 
he
av
ily
 
sta
in
ed
 
ar
ea
s 
w
ith
in
 
th
e 
m
ye
nt
er
ic
 
pl
ex
us
 
are
 
ni
tri
c 
ox
id
e 
sy
nt
ha
se
 
co
nt
ai
ni
ng
 
ne
ur
on
s.
1078.0±64.6 finol/mg (n=14) and from 30.9±3.4 finol/mg (n=14) to 164.3+22.0 
finol/mg (n=12), respectively, in response to electrical field stimulation (~ 60 
pulses at 10Hz, supramaximal voltage, 0.1 ms) in the presence of atropine and 
phentolamine (each lpM). Nerve stimulation in the presence of apamin 
(0.5pM) *md suramin (lOOpM), which revealed smaller apamin- and suramin- 
insensitive IJPs, did not antagonize the electrically-evoked increases in either 
cyclic nucleotide, and, in fact, increased cGMP levels significantly (P<0.05) 
above that produced by nerve stimulation alone in the case of suramin (Figs. 54 
& 56).
The electrically-evoked increases in both cAMP and cGMP levels were 
abolished by a combination of apamin (0.5pM) plus L-NAME (lOOpM), 
suramin (lOOpM) plus L-NAME (lOOpM) and L-NAME (lOOpM) alone (Figs. 
54 & 56).
II) Effects of Exogenous Drugs
SNP (lOpM), which releases NO, was the only drug that significantly 
increased both cAMP and cGMP levels from control values of 461.0±60.8 
finol/mg (n=8) to 819.2±47.9 fmol/mg (n=12; P<0.01) and from 30.9+3.4 
finol/mg (n=14) to 154.3+23.8 fmol/mg (n=8; PO.OOl) respectively. ATP 
(lOpM), VIP (0.5pM) and VIP+L-NAME (lOOpM) also significantly (PO.05) 
elevated cAMP levels from a control of 461±60.8 fmol/mg (n=8) to 720.6±78.6 
fmol/mg (n=13), 705.8±53.2 finol/mg (n=10) and 1178.2+151.6 fmol/mg 
(n=l 1) respectively. These results indicate that it is only NO that mimics the 
effect of nerve stimulation by increasing the levels of both cyclic nucleotides 
(Figs 55 & 57). Interestingly, the combination of VIP+L-NAME significantly 
(PO.05) raised cAMP levels above those produced by VIP alone.
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Figure 54: Effect of nerve stimulation (N.S.; -60  pulses, supramaximal 
voltage, 0.1ms, 10Hz) alone and in the presence of apamin (AP; 0.5pM), 
apamin and L-NAME (lOOpM), suramin (SUR; lOOpM), suramin and L- 
NAME (lOOpM) and L-NAME alone (lOOpM) on cAMP levels (fmol/mg) in 
the gpIAS. Each bar represents the mean ± S.E.M., n = 8 tissues (minimum). 
Nerve stimulation alone, nerve stimulation plus apamin and nerve stimulation 
plus suramin significantly (PO.OOl) raised cAMP levels relative to control.
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Figure 55: Effect of SNP (10gM), VIP (0.5pM), VIP+L-NAME 
(lOOpM) and ATP (lOpM) on cAMP levels (finol/mg) in the gpIAS. Each bar 
represents the mean ± S.E.M., n = 11 tissues (minimum). All of the drugs 
produced a significant (PO .05) increase in cAMP levels relative to control. 
The increase produced by VIP+L-NAME was significantly (P<0.05) greater 
than that produced by VIP alone as denoted by #.
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Figure 56: Effect of nerve stimulation (N.S.; ~60 pulses, supramaximal 
voltage, 0.1ms, 10Hz) alone and in the presence of apamin (AP; 0.5pM), 
apamin and L-NAME (lOOpM), suramin (SUR; lOOpM), suramin and L- 
NAME (100/iM) and L-NAME alone (lOOpM) on cGMP levels (fmol/mg) in 
the gpIAS. Each bar represents the mean ± S.E.M., n=8 tissues (minimum). 
Nerve stimulation alone, nerve stimulation plus apamin and nerve stimulation 
plus suramin significantly (P<0.01) raised cGMP levels relative to control. The 
increase produced by nerve stimulation in the presence of suramin was 
significantly (P<0.05) greater than that produced by nerve stimulation alone as 
denoted by #.
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Figure 57: Effect of SNP (10pM), VIP (0.5pM), VIP+L-NAME 
(lOOpM) and ATP (lOpM) on cGMP levels (fmol/mg) in the gpIAS. Each bar 
represents the mean ± S.E.M., n = 7 tissues (minimum). Only SNP significantly 
(PO.OOl) raised cGMP levels relative to control.
DISCUSSION
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Relaxation of the gpIAS was studied using two approaches; a) intracellular 
electrical, combined with simultaneous mechanical, recording and b) biochemical 
measurements.
The use of intracellular electrical and mechanical recording has proved a 
very valuable and powerful means of analysing relaxation in the gpIAS. Using this 
technique detailed analysis of the electrical responses from individual cells, 
representative of the entire smooth muscle preparation, together with the 
mechanical activity of the whole tissue, was made. The technique was also of great 
benefit as it allowed the prolonged analysis of membrane phenomena, essential for 
monitoring transmitter-mediated events, without damaging the cells. Furthermore, 
it is unlikely that the two separate components of relaxation, or their 
characteristics (see later), would have been discovered without the aid of 
intracellular electrical recording.
The well maintained tone (0.5-3g) of the gpIAS enabled the inhibitory 
NANC-mediated, electrical and mechanical effects of nerve stimulation to be 
easily seen. In this respect the tissue is rather unusual and compares favourably 
with other tissues such as the taenia caeci, where spontaneous tone is sporadic and 
often only lasts for short periods without drugs (Bennett & Rogers, 1967), and the 
BRP, where no tone exists in the absence of drugs (Gillespie, 1972; Creed et al, 
1975). The ability to maintain tone in the gpIAS is presumably influenced by Ca2+ 
influx during the action potential rather than diffusion of the ion into the muscle at 
rest (Ward et al, 1992 c), as both action potential discharge and tone were 
abolished by the Ca2+ channel antagonist nifedipine. The membrane potential 
which, under resting conditions was -44.2±0.2mV (n=l 119 cells), very similar to 
that previously reported (Lim & Muir, 1983, 1985, 1986), was also within the 
range where, in other GI smooth muscles (Ward et a!, 1992 c), Ca2+ channels are 
activated. Tone may also be influenced, to a small degree, by NO as L-NAME,
which inhibits NOS (Hobbs & Gibson, 1990), raised tone (0.35±0.2g, n=6 from 20 
tissues). On the other hand, it was my experience that cell impalement was easier 
when spontaneous activity was absent. This could be achieved by recording from
7
areas of low stretch tension where non-firing cells predominated.
Electrically-stimulated relaxation of the gpIAS was manifested electrically 
as NANC-mediated IJPs. These have long been utilised as a means of studying 
relaxation mechanisms and differ widely in duration and amplitude throughout the 
GI tract (see for example Ward et a!, 1992 c; He & Goyal, 1993; Zagorodnyuk & 
Maggi, 1994) and between GI and non-GI smooth muscles, such as the BRP and 
the RAc (Creed et a!, 1975; Byrne & Muir, 1984, 1985; Byrne et al, 1984). This is 
probably a reflection of different inhibitory processes among the tissues. Within 
the gpIAS, the NANC, TTX-sensitive IJPs were very large in comparison to those 
from other tissues, exceeding 40mV in response to a single pulse, significantly 
greater than that previously reported (Lim & Muir, 1985; Baird, 1990), possibly 
because of more advanced recording techniques. Pharmacological dissection and 
manipulation of the IJPs was made considerably easier by their large amplitude. 
As a result of this "dissection", using the bee venom apamin, two distinct IJP 
components indicated the involvement of at least two transmitters. This result 
extends previous investigations in this tissue (Lim & Muir, 1985; Baird, 1990) in 
which apamin abolished the IJPs. The high concentrations (0.1-5pM) of apamin 
used in the previous studies may have produced non-specific effects by blocking 
other channels besides small conductance Ca2+-activated K+ channels.
Previous studies proposed that ATP, or a related nucleotide, was involved 
as a mediator of the IJPs in this tissue as it could mimic them, both in amplitude 
and duration (Lim & Muir, 1986; present investigation) and in its ability to 
produce a K+ efflux (Lim & Muir, 1985). Nerve stimulation also increased the 
release of [3H] adenine nucleotides (Beattie et al, 1985). Importantly, the ATP-
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induced hyperpolarizations and relaxations were antagonized by apamin (0.3 pM), 
an effect noted in several other tissues (Vladimirova & Shuba, 1978, Maas & Den 
Hertog, 1979; Nelemans & Den Hertog, 1987 a) and a prerequisite for ATP's 
proposed transmitter role.
The evidence for purine involvement was further investigated using the P2- 
purinoceptor antagonists reactive blue 2 (RB2; Kerr & Krantis, 1979; Crema et al, 
1983; Manzini et al, 1986; Crist el al, 1992) and suramin (Dunn & Blakeley, 
1988; Den Hertog et al, 1989; Ohno et al, 1993; Soediono & Bumstock, 1994; 
Zagorodnyuk & Maggi, 1994). Their effectiveness differed markedly. RB2 
(procion blue) reduced IJP amplitude, but irreversibly hyperpolarized the 
membrane; this could have accounted for its inhibitoiy effect on the IJPs. Suramin 
on the other hand, despite reservations concerning its specificity (Hoyle et al, 
1990; McConalogue et al, 1995), was the more effective; membrane potential was 
unaffected and both NANC inhibitoiy responses and those of ATP were 
antagonized in parallel. Suramin, like apamin, also revealed an apparently distinct, 
slower-to-peak and smaller IJP (see later). Together these findings support and 
extend the evidence already presented (Lim & Muir, 1986) for the involvement of 
ATP in the neuronally-mediated IJPs of the gpIAS. However, one major 
discrepancy persists in this proposal; prolonged application of a desensitizing 
concentration of the drug failed to block the evoked IJPs. Similar results in other 
tissues has led to the rejection of ATP as a transmitter candidate (Ward et al, 1992
c). Clearly, either desensitization may have been incomplete, by the present 
procedure, or the substance released by NANC nerves may be a closely related 
analogue of ATP rather than the nucleotide itself.
The emergence of NO as a mediator of inhibitory transmission in several 
sphincteric tissues, such as the opossum lower oesophageal (Tottrup et al, 1991), 
canine ileocolonic (Ward et al, 1992 c), rat pyloric (Soediono & Bumstock, 1994)
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and human, rabbit and opossum internal anal (Burleigh, 1991, 1992; Tottrup et al, 
1992, 1993) and the gpIAS (Craig & Muir, 1991), suggested a high probability for 
NO involvement in the evoked IJPs of the gpIAS. Although initial investigations 
seemed to rule this out, with the IJPs unaffected by the NOS inhibitor, L-NAME, 
the identification of NO as the mediator of the apamin-insensitive IJP in the 
guinea-pig ileum (Lyster et al, 1992 a, b; Bywater et al, 1993; He & Goyal, 1993) 
was encouraging in this context. Subsequent experiments demonstrated that the 
apamin-insensitive IJPs were:-
a) evoked by narrow (0.1 ms) pulse widths, indicating their neuronal origin,
b) stereospecifically abolished by L-NAME, the NOS inhibitor,
c) inhibited by HbO, the NO scavenger, and
d) restored by L-arginine, the NO precursor.
Furthermore, histological studies demonstrated the presence of NOS- 
containing neuronal elements in the myenteric plexus of this tissue. These 
provided strong evidence in favour of neuronally-released NO as being the 
mediator of this IJP component.
Confirmation that the suramin-insensitive IJP component was also mediated 
by NO suggested that suramin and apamin each revealed what appeared to be 
identical NO-mediated IJP components and that the two drugs, although acting at 
different locations (receptor and channel respectively), produced essentially the 
same effect - antagonism of purinergically-mediated events. It is not obvious why 
apamin or suramin treatment was required to uncover the NO-mediated component 
of the IJP. It may be that during the IJP, conductance of the small Ca2+-activated 
K+ channels dominates other conductances, necessitating their blockade to enable 
the contribution of those other channels to be seen. It is equally unclear why L- 
NAME, which reduced NANC nerve-induced relaxations (Craig & Muir, 1991;
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present investigation), did not, in the absence of either apamin or suramin, 
significantly reduce the amplitude of the apamin- and suramin-sensitive IJPs.
In addition to TTX, evidence to support a neuronal source of NO came with 
the virtual elimination of the muscle as an alternative; L-NAME failed to affect 
VIP-induced relaxations. Thus, VIP-mediated NO generation from smooth muscle 
cells (see Makhlouf & Grider, 1993; Makhlouf, 1994) seemed unlikely.
The proposed combination of ATP and NO as mediators of inhibitory 
responses is not unique to this tissue or species. A similar combination, based on 
both electrical and mechanical observations, reportedly accounts for NANC nerve- 
mediated responses in the rabbit portal vein (Brizzolara et al, 1994), rat pyloric 
sphincter (Soedino & Bumstock, 1994), guinea-pig colon (Zagorodnyuk & Maggi, 
1994) and rabbit IAS (together with a “non-L-NNA, non-apamin-sensitive agent”) 
(Tottrup et a!, 1993). The fast apamin-sensitive IJP component revealed within the 
circular muscle of the guinea-pig ileum (Humphreys et al, 1991; Lyster et al, 1992 
a, b; Bywater et al, 1993; He & Goyal, 1993), stomach, small and large intestine 
(Vladimirova & Shuba, 1984) and human colonic muscle (Keef et al, 1993; 
Boeckxstaens et al, 1993) may also be ATP, therefore joining NO (the apamin- 
insensitive transmitter) as an inhibitoiy mediator in these tissues.
Are ATP and NO co-mediators released from the same nerves? Within the 
gpIAS several observations suggested that ATP and NO may indeed be released 
from the same nerves thus, a) both components were abolished by TTX, indicating 
their neuronal origin, b) the latencies of the two IJP components did not differ 
significantly and c) the IJPs could not be selectively evoked by varying stimulus 
parameters. Two recent studies have also investigated the possibility of co­
mediation in the guinea-pig colon (Zagorodnyuk & Maggi, 1994) and taenia caeci 
(Bywater et al, 1993) using the N-type voltage-dependent calcium channel blocker 
co-conotoxin GVIA (McCleskey et al, 1987). Like the gpIAS, these tissues also
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displayed distinct apamin-sensitive and -insensitive IJP components which, in the 
case of the guinea-pig colon, were also believed to be mediated by ATP and NO 
respectively, co-conotoxin GVIA blocked or reduced the apamin-sensitive 
component leaving the apamin-insensitive component unaffected in both tissues. 
This implied that different release mechanisms were utilised for each substance 
and that separate nerves may control the release of the apamin-insensitive 
mediator. The fact that the separate IJP components in the guinea-pig taenia caeci 
could be evoked selectively and appeared to have different latencies, the apamin- 
insensitive slow IJP being elicited at smaller (0.06 ms) pulse widths and having a 
latency in excess of 200 ms with the fast IJP predominating at larger (0.3 ms) 
pulse widths and having a significantly shorter latency of 144 ms (Bridgewater et 
al, 1994), further supported the proposal for differential release. Fundamental 
differences apparently exist between the taenia caeci and the IAS of the guinea-pig 
which merit further investigation.
Although the question of co-mediation remains to be fully resolved there is 
clear evidence that both substances are involved in the relaxation. The relative 
contribution of each mediator however, appears to be different; the ATP-mediated 
IJP, although some 50% larger in amplitude than the NO-mediated IJP, evokes 
only 20% of the mechanical response. In the light of this, the question arises as to 
the function of this purinergic component. Few studies have investigated possible 
ATP involvement in inhibitoiy co-transmission/co-mediation. In contrast, its role 
as an excitatoiy co-transmitter, in conjunction with noradrenaline, for example, in 
the rat tail artery (e.g. Sneddon & Bumstock, 1984; Muir & Wardle, 1988, 1989) 
and guinea-pig vas deferens (e.g. Sneddon & Westfall, 1984), has been well 
documented. Although not directly comparable, a distinct parallel exists between 
the inhibitory and excitatoiy actions in the gpIAS and the aforementioned tissues, 
in that ATP appeared to evoke the major component of the electrical events but
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appeared to play only an ancillary role in the mechanical response to nerve 
stimulation. In both cases ATP may act as a "primer" for the other transmitter, be it 
noradrenaline or NO, possibly acting via an additional or separate transduction 
mechanism as in the rabbit saphenous artery where, in addition to the 
phosphoinositide hydrolysis promoted by NA, ATP also stimulated 
phosphatidylcholine hydrolysis (Nally et al, 1992).
Although the nature of the mediators of the two IJP components had been 
determined the identity of the ions involved was still unclear. The IJPs in this 
tissue had been associated with an increased K+ conductance (Lim & Muir, 1985). 
The IJP component abolished by apamin implied its mediation by KT ions, as 
apamin blocks small conductance Ca2+-activated K+ channels (Banks et al, 1979; 
Capoid & Ogden, 1989). ATP-activated K+ channels (KATP) were unlikely to also 
be involved in the IJPs as the hyperpolarization and relaxation produced by the 
Katp channel opener, lemakalim, was slow in onset and recovery and unaffected by 
apamin (Baird, 1990), unlike the evoked IJPs. Glibenclamide, the KATP channel 
antagonist, failed to affect IJPs or relaxations.
Although the role of K+ in the apamin-insensitive IJP component remained 
undetermined, evidence suggested possible Cl' involvement. For example, the 
relationship between membrane potential and [K+]0 in the gpIAS was not linear 
(Lim, 1985) and NO, the mediator of the apamin-insensitive IJP component, 
hyperpolarizes several tissues, such as arterial smooth muscle (Kreye et al, 1977), 
BRP (Byrne & Muir, 1985), opossum lower oesophageal sphincter (Saha & Goyal, 
1992) and oesphageal circular muscle (Crist et al, 1991 b), by decreasing resting 
Cl" conductance. Additionally, in the guinea-pig ileum, in which an apamin- 
sensitive and NO-mediated, apamin-insensitive IJP also exists (Lyster et al, 1992 
a, b; Bywater et al, 1993; He & Goyal, 1993), the latter was also the result of 
decreased Cl' conductance (Crist et a!, 1991 a).
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For an IJP to involve Cl" this ion must already contribute to the resting 
membrane potential (Holman, 1958; Kuriyama, 1963). As the chloride channel 
antagonist IAA-94 (Landry et al, 1987, 1989) produced a reversible
hyperpolarization and relaxation, chloride ions appeared to be involved in the 
gpIAS. On the other hand, the apparent ability of IAA-94 to block K+ channels as 
well as Cl" conductance (see later) casts doubt on the specificity of the drug. The 
results of experiments in which [Cl"]0 was substituted with glucuronate/gluconate 
raised further doubts regarding the role of chloride in maintaining resting 
membrane potential. This substitution also hyperpolarized the membrane. 
Normally it would have been expected to favour an increase in the driving force 
for the efflux of Cl', therefore initially depolarizing the cells (Aickin & Brading, 
1983), before subsequently decreasing the driving force, by reducing [Cl'Jj, 
following continued perfusion with 0[Cl"]o (Aickin & Brading, 1982, 1983, 1984), 
thereby hyperpolarizing the tissue. As only hyperpolarization was seen it 
suggested that Cl" was not involved in regulating membrane potential in contrast to 
the result with IAA-94. Together, these results are apparently contradictory but the 
lack of specificity of IAA-94 however, suggested that the Cl" substitution 
experiments may have been the more meaningful and that chloride ions were not 
involved in the resting membrane potential.
If a decreased Cl" conductance contributes to the NO-mediated IJPs then 
the amplitude of the IJP should initially increase with the increased driving force, 
resulting from [Cl"]0 depletion (Crist el al, 1991 a). No such increase was observed 
and 0[Cl"]o invariably reduced the amplitude of both the apamin-sensitive and - 
insensitive IJPs. In this context IAA-94 also reduced the amplitude of the suramin- 
insensitive IJPs although the ability of the drug per se to hyperpolarize the 
membrane complicates the significance of this finding. In addition to its effects on 
Cl" conductances, IAA-94 also reduced the amplitude of the K+-mediated apamin-
and suramin-sensitive component of the IJP indicating some degree of non­
selectivity of the drug. The reduction of IJP amplitude seen using either IAA-94 or 
0[Cl’]o is unlikely to have arisen from a decrease in transmitter release from nerve 
terminals as chloride conductance is not critically involved in pre-synaptic events, 
such as a-autoinhibition (Alberts et al, 1981).
Together, these results suggest that chloride ions are probably not involved 
in either maintaining the resting membrane potential or in the mediation of the 
apamin- or suramin-insensitive IJPs. In order to verify this latter proposal it would 
be necessary to demonstrate that this IJP component did not occur as a result of a 
decrease in membrane conductance, that it did not have a reversal potential similar 
to that of the chloride equilibrium potential (approximately -25mV) and that the 
reduction in IJP amplitude produced by chloride channel antagonists, like IAA-94, 
was not due to a membrane hyperpolarization.
These membrane changes associated with transmitter release are however, 
only one aspect of the inhibitoiy process. There is now little doubt that these 
membrane changes are triggered by the inhibitoiy transmitter signal via the 
participation of an intracellular transduction system, possibly the phosphoinositide 
system or, more commonly, the cyclic nucleotides (see Relaxant Transduction 
Mechanisms).
Within the gpIAS there was already evidence for cyclic nucleotide 
involvement in the inhibitory response to NANC nerve stimulation (Baird & Muir, 
1990). It was therefore important to determine whether, and to what degree, 
changes in cyclic nucleotide levels accompanied each of the two IJP components. 
Indirect observations, obtained by pharmacologically altering intracellular cGMP 
levels ([cGMPJj), i.e. using M&B 22948, the cGMP phosphodiesterase inhibitor, 
8-br-cGMP, the membrane-permeable cGMP analogue and the NO-donor SNP,
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each of which hyperpolarized and relaxed the gpIAS, suggested cyclic nucleotide 
involvement in relaxation.
Direct confirmation was obtained using a radioimmunoassay (R1A) binding 
technique (Steiner et al, 1972). This method is simple, highly specific for both 
cyclic nucleotides and allows absolute quantification of basal and stimulated 
cAMP and cGMP levels to be made. In contrast to other techniques, such as the 
incorporation of 32P into cellular proteins, where drug-induced responses, rather 
than cyclic nucleotide quantities, produced by analogues of the cyclic nucleotides 
are investigated, RIA allows the direct measurement of cAMP and cGMP levels 
following treatment. This technique confirmed that both cAMP and cGMP were 
involved in the NANC neuronally-mediated relaxation of the gpIAS; both cyclic 
nucleotide levels increased concomitantly with the point of maximum relaxation of 
the tissue.
During the present investigation it was notable that the quantities of cyclic 
nucleotides varied markedly in comparison to previous studies of sphincteric tissue 
where electrically- or pharmacologically-stimulated increases in the cyclic 
nucleotides have been described (Baird & Muir, 1990; Chakder & Rattan, 1993 b). 
With the possible exception of the study of Chakder & Rattan (1993 b), where 
cyclic nucleotide content was calculated as a function of protein content rather 
than wet tissue weight, it is unclear why such large discrepancies should exist as 
each study utilised the RIA technique, albeit with slight modifications among the 
studies. Direct comparison among the studies was made possible however, by 
measuring the stimulated percentage increase in cyclic nucleotide content relative 
to control.
Inhibitoiy NANC nerve stimulation increased [cGMPJj levels ([cGMP];) by 
~ 430%, more than one and half times greater than that previously reported for 
both the gpIAS (Baird & Muir, 1990) and opossum IAS (Chakder & Rattan, 1993
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b). Differences in techniques are, however, unlikely sources of this discrepancy as
/
changes in cAMP levels among the different studies were similar (see later). 
[cGMP], levels were further enhanced by apamin (see also Baird & Muir, 1990) 
and by suramin suggesting that the purinergic transduction process antagonized 
this additional electrically-stimulated cGMP rise, possibly by inhibiting the 
activity of guanylyl cyclase. Because of the inhibitory effect of L-NAME on 
nerve-stimulated [cGMP]j and the enhancing effect of SNP on basal [cGMP]i5 NO 
involvement was implied. Interestingly, neither ATP, in contrast to a previous 
study (Baird & Muir, 1990), nor VIP, stimulated [cGMP]r
In comparison to the effects on [cGMPJj, field stimulation raised 
intracellular cAMP levels ([cAMP],) by only -130%, almost identical to that 
witnessed both in the gpIAS (Baird & Muir, 1990) and opossum IAS (Chakder & 
Rattan, 1993 b). Significantly, this increase was abolished by L-NAME. Although 
this may have been a non-specific effect of L-NAME on adenylyl cyclase, no 
evidence exists for such a proposal, and it is therefore tempting to speculate that L- 
NAME blocked an electrically-induced rise in [cAMP]j mediated by neuronally- 
released NO. In support, SNP-released NO increased [cAMP],, an effect also seen 
in the opossum IAS (Chakder & Rattan, 1993 b), canine lower oesophageal 
sphincter (Barnette et a!, 1990) and in the non-sphincteric rat gastric fundus (Ito et 
a!, 1990). Furthermore, apamin, as well as suramin, which each antagonize the 
purinergically-mediated IJP, had no effect on the electrically-evoked rise in 
[cAMP]r The latter finding also contrasts with the earlier study of Baird & Muir 
(1990) in which apamin blocked the neuronally-stimulated increase in [cAMP]j. 
This, however, was probably due to a non-specific inhibitory effect caused by the 
very high apamin concentration (5pM) used in the earlier study.
How then does NO stimulate cAMP production? In the absence of direct 
NO stimulation of adenylyl cyclase, the [cAMP]j rise could have been due to the
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ability of guanylyl cyclase to catalyse the formation of both cGMP and cAMP 
(Mittal & Murad, 1977; Braughler et al, 1979; Gerzer et a!, 1981) and/or to 
cGMP-dependent inhibition of cAMP hydrolysis by type III PDE (a cAMP 
selective isozyme) (Harrison et al, 1986). Interestingly VIP, although unlikely to 
play any role in this tissue (Lim & Muir, 1986; present investigation), increased 
[cAMPJj, an effect enhanced by L-NAME, possibly by antagonizing a NO- 
mediated, negative feedback effect on adenylyl cyclase production.
The involvement of both cAMP and cGMP in the neuronally-mediated 
relaxation of the gpIAS and in the opossum IAS (Chakder & Rattan, 1993 b), 
contrasts with prior investigations in the opossum LOS (Torphy et al, 1986; 
Barnette et at, 1989) and in the canine IAS (Joslyn et al, 1990) where only cGMP 
levels were raised by nerve stimulation; apparently not all sphincters utilise the 
same second messenger systems.
In light of both the biochemical and electrophysiological findings of the 
present study, what can be deduced about the respective roles of the two putative 
mediators of relaxation in this tissue? The apamin-insensitive component, which is 
probably mediated by NO, or a related substance, was responsible for the major 
component of relaxation (-80%) and appeared to be the main instigator of both 
cGMP and cAMP production. As the IJP is dependent on the generation of cGMP 
and/or cAMP it may explain why it is significantly slower to peak than the 
apamin-sensitive IJP. On the other hand, purinergic block, using apamin or 
suramin, failed to significantly reduce the nerve-evoked rise in either cyclic 
nucleotide and L-NAME had no effect on the apamin-sensitive IJP but 
antagonized the elevation of both [cAMP], and [cGMPJj. This suggested that the 
apamin-sensitive purinergic inhibitory component, responsible for the large 
electrically-evoked IJP component, appeared to mediate its effects by mechanisms 
other than via the cyclic nucleotides. The question arises then as to the identity of
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the transduction mechanism for ATP. The majority of evidence suggests that 
stimulation of P2y-purinoceptors, which mediate relaxation in the gpIAS (Lim, 
1985), is linked to increased phosphoinositide turnover (see inter alia Pirotton et 
al, 1987; Berrie et al, 1989; Boyer et al, 1989; Cooper et al, 1989; Van der 
Merwe, 1989; Harden et al, 1990; Flitz et al, 1994). However, if this is so in the 
gpIAS, the ability of exogenous ATP to significantly increase [cAMPJj levels 
remains unexplained. One possibility is that ATP is able to activate two second 
messenger systems as in the rabbit saphenous artery (Nally et al, 1992). In the 
gpIAS a Ca2+-sensitive adenylyl cyclase (Mollner & Pfeuffer, 1988; Pfeuffer et al, 
1989; Feinstein et al, 1991) may be stimulated by increased [Ca2+];, via increased 
ATP-induced inositol phosphate metabolism, thereby producing a rise in [cAMPfy 
However, if this were the case then the increase should be antagonized by apamin 
or suramin. Perhaps the simplest explanation is, however, that the apamin-sensitive 
transmitter is not ATP but a closely related analogue which does not raise 
[cAMP]r
Whatever the mechanism involved in mediating the effects of the 
purinergically-mediated IJP component it is clear that it plays a role, albeit 
apparently minor, in the inhibitoiy response to field stimulation. The ability of 
ATP to maximally relax the gpIAS (present investigation) clearly demonstrates the 
propensity of this compound to be the apamin-sensitive inhibitory transmitter in 
this tissue.
Conclusions
It was the aim of this thesis to investigate and identify the transmitter 
processes underlying the neuronally-mediated relaxation of the gpIAS using 
electrical and mechanical recording and biochemical measurements. To this end, 
this study has revealed that the neuronally-mediated relaxation is initiated by the
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release of two substances, probably ATP and NO, which mediate two distinct 
components of relaxation involving increases in intracellular cyclic nucleotide 
levels.
ATP, or a closely-related analogue, is responsible for the large, fast apamin- 
and suramin-sensitive IJP component which mediates about 20% of the overall 
relaxation. It triggers relaxation by an as yet unidentified second messenger system 
which appears to increase the open probability of K+ channels probably via the 
release of [Ca2+]i5 thereby hyperpolarizing the membrane, reducing Ca2+ entry and 
eliciting relaxation.
NO mediates the smaller, slower-to-peak IJP component which accounts for 
the other 80% of the relaxation, in response to field stimulation. NO appears to 
decrease tone by activating cAMP- and cGMP-dependent intracellular cascade 
systems which in turn hyperpolarize the gpIAS. Chloride ions do not appear to be 
the ionic mediators of this IJP component.
Both mediators are released simultaneously by nerve stimulation, possibly 
from the same nerves. However the question of their co-transmission must await 
further investigation.
Relaxation of the gpIAS is a process that can be achieved by the activation 
of multiple pathways capable of acting synergistically to attain this end-point.
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Abbreviations
Ach Acetylcholine
ATP Adenosine triphosphate
8-br-cGMP 8-bromo-cyclic guanosine 3 ',5 '-monophosphate
[Ca2^ Intracellular free Ca2+
cGMP Cyclic guanosine 3', 5'-monophosphate
[cGMP]j Intracellular cyclic guanosine 3', 5'-monophosphate
DA Dopamine
DTZ Diltiazem
EDRF Endothelium-derived relaxing factor
EJP Excitatoiy junction potential
gpIAS Guinea-pig internal anal sphincter
GI Gastrointestinal
GTN Glyceryl trinitrate
HbO Oxyhaemoglobin
5-HT 5-Hydroxytryptamine
IAS Internal anal sphincter
IDN Isosorbide dinitrate
[K+]0 Extracellular potassium concentration
NANC Non-adrenergic, non-cholinergic
NO Nitric oxide
RDC Rabbit distal colon
RPV Rat portal vein
SNP Sodium nitroprusside
TTX Tetrodotoxin
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SUMMARY
158
1) The effect of the nitrovasodilators sodium nitroprusside (SNP), 
glyceryl trinitrate (GTN) and isosorbide dinitrate (IDN), which each release 
nitric oxide (NO), on the spontaneous extracellular electrical and mechanical 
activity of the guinea-pig and human internal anal sphincter and the 
intracellular electrical activity of the mouse vas deferens, has been investigated.
2) Under resting conditions, the guinea-pig internal anal sphincter 
(gpIAS), mounted in a Golenhofen apparatus, exhibited two distinct patterns of 
activity. One consisted of almost continuous spontaneous electrical spiking 
accompanied by rapid mechanical oscillations in tone. The other was also a 
continuous spike discharge upon which bursts of spikes were superimposed.
3) SNP, GTN and IDN each possessed stimulatory and inhibitory effects 
on the gpIAS. SNP was the most effective and was used as a model for this 
type of drug. At lower concentrations (10-8- 10-6 M) it reduced tone and 
decreased the frequency of the bursts of electrical and mechanical activity. It 
increased the maximum amplitude of contractions and, occasionally, of the 
electrical spikes. At higher concentrations (>106 M) SNP reduced or abolished 
all spontaneous activity.
4) The actions of SNP were mediated by NO as its effects were
a) mimicked by the membrane permeable cyclic guanosine 3', 5'- 
monophosphate (cGMP) analogue, 8-bromo-cGMP and b) inhibited by the 
nitric oxide scavenger oxyhaemoglobin (HbO). Significantly, the effects of
SNP were not mimicked by potassium ferrocyanide, which structurally 
resembles SNP, but does not release NO.
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5) Calcium (Ca2+) availability was a determinant of SNP' s effects; the 
Ca2+ channel antagonist, diltiazem (ICHM), abolished, whereas the Ca2+ 
channel agonist, BAY K 8644 (10_6M), enhanced, the stimulatory actions of the 
drug.
6) Membrane hyperpolarization, possibly due to potassium ion efflux, 
may have accounted for the effects of SNP. Raising extracellular potassium ion 
concentration ([K+]0) from 4.7mM to 14.1mM enhanced, whereas eliminating 
[K+]0 abolished, the stimulatory response to SNP. In addition, SNP and the 
potassium channel opener, lemakalim each, in subthreshold concentrations, had 
no effect on it, but together abolished spontaneous activity, indicating that a K+ 
efflux was involved in the responses to SNP.
7) Increased intracellular cGMP ([cGMP]j) levels may produce an influx 
of extracellular Ca2+ accounting for the initial stimulation by SNP. However, 
the Ca2+ influx may also increase the open probability of Ca2+ -activated K+ 
channels thereby hyperpolarizing the tissue and reducing tone. As the degree of 
membrane hyperpolarization increases with the increasing concentration of 
SNP, closure of voltage-dependent Ca2+ channels ensues, and both spontaneous 
electrical and mechanical activity declines and is eventually abolished.
8) The effects of SNP, added by pressure ejection, on the mouse vas 
deferens were examined using intracellular electrical recording. SNP produced 
two types of effects; an increase in the amplitude of the spontaneous excitatory 
junction potentials (EJPs) and a membrane hyperpolarization without any 
change in EJP amplitude.
160
9) The effect of SNP on the mechanical activity of the human internal 
anal sphincter was also examined. SNP relaxed the tissue but did not produce 
any stimulatory effect.
161
INTRODUCTION
162
The classical neurotransmitters, acetylcholine (Ach) and noradrenaline 
(NA), each produce excitatoiy and inhibitory effects in different smooth 
muscles. For example, Ach contracts most gastrointestinal (GI) smooth 
muscles but relaxes vascular tissues by stimulating endothelial cells to release 
endothelium-derived relaxing factor (EDRF; Furchgott & Zawadski, 1980). 
Similarly, NA activation of a ,-adrenoceptors in vascular smooth muscle raises 
tone but relaxes most GI smooth muscles (see Bulbring & Tomita, 1987). 
Knowledge of drug-receptor interactions enables one to understand these 
phenomena. It is clear that drugs can interact with different, specific receptors 
to produce, in some cases, opposite responses; in the case of vascular and GI 
smooth muscle this is usually because of differences in the signal transduction 
mechanisms among the receptors. Thus, a]-adrenoceptor activation, in the 
vasculature increases [Ca2+]j levels causing a contraction, but in the GI tract 
the reverse occurs, with a lowering of [Ca2+]j levels and a reduction in tone 
(Bulbring & Tomita, 1987).
The more recently discovered putative transmitters, dopamine (DA), 
5-hydoxytryptamine (5-HT), and adenosine triphosphate (ATP) are also each 
capable of producing apparently opposite effects. For example, DA stimulates 
or inhibits the activity of adenylyl cyclase by acting either on D, or D2 
receptors respectively (Kebabian & Colne, 1979). In the dog, 5-HT elicits both 
coronary vasodilatation and vasoconstriction via 5-HT,-like and 5-HT2 
receptors respectively (Cocks & Angus, 1983; Houston & Vanhouette, 1988; 
Toda & Okamura 1990). ATP wasoconstricts the mesenteric arteries of several 
species (Ishikawa, 1985; Kiigelgen & Starke, 1985; Muramatsu & Kigoshi, 
1987; Machalay el al, 1988; Muramatsu ef al, 1989) via P2x-purinoceptors, but 
also^a^bdilates the rabbit mesenteric artery and portal vein (Mathieson & 
Bumstock, 1985; Bumstock & Warland, 1987; Reilly et al, 1987) via 
P2y™PUrin0Cept°rS.
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The newly discovered transmitter nitric oxide (NO), or a closely related 
substance (Myers et al, 1987; Rubanyi et al, 1988; Vedernikov et al, 1992), 
mediates a large variety of biological processes such as intracellular 
communication in the central nervous system (Garthwaite, 1990), macrophage 
cytotoxicity (Hibbs et al, 1990) and, importantly in terms of this thesis, 
relaxation of vascular (Moncada et al, 1991) and non-vascular (Rand, 1992; 
Sanders & Ward, 1992; Sanders et al, 1992) smooth muscle. In its proposed 
transmitter role, the overwhelming majority of evidence suggests that the 
effects of NO are purely inhibitory (for reviews see Moncada el al, 1991; 
Sanders & Ward, 1992; Rand, 1992). NO however, may be unique among the 
proposed named transmitters. It is a highly labile gas, with a half-life as short 
as ~ 0.1s (Kelm & Schroder, 1990) making its conventional storage prior to 
release unlikely. Its receptor target, the cytosolic enzyme guanylyl cyclase 
(Arnold et al, 1977), is intracellularly located, in contrast to the extracellular 
membrane-bound receptors, with which the more "classical" neurotransmitters 
interact. NO may therefore not behave like other "conventional" transmitters 
and may not display such a spectrum of excitatory and inhibitory effects.
On the other hand, using nitrovasodilators, such as sodium 
nitroprusside (SNP) and glyceryl trinitrate (GTN), which release NO (see 
Kerwin & Heller, 1994), an increasing number of studies have revealed that 
NO has excitatory properties, particularly on spontaneously active smooth 
muscle. For example, nitrovasodilators, in particular SNP, increased the 
frequency and amplitude of spontaneous electrical and mechanical events in 
the rabbit distal colon (RDC; Smith, 1994) and stimulated the peristaltic reflex 
in isolated guinea-pig ileal segments in a cGMP-dependent manner (Sugisawa 
et al, 1991). In the latter case it was postulated that free [ C a 2+]j may have been 
decreased by SNP as a result of an elevation of intracellular cGMP (Greutter et 
al, 1981) which in turn would increase neuronal excitability by decreasing K+ 
efflux and depolarizing the membrane.
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The electrically-evoked, NANC-mediated contractions of rat ileal 
longitudinal muscle were antagonized by NO synthase inhibitors and restored 
by the NO precursor L-arginine. In addition, SNP also produced contractions 
of this tissue (Bartho et al, 1992). However, it was possible that these effects 
could have been caused by the secondary release of an excitatory transmitter. 
Such a secondary excitation response to NO was witnessed in oesophageal 
smooth muscle where NO, SNP and the membrane permeable cGMP 
analogue, 8-bromo-cGMP (8-br-cGMP), each evoked a concentration- 
dependent relaxation followed by a rebound contraction (Saha et al, 1993). 
The rebound contraction however, also involved products of the 
cyclooxygenase pathway, as was also the case in the canine and feline colon in 
response to NANC nerve stimulation (Ward et al, 1992; Venkova & Krier, 
1994).
Excitatory effects of NO are also seen in non-GI spontaneous smooth 
muscle. For example, in the rat portal vein (RPV), the frequency of 
spontaneous contractions and extracellularly-recorded discharges was 
increased by GTN (Bray et al, 1987; Wylie, 1988; Smith, 1994), SNP and 
isosorbide dinitrate (IDN; Smith, 1994) although the amplitude of both 
parameters was decreased.
Evidence for an excitatory role for NO clearly exists, although the 
underlying mechanisms appear to differ. These findings modify our concept of 
NO as simply an inhibitory transmitter and have possible significant clinical 
consequences for the use of nitrovasodilators. For example, would the increase 
in spontaneous activity seen in the rat portal vein in response to 
nitrovasodilators (Bray et al, 1987; Wylie, 1988; Smith, 1994) make these 
compounds any less effective for the treatment of hypertension? Would the 
excitatory effects of these compounds, acting directly or indirectly, on a 
variety of gut smooth muscles (Sugisawa et al, 1991; Bartho et al, 1992; Ward
165
et al, 1992; Saha et al, 1993) be significant in the treatment of conditions such
7
as achalasia? (
The existence of NO-mediated excitatory events led to my examination 
of its effects, using nitrovasodilators, on the extracellular electrical and 
mechanical responses of the spontaneously active guinea-pig internal anal 
sphincter (gpIAS) and human IAS, where the principal response to nerve 
stimulation is inhibitory (Burleigh & D'Mello 1983; Lim & Muir, 1985) and 
where NO has already been implicated as a putative inhibitory transmitter in 
these and other species (Burleigh, 1991; Craig & Muir, 1991; Chakder & 
Rattan, 1992, 1993 a, b; Rattan & Chakder, 1992). Possible neuronal 
mechanisms underlying the NO excitatory effects were investigated in the 
spontaneously active mouse vas deferens using intracellular electrical 
recording techniques.
AIMS
To date, the most frequently described effects of NO as a transmitter in 
smooth muscle have been inhibitory. However, examples of NO-induced 
excitation, although still relatively rare and poorly understood, are emerging 
more frequently. Such findings could have important pharmacological and 
clinical implications, particularly with regard to the therapeutic usefulness of 
the NO-donating nitrovasodilators which are often used clinically as relaxants. 
The ability of nitrovasodilators to stimulate contraction, either directly or 
indirectly, in a variety of GI smooth muscles, such as the ileum (Sugisawa et 
al, 1991) and colon (Ward et al, 1992), might affect their usefulness for the 
treatment of gut disorders such as achalasia and spasm of the IAS. 
Additionally, most, if not all, of the established transmitters, such as NA and 
Ach, have demonstr ated both excitatory and inhibitoiy properties. It is possible 
therefore that NO too has the, as yet largely undiscovered, ability to cause 
excitation as well as inhibition. In spite of the potential importance of such
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questions the phenomenon of possible NO-induced excitation has largely been 
ignored.
Due to this lack of knowledge and previous results regarding NO- 
associated excitatory phenomena produced within this laboratory (Wylie, 
1988; Smith, 1994), the effects and possible underlying mechanisms of 
nitrovasodilator action were examined on the spontaneously active smooth 
muscle, in vitro, of the gpIAS, the human IAS and the mouse vas deferens. 
Both intracellular and extracellular electrical and simultaneous mechanical 
recording techniques were employed for this purpose.
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METHODS AND MATERIALS
168
1) ANATOMY AND FUNCTION
I) G u in ea -P ig  In ternal A nal S p h in c ter
The anatomy and function of the guinea-pig internal anal sphincter 
(gpIAS) was as previously described (see C hapter 1-Methods and M aterials, 
p. 58-59).
II) H u m a n  In terna l A n a l Sp h in cter
The anal sphincteric region in man, like most mammalian species, 
consists of two sphincters, internal and external. The internal anal sphincter 
(IAS) is responsible for the involuntary retention of contents in the anal canal. 
To this end, it is nearly always in a contracted state, resulting in a very high 
intraluminal pressure (some 85% of the total pressure in the anal canal 
(Freckner & Von Euler, 1975)) relative to the rectum (Duthie & Bennett, 1963; 
Bennett & Duthie, 1964; Collins et al, 1967; Schuster, 1975).
The IAS is situated at the level of the dentate line where the circular 
muscle of the rectum becomes considerably thickened (5-8mm) to form the 
sphincter. The sphincter surrounds the upper three quarters (~30mm) of the 
anal canal and terminates below the level of the white line (vide infra) 
(Warwick & Williams, 1973).
The IAS receives its excitatory sympathetic innervation via the 
hypogastric nerves from the fifth lumbar segment and its parasympathetic 
supply via the first, second and third sacral segments, although the 
parasympathetic division appears to have very little influence on the tone or 
function of the sphincter (see Burleigh & D'Mello, 1983). The human IAS 
also possess an intrinsic inhibitory non-adrenergic, non-cholinergic (NANC) 
innervation thought to be mediated by NO (Burleigh, 1991, 1992; O'Kelly et 
al, 1994).
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I l l )  M o u s e  V as  D eferen s
The vas deferens (~3cm long) is responsible for the transport of 
spermatozoa and seminal fluid from the epididymus of the testis to the seminal 
vesicle duct near the prostate gland. It comprises three smooth muscle layers; 
an outer and inner longitudinal, which surround a circular layer. The smooth 
muscle cells are surrounded by connective tissue and overlap in an 
interweaving fashion (Merrillees, 1968).
The tissue receives, principally, an excitatory sympathetic innervation 
by the hypogastric nerves, which originate at the T9-T10 level of the spinal 
cord and run to the inferior mesenteric ganglion. The hypogastric nerves, 
containing mainly preganglionic sympathetic fibres, pass from the inferior 
mesenteric ganglion to a plexus of ganglia located within 1cm of the prostatic 
end of the vas deferens (Sjostrand, 1965; Bumstock, 1970). From this plexus, 
postganglionic, mainly non-myelinated sympathetic nerve fibres, run first to 
the prostatic and then towards the epididymal end, sending off radial branches 
into the muscle, which form preterminal axons from which transmitter is 
released. The preterminal axons are predominantly non-myelinated, 
surrounded by a Schwann cell sheath and beaded, due to the varicosities of 
nerve endings (see Taylor, 1987).
2) DISSECTION
I) G u in ea -P ig  In ternal A n al S p h in cter
The gpIAS was dissected as previously described (see C hapter 1- 
Methods & M aterials, p. 60) and placed into the Golenhofen apparatus 
(Golenhofen & Von Loh, 1970; see Apparatus and Techniques; Fig. 1) 
between the four platinum wire ring electrodes, perfused, using a pump 
(Gilson Minipuls 3; 4ml min"l), with oxygenated Krebs' solution (95% 0 2, 
5% C 0 2) maintained at 37±0.5°C. The gpIAS was attached by a thread to an 
isometric force displacement transducer (Grass FT03C) and a fixed anchor
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activity from the Golenhofen apparatus.
hook at the opposite end, to measure mechanical activity. It was initially 
placed under lg stretch and allowed to equilibrate for at least 40 minutes prior 
to experimentation. On most occasions during this time, the IAS' developed 
spontaneous additional tone (0.8±0.5g, n=14). Phenylephrine (lO-MO-3 M), 
injected onto the tissue within the Golenhofen apparatus, contracted the 
sphincter.
II)  H u m a n  In terna l A n a l S p h in cter
Five IAS tissues, from patients undergoing abdomino-perineal resection 
of the rectum and anal canal for low lying rectal carcinoma were available.
After removing fat, connective tissue and mucosa, strips of the anal 
sphincter (2cm long x 0.5cm wide) containing both longitudinal and circular 
muscle, with the circular muscle bundles running lengthways, were mounted 
in the Golenhofen as previously described for the gpIAS. Tissues were initially 
placed under lg stretch and allowed to equilibrate for at least one hour prior to 
experimentation. Two of the five IAS' developed spontaneous, active tone in 
addition to the stretch placed upon them (l.Og & 3.1 g respectively). One tissue 
failed to contract to phenylephrine (10-3M) and was discarded.
III)  M o u se  V as  D eferen s
Male adult Theiler's Original mice (20-35g) were killed by a blow to 
the head and exsanguinated. The abdominal cavity was opened by a midline 
incision and the testes pushed into the peritoneal cavity. The epididymal end 
of the vas deferens was tied and the surrounding connective tissue and fat 
carefully removed. The vas deferens was then cut at the prostatic end and 
transferred to a Sylgard-coated petri dish containing oxygenated Krebs' 
solution (95% 0 2, 5 % C 0 2) where any remaining fat and connective tissue 
were removed under a dissecting microscope. The tubular vas deferens was 
then transferred to a horizontal organ bath and pinned to the Sylgard-coated
base. It was continually superfused with oxygenated Krebs' solution, using a 
pump (Gilson Minipuls 3; 4ml min-1), at 37±0.5°C. The tissue was attached by 
a thread to an isometric force displacement transducer (Grass FT03C) to 
measure mechanical activity. The tissue was allowed to equilibrate for at least 
40 minutes prior to experimentation.
3) APPARATUS AND TECHNIQUES
I) Extracellular Electrical and Simultaneous Mechanical Recording.
Extracellular electrical and simultaneous mechanical activity was 
recorded from the gpIAS and human IAS, separately, using the Golenhofen 
apparatus (Golenhofen & Von Loh, 1970; Fig. 1). This equipment consists of 
four platinum wire ring electrodes (i.d. ~2.5mm) contained within a narrow, 
water jacketed (37±0.5°C) glass capillary (i.d. ~2.3mm). These electrodes 
could be used for either recording or stimulating, as required. Electrical signals 
were amplified (xlOOO, Neurolog A.C. preamplifier NL104) and filtered 
(Neurolog NL115, low frequency cut-off 10 Hz, high frequency cut-off 
10kHz). Mechanical activity was monitored using an isometric force- 
displacement transducer (GRASS FT03). Electrical and mechanical activity 
were displayed on a storage oscilloscope (Hitachi VC-6023) and recorded on 
an instrumentation tape recorder (Racal, Store 4DS ) and U.V. oscillograph 
(Thom EMI 6150-Mk II; Fig 2).
The Krebs' solution superfusing the tissue flowed through a heat 
exchange coil, jacketed with water (37±0.5°C), before entering the 
Golenhofen apparatus.
II) Intracellular Electrical Recording
The apparatus and techniques used for intracellular electrical recording 
from the mouse vas deferens were the same as those described previously (see 
Chapter 1-Methods and M aterials, p. 61) except that in the present study the
172
electrical signals were amplified by a unity gain high impedance (1010Q) D.C. 
preamplifier (W.P.I. M4A) and monitored on a digital voltmeter. The electrical 
and mechanical signals in this case were recorded on an instrumentation tape 
recorder (Racal, Store 4DS) and U.V. oscillograph (Thom EMI 6150-Mk II).
III)  C riteria For Cell Penetration
The criteria for accepting a cell for electrophysiological investigation 
were the same as those described previously (see C hapter 1-Methods and 
M aterials, p. 62).
IV )  Administration of Drugs
In the case of the Golenhofen apparatus drugs were added to 
oxygenated (95% 0 2, 5% C 0 2) Krebs' solution, which was pumped (Gilson 
Minipuls 3; 4ml min-1) through polythene tubing (i.d. 3mm) to the Golenhofen 
apparatus.
Each drug under investigation was allowed to superfuse the tissue until 
equilibration had been reached, usually between 7-15 minutes after addition. 
Electrical and mechanical activity was recorded prior to the drug reaching the 
tissue and for approximately 15 minutes thereafter. A representative example 
of tissue activity (~2 minute duration), after equilibration, was recorded on the 
U.V. oscillograph.
For intracellular recording, drugs were administered to the vas deferens 
by pressure injection using a Picospritzer (Picospritzer II, General Valve 
Corporation, N.J., U.S.A.). Using this technique the applied substances are 
less likely to cause desensitization of the entire tissue because of the small area 
over which the drug is added. However, for the same reason, no changes in 
tension are detectable. Drugs were applied from micropipettes which had their 
tips broken back to 2-20pM diameter. The pipette tip was placed to within
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~lm m  of the recording site before application of the drugs (20-30 psi). The 
duration of ejection is indicated in the text.
4) SOLUTIONS AND DRUGS
I) P h y s io log ica l  Sa lt  Solution
Krebs' solution with the following composition (mM) was used 
throughout the investigation: NaCl, 118.4; NaHC03, 25.0; NaH2P 0 4, 1.13; 
KC1, 4.7; CaCl2, 2.7; MgCl2, 1.3; glucose 11.0; pH 7.4.
When altering the [K+] of the Krebs' solution, the isotonicity of the 
solution was maintained by substituting KC1 with an equivalent amount of 
NaCl. Thus, the [K+]0-free Krebs' solution was of the following ionic 
composition (mM): NaCl, 123.1; NaHC03, 25.0; NaH2P 0 4, 1.13; CaCl2, 2.7; 
MgCl2, 1.3; glucose 11.0; pH 7.4.
The 14.1mM [K+]0-containing Krebs' solution was of the following 
ionic composition (mM): NaCl, 109.0; NaHC03, 25.0; NaH2P 0 4, 1.13; KC1, 
14.1; CaCl2, 2.7; MgCl2, 1.3; glucose 11.0; pH 7.4.
In the case of Ca2+-free solutions, no ionic substitution was made.
II)  D ru g s
BAY K 8644 (Bayer A.G.), bovine haemoglobin (HbO; Sigma), 8- 
bromoguanosine 3', 5'-cyclic monophosphate (sodium salt) (8-br-cGMP; 
Sigma), diltiazem hydrochloride (DTZ; Sigma), glyceryl trinitrate (GTN; 
kindly donated by Napp Laboratories), isosorbide dinitrate (IDN; Sigma), 
phenylephrine hydrochloride (Sigma), lemakalim (LMK; BRL 38227; kindly 
donated by Dr. W. Martin), potassium ferrocyanide (Hopkin and Williams), 
sodium nitroprusside (SNP; BDH), tetrodotoxin (TTX; Sigma).
With the exception of tetrodotoxin and haemoglobin, the concentrations 
in the text refer to those of the salts. With the following exceptions, stock 
solutions of drugs were prepared in distilled water before dilution with Krebs'
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solution prior to use. The following were initially prepared as 10_3M stock 
solutions as indicated before dilution with Krebs' solution; lemakalim (50% 
methanol), BAY K 8644 (70% ethanol). Oxyhaemoglobin was prepared by 
reduction of bovine haemoglobin as described previously (Martin et al, 1985 
a, b).
5) ANALYSIS
I) Guinea-pig Internal Anal Sphincter
Two distinct patterns of activity were evident in the gpIAS. One 
consisted of a continuous discharge of spikes of roughly comparable amplitude 
accompanied by small oscillations in tone. Under these conditions spike 
frequency (spikes/min.) and contraction frequency (contractions/min) were 
measured. The second pattern of activity was also a continuous spike 
discharge upon which was superimposed bursts of spikes. In these cases the 
frequency of the bursts (bursts/min) and changes in tone (contractions/min) 
were measured). In both situations results were expressed as mean±S.E.M. of 
n (a number of) tissues. Drugs modified the pattern and the degree of tone. 
Their effects were usually assessed visually since the increase in spike 
frequency frequently precluded measurement of individual spikes.
It) Human Internal Anal Sphincter
Two of the human IAS' exhibited spontaneous mechanical activity. The 
frequency of contractions, the degree of spontaneous tone and the extent of 
relaxation produced by SNP were expressed as mean±S.E.M. of n (a number 
of) tissues.
I ll)  Mouse Vas Deferens
Where appropriate, results, i.e. resting membrane potential and 
spontaneous EJP frequency and amplitude, were expressed as mean ± S.E.M.,
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of n (a number of) cells. Statistical analysis of the EJP amplitude and 
frequency was performed by means of Student's / test for paired data for 
significance between means. A t-value of P<0.05 was taken as being 
significant. A minimum of three tissues were used to investigate the effects of 
SNP.
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RESULTS
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1) GUINEA-PIG INTERNAL ANAL SPHINCTER
I) C h a ra c te r is t ic s  o f  S p on tan eou s  A c t iv i ty .
After equilibration, bursts of spontaneous electrical and mechanical 
activity were always seen. This activity was usually rapid (33.8±10.4 
contractions/min., n=39; maximum contraction strength 0.9±0.5g, n=39) with 
the electrical spiking almost continuous (430 ± 40.6 spikes/min., n=10; Fig. 3), 
or burst-like (15.8 ± 0.8 contractions/min) with bursts of spikes (17.1 ± 6.8 
bursts/min., n=6; e.g. Fig. 8) superimposed on the almost continual discharge.
Spontaneous electrical and mechanical activity was myogenic and Ca2+- 
dependent; it was unaffected by tetrodotoxin (5xlO_6M; Fig. 4) and abolished 
after removal of [Ca2+]0 from the perfusing Krebs' solution (n=3; Fig. 5).
II) E ffect  o f  T e m p e r a tu r e  and Stretch
Decreasing the temperature of the perfusing Krebs' solution from 
37.5°C to 26°C reversibly decreased the tone and the frequency of 
spontaneous electrical and mechanical activity (n=3; Fig. 6), probably by 
decreasing tissue metabolism, and therefore the activity of the ion pumps 
controlling spontaneous activity.
Increasing stretch on the gpIAS, by up to 6g, had no significant effect 
on spontaneous activity relative to control, but a tension-dependent reduction 
in the frequency of spontaneous activity and spike amplitude occurred between 
7g and 15g stretch (n=3; Fig. 7). The increased amount of stretch may have led 
to a form of depolarizing block which decreased, before it eventually 
abolished, spontaneous activity. On the other hand, stretching the tissue 
beyond a certain tension may have damaged the tissue and the close junctions 
between the cells reducing synchronised activity.
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III)  E ffects  o f  N itrovasod ila tors
The effects of the following nitrovasodilators on the spontaneous 
activity of the gpIAS were studied:
Sodium nitroprusside (SNP; 5xlO-8M-l(MM) Fig. 8
Glyceryl trinitrate (GTN; 10*6M-10-3M) Fig. 9
Isosorbide dinitrate (IDN; 10-5M-10'3M) Fig. 10
These nitrovasodilators, upon addition to the perfusing Krebs' solution, 
each produced a reversible, qualitatively similar, concentration-dependent 
alteration in the spontaneous electrical and mechanical activity of the gpIAS 
with a rank order of potency SNP > GTN > IDN. SNP (10-MCHM), GTN 
(10-6-lO 3M) and IDN (10_5-10-3M) each lowered tone and altered the pattern 
of continual discharge (minimum n=3), initially producing a more 
synchronised pattern of mechanical and electrical activity before abolishing, or 
reducing, both.
At lower concentrations, SNP (10-8-lO 6M), GTN (10-6-10-5M) and 
IDN (lOMCHM), after relaxing the gpIAS (by 77.4±13.6% from control, 
n=13, using 5xl0-7M SNP), increased the maximum amplitude of spontaneous 
contractions and, on occasion, spikes, as well as the number of spikes in each 
burst of activity. They also produced a more intermittent pattern of activity. At 
higher concentrations [SNP (>10 6M), GTN (>10'5M), IDN (MCHM)] the 
frequency and amplitude of both spikes and contractions were reduced or 
abolished.
IV ) E ffects  o f  S N P
The most potent nitrovasodilator, SNP, was chosen for further study.
As expected, SNP appeared to exert its effects via NO-dependent 
cGMP stimulation. Oxyhaemoglobin (HbO; 10 5M), which binds NO (Keilin
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& Hartree, 1937; Martin el al, 1985 a, b; 1986), antagonized the reduction in 
tone and the increase in the maximum amplitude of contractions and spikes 
produced by SNP (106M; n=4; Fig. 11). 8-br-cGMP (2xlO'5-3xlO-5M), the 
membrane-permeable cGMP analogue, which, by raising [cGMP]; levels, 
mimics the effects of NO stimulation of cytosolic guanylyl cyclase, also 
reproduced the excitatory (83.0±18.6%, n=3, increase in the maximum 
amplitude of contractions) and inhibitory effects of SNP (Fig. 12). Potassium 
ferrocyanide, a compound structurally similar to the nitroprusside molecule 
but devoid of NO (Fig. 13), failed to mimic the effects of SNP (n=3; Fig. 14), 
indicating that the effects of SNP on the gpIAS were not due to the 
ferrocyanide portion of the molecule and were likely to involve NO.
The question remained however, as to how SNP, via NO, exerted its 
effects on the gpIAS. That a hyperpolarization was responsible was 
investigated by varying the extracellular concentration of K+ ([K+]0). Raising 
[K+]0 from 4.7mM to 14. ImM, enhanced the amplitude of contractions and the 
number of spikes per burst of electrical activity produced by a concentration of 
SNP (5x1 O'7 -1(>6M) which, under control conditions ([K+]0 = 4.7mM), 
reduced tone and mechanical and electrical activity (n=4; Fig. 15). So by 
raising extracellular [K+]0, and, presumably, depolarizing the gpIAS, the 
inhibitory effects of SNP were antagonized. The "stimulatory" effect of 
increased [K+]0 was reversed by eliminating [K+]0 (n=4; Fig. 16). This 
presumably hyperpolarized the gpIAS and enhanced the inhibitory effects of 
the drug.
K+ involvement was further investigated using the ATP-dependent 
K+-channel opener, lemakalim (see Weston & Edwards, 1992). SNP and 
lemakalim each, in subthreshold concentrations (10-8M and 5xlO'8M 
respectively), had no significant effect on spontaneous activity but together 
abolished spontaneous activity (n=3; Fig. 17), indicating that K+ was involved 
in the response to SNP.
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Figure 15: The effect of raising [K+]0 in the absence and presence of 
sodium nitroprusside (SNP; 5xlO'7M) on the spontaneous electrical (upper 
traces) and mechanical activity of the gpIAS. In 4.7mM [K+]0 Krebs' solution, 
SNP (5xlO-7M) produced minimal excitatory effects on the gpIAS, increasing 
the amplitude of contractions but reducing tone (by 87%) and frequency of 
spontaneous activity relative to control (a). 14.1mM [K+]0 Krebs' solution, 
increased tone (by 33%) and the amplitude of contractions and spikes relative 
to control (a). SNP (5xlO_7M), in 14.1mM [K+]0 Krebs' solution, increased the 
amplitude of contractions but reduced tone (by 68%) and frequency of 
spontaneous activity relative to control (b) indicating that increasing [K+]0 
antagonized the inhibitory effects of SNP.

Figure 16: The effect o f eliminating [K+]0 in the absence and presence 
of sodium nitroprusside (SNP; 5xlO-7M) on the spontaneous electrical (upper 
traces) and mechanical activity of the gpIAS. In 4.7mM [K+]0 Krebs' solution, 
SNP (5xlO-7M) produced minimal excitatory effects on the gpIAS, increasing 
the amplitude of contractions but reducing tone (by 87%) and frequency of 
spontaneous activity relative to control (a). OmM [K+]0 Krebs' solution, reduces 
tone (by 83%) and the amplitude of contractions relative to control (a). SNP 
(5xlO_7M) in OmM [K+]0 Krebs' solution abolished spontaneous activity 
indicating that eliminating [K+]0 enhanced the inhibitory effects of SNP.

Figure 17: The effects o f sodium nitroprusside (SNP; 10_8M) alone and 
with lemakalim (5x1 (HM) on the spontaneous electrical (upper traces) and 
mechanical activity of the gpIAS. Neither (a) SNP (10_8M) nor (b) lemakalim 
(5xlO-8M) alone was effective, but (c) together they abolished spontaneous 
activity implying a synergistic action between the two compounds.
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[Ca2+]0 was also involved. The calcium channel antagonist diltiazem 
(DTZ; 10-4 M) reduced or abolished spontaneous activity in combination with 
SNP (5xlO'7M; n=3; Fig. 18). The calcium channel agonist BAY K 8644 
(10'6M), which increases the open probability of Ca2+ channels, enhanced the 
maximum amplitude of both contractions (by 215.7±163.2%, n=3) and spikes 
produced by SNP (5x1 O'7 -2x10-6 M; Fig. 19).
2) HUMAN INTERNAL ANAL SPHINCTER
I) Effects of SNP
Four of the five tissues responded electrically, with the firing of action 
potentials (maximum amplitude ~240pV), and mechanically, with a 
contraction, to phenylephrine (10-3 M; Fig 20 (b)). Two of the five tissues 
exhibited spontaneous tone (4.1g & 2.0g) and mechanical activity 
(8.8±0.8 contractions m iir1, n=2; Fig. 20). SNP (5x1 O'8 M) relaxed the two 
LAS' (by 69.3±3.2% , n=2, from control); no stimulatory effects were seen 
(Fig. 21).
3) MOUSE VAS DEFERENS
I) Resting Properties
The mean resting membrane potential of the longitudinal smooth muscle 
cells of the mouse vas deferens was -72.7±0.5mV (n=345 cells from 31 
preparations). Electrically they displayed spontaneous excitatoiy junction 
potentials (EJPs) with a frequency of 32.0±6.4 m ur1 (n=l 1 cells from 9 
preparations) and a mean amplitude of 7.0±0.6mV (n=13 cells from 10 
preparations). No spontaneous mechanical activity could be detected.
I ll Effects of SNP
SNP (10-3 M), applied by pressure ejection (20-30 p.s.i., 50-1000ms 
duration), produced two kinds of activity on the mouse vas deferens; a
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membrane hyperpolarization (4.9±0.2mV, n=13 cells from 10 preparations) 
with or without a significant increase in the amplitude or frequency of 
excitatory junction potentials, indicating a post-synaptic locus of action, and b) 
a significant (PO.OOl) increase in amplitude (by 377.0±9.6% above control, 
n=10 cells from 8 preparations) of spontaneous EJPs, indicating a pre-synaptic 
enhancement of transmitter release, sometimes accompanied by a membrane 
depolarization (Fig. 22). No contractions were measured during these 
depolarizations. Occasionally, in response to SNP, a hyperpolarization would 
precede the increase in spontaneous EJP amplitude indicating that both 
inhibitory and excitatory events could occur simultaneously (see Fig. 22 b).
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DISCUSSION
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In contrast to the vast majority of studies investigating the role of NO 
within smooth muscle, which substantiate its inhibitory role (see Rand, 1992; 
Sanders et al 1992, Sanders & Ward, 1992), this investigation demonstrates 
that nitrovasodilators, which release NO, also exert excitatory effects on 
gpIAS and mouse vas deferens smooth muscle.
1) GUINEA-PIG INTERNAL ANAL SPHINCTER
Under resting conditions the gpIAS exhibits a high degree of almost 
continuous myogenic spontaneous electrical and mechanical activity which is 
probably related to its physiological role as a regulator of rectoanal continence 
(Gowers, 1887; Denny-Brown & Robertson, 1935; Papasova, 1989).
The nitrovasodilators SNP, GTN and IDN each affected this resting 
activity. However, the potency of these drugs to effect changes in activity 
differed markedly; SNP was significantly more potent than the others, a 
similar finding to those in the rabbit distal colon (RDC) and rat portal vein 
(RPV; Smith, 1994). The biotransformation of SNP differs from that of the 
organic nitrates (Gryglewski et a!, 1992) in that it is probably activated 
intracellularly (Gryglewski et a!, 1992) whereas the organic nitrates IDN and 
GTN are effectively decomposed to release NO only when they come in 
contact with cysteine or N-acetylcysteine (Feelisch, 1991). Consequently, the 
chances of NO so released coming into contact with guanylyl cyclase are 
reduced, so making them less effective than SNP. Differences may also exist 
between the organic nitrates themselves as IDN is more potent than GTN in 
the RDC and vice versa in the RPV (Smith, 1994) and gpIAS (present 
investigation). The reason for this is unclear but may be related to their 
respective affinities for the metabolizing enzyme, possibly cytochrome P-450 
(Schroder, 1992), due to their different chemical structures (Tzeng & Fung, 
1992). As SNP was the most effective compound, it was used as a model for 
the actions of this type of drug in the present study.
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The release of NO (by SNP) and its subsequent stimulation of guanylyl 
cyclase, to increase intracellular ([cGMP]j) levels, appeared responsible for 
both aspects of activity; potassium ferrocyanide, which lacks NO, had no 
effect on the spontaneous activity of the gpIAS, while HbO inhibited SNP's 
activity and 8-br-cGMP mimicked both the stimulatory and inhibitory actions 
of the drug.
The question remains as to how the increase in NO-stimulated [cGMP]j 
mediates the effects of the nitrovasodilators seen here. The increase in this 
cyclic nucleotide may evoke a membrane hyperpolarization, although this 
cannot be measured using the Golenhofen apparatus. Nitrovasodilators 
hyperpolarize and relax a number of smooth muscles including rabbit 
pulmonary artery (Ito et al, 1978), rat tail artery (Cheung & MacKay, 1985) 
guinea pig uterine artery (Tare et al, 1990) and, importantly, the gpIAS (Baird 
& Muir, 1990; present investigation-see Chapter 1-Results, pp.76-77). This 
hyperpolarization was manifested as a decrease in tone and a resetting of the 
pacemaker activity, resulting in more synchronised, burst-like activity.
K+ replacement experiments and lemakalim, supported the proposal that 
a membrane hyperpolarization may be involved in mediating the actions of 
SNP; removal of [K+]0 and lemakalim each enhanced the inhibitory effects of 
the drug. Although not seen in tissues such as the RDC and RPV (Smith, 
1994), this may have been mediated by a K+ efflux, a well known mechanism 
of inducing smooth muscle hyperpolarization (e.g. guinea-pig taenia caeci - 
Bennett et al, 1963; jejenum -Hidaka & Kuriyama, 1969; gpIAS -Lim & Muir, 
1985). Cl" may also be involved in the hyperpolarizing response to SNP, as 
evidenced in the opossum LOS (Saha & Goyal, 1992), although experiments 
have not been carried to investigate this possibility in the gpIAS.
Ca2+ availability was necessary for maintaining both normal 
spontaneous tone and rhythm, and the stimulatory effects of SNP (Smith, 
1994; present investigation). Diltiazem (DTZ) which antagonizes, and BAY K
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8644 which opens, Ca2+ channels blocked and enhanced, respectively, the 
excitatory effects of SNP.
How does the interaction between K+ and Ca2+ fluxes contribute to the 
excitatory and inhibitory effects of SNP? In ganglia, dibutryl cGMP which, 
like SNP, increases [cGMP]j, produced a concentration-dependent, transient 
inward Ca2+ current (Nishimura et al, 1992). If so, then this may account for 
the enhancing effect of SNP in the gpIAS. On the other hand, one might expect 
that an inward, stimulatory flux of Ca2+ would increase, rather than decrease, 
tone as seen here. However, raised [cGMP]j levels cause a decrease in [Ca2+]j 
levels by increasing the binding, sequestration or efflux of the ion (Lincoln & 
Johnson, 1984) which may explain why tone decreased in response to SNP.
The proposed membrane hyperpolarization produced by SNP probably 
results from the opening of Ca2+-activated K+ channels due to the influx of 
Ca2+. As the degree of hyperpolarization, induced by higher concentrations of 
SNP increased, the open probability of voltage-dependent Ca2+ channels 
would decrease (Nelson et al, 1990), leaving the muscle increasingly unable to 
respond to this challenge until, eventually, all activity ceases.
2) HUMAN INTERNAL ANAL SPHINCTER
Two IAS' displayed spontaneous mechanical activity. In these tissues 
SNP produced a relaxation but did not reproduce the excitatory effects seen in 
the gpIAS. This may have been due to several reasons; a) the effects witnessed 
in the gpIAS may have been species-dependent; b) inappropriate 
concentrations of SNP may have been used to produce excitatory effects in the 
human IAS, although this is unlikely as the effects of a wide concentration 
range were examined in both tissues, or c) the tissues may have been unable to 
respond in such a way to the nitrovasodilator, possibly because the tissues 
were only available several hours into the operations, during which time they
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had undergone relatively severe mechanical stresses which may have affected 
their physical condition.
3) MOUSE VAS DEFERENS
Intracellular electrical analysis of the mouse vas deferens confirmed the 
post-synaptic hyperpolarizing effect of SNP, also proposed to occur in the 
gpIAS (present investigation). However, this study also demonstrated a pre- 
synaptically-mediated excitatory effect of the drug on spontaneous transmitter 
release.
Although not investigated, it is possible that the mechanism underlying 
the inhibitory hyperpolarizing response to SNP is similar to that proposed for 
the gpIAS, namely, a K+ efflux, possibly induced by an initial Ca2+ influx.
The stimulatory effect of SNP in the vas deferens, manifested as an 
increase in spontaneous EJP amplitude, indicated that the drug enhanced the 
release of an excitatory transmitter. How SNP produced this increase is 
unclear. It can be speculated however, that, as transmitter release is a Ca2+- 
dependent process, SNP enhances the neuronal Ca2+ influx. This could be 
achieved indirectly by raising intracellular cGMP levels, which in turn may 
transiently increase Ca2+ influx, as in parasympathetic ganglia (Nishimura et 
al, 1992), or, less likely, the nitroprusside molecule, by blocking pre-synaptic 
receptors, such as a 2-adrenoceptors, which regulate the release of transmitter 
(see Illes & Starke, 1983), could prevent negative feedback and thereby 
enhance transmitter release.
Such an enhancement of excitatory transmitter release may explain 
some excitatoiy effects of the drug in other tissues. Indeed, previous work in 
this laboratory has shown that the SNP-induced increase in frequency of both 
electrical and mechanical activity in the RPV was blocked by a combination of 
phentolamine and propranolol (Smith, 1994). Within the gpIAS, SNP, under
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certain circumstances may also enhance the release of a transmitter, such as 
noradrenaline, which is a known excitatory transmitter in this tissue.
Clearly, from these and other studies, the nitrovasodilators possess a 
spectrum of activity, with some drugs more effective than others depending on 
the tissue and species utilised. Nitrovasodilators are used clinically for their 
relaxant properties, as in the treatment of angina pectoris or achalasia. The 
excitation observed in tissues such as the gpIAS, mouse vas deferens (present 
investigation), RDC and RPV (Smith, 1994), in response to the 
nitrovasodilators, would clearly be an unwanted side effect in the treatment of 
conditions where relaxation is required and may therefore warrant a re­
assessment of the clinical usage of such drugs.
Further work is required to fully elucidate the mechanism of action 
involved in mediating the excitatoiy effects of these drugs within 
spontaneously active smooth muscle and to determine the possible 
consequences of these effects in disease therapy.
4) CONCLUSIONS
This part of my work was undertaken to further investigate possible 
excitatory effects of nitrovasodilators on spontaneously active smooth muscles 
first demonstrated in this laboratory by Wylie (1988), in the RPV, and Smith 
(1994) in the RDC and RPV. The results indicate that within the gpIAS and 
the mouse vas deferens the actions of these drugs were complex.
Although NO is regarded mainly as an inhibitory NANC transmitter 
within the majority of smooth muscles (see Rand, 1992; Sanders & Ward, 
1992; Sanders et al, 1992) the nitrovasodilators both enhanced and inhibited, 
spontaneous electrical and mechanical activity in certain smooth muscles. 
Inhibition in the gpIAS appeared as a reduction in tone and a decrease in the 
amplitude of both the contractions and accompanying electrical activity.
Within the mouse vas deferens it was manifested as a membrane 
hyperpolarization. Both effects were probably the result of a K+ efflux leading 
to reduction in [Ca2+]j levels.
Excitation in the gpIAS was manifested as an increase in both the 
maximum amplitude of spontaneous contractions and electrical spikes and 
within the mouse vas deferens as an increase in the amplitude of spontaneous 
EJPs. The reasons underlying the excitation are unclear but, in the gpIAS may 
be due to a NO/cGMP-induced influx of Ca2+ across the membrane. In the 
mouse vas deferens, the enhanced transmitter release may also be due to a 
transient Ca2+ influx into the nerves.
These results support previous findings of nitrovasodilator-induced 
excitation responses in this and other laboratories, i.e. in the RPV (Bray et al, 
1987), guinea-pig ileum (Sugisawa el a!, 1991) and rat ileum (Bartho et al, 
1992) suggesting that endogenous NO may, like most other neurotransmitters, 
possess both inhibitory and excitatoiy properties.
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